{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!pip install scipy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "fn_files = ['cf74','cf75','cf76','cf77', 'cf78', 'cf79']\n",
    "fn_queries = 'cfquery' "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'79001': \"'Rusters'.  The corrosive action of palmar sweat: I. Sodium chloride in sweat.CORROSION.  HYPERHIDROSIS.  METALLURGY.  OCCUPATIONAL-MEDICINE. SODIUM-CHLORIDE.  SWEAT: an.Sweat from 8 'rusters' and 8 control persons was examined for its sodium concentration. Sweating was induced by iontophoresis of pilocarpine on the distal forearm. In no case did the concentrations exceed the normal upper limit for this procedure, and no difference was found between the two groups. In this way the study failed to confirm earlier reports of elevated sodium chloride concentrations in sweat from 'rusters'. Proposals of a relationship between 'rusters' and patients with pancreatic cystic fibrosis were not substantiated. Hyperhidrosis of the palms and volar surfaces of the fingers was present in all 'rusters'. This seemed to be the main cause of the corrosive tendency, and patients referred for palmar hyperhidrosis were found to produce corrosion similar to the 'rusters'. Topical application of aluminium chloride hexahydrate in a 25% solution in absolute ethyl alcohol proved effective against both hyperhidrosis and the corrosive tendency.\",\n",
       " '79002': 'Inflammatory middle ear diseases in patients with cystic fibrosis.CYSTIC-FIBROSIS: co.  OTITIS-MEDIA: et.111 patients with cystic fibrosis (CF), aged 7 months to 29 years, were examined to detect inflammatory middle ear diseases. 35% had a history of one or more attacks of acute otitis media, an incidence at the same level as in non-CF patients. None had chronic suppurative otitis. Only 4 out of the 88 patients able to cooperate in audiometry had a hearing impairment. In 2, the hearing loss was perceptive, in 3 very mild, and in the fourth case, moderately severe. The middle ear pressure was measured in 108 patients, in 86 of whom it proved normal. In 15 patients the middle ear pressure was lower than--100 mmH2O, indicating tubal occlusion, and in 7 patients the impedance minimum was lacking, indicating an accumulation of mucus. These 7 patients (6%) had secretory otitis media. Nasal polyps were or had been present in 32%. There was no correlation between nasal polyps and tubal occlusion or secretory otitis. The incidence of inflammatory middle ear diseases in CF patients was in the same range as in non-CF patients, a finding at variance with some previous investigations showing middle ear pathology in 25--48%.',\n",
       " '79003': 'Precipitating antibodies against Escherichia coli, Bacteroides fragilis ss.  thetaiotaomicron and Pseudomonas aeruginosa in serum from normal persons and cystic fibrosis patients, determined by means of crossed immunoelectrophoresis.ANTIBODIES-BACTERIAL.  BACTEROIDES-FRAGILIS: im.  CYSTIC-FIBROSIS: im. ESCHERICHIA-COLI: im.  PSEUDOMONAS-AERUGINOSA: im.Serum from normal persons and from 133 cystic fibrosis patients was examined for precipitins against faecal bacteria (E. coli and B. fragilis) and against P. aeruginosa by means of crossed immunoelectrophoresis.  27% of the normal sera contained 1-2 precipitins against E. coli, 16% contained one precipitin against B. fragilis and 6% contained one precipitin against P. aeruginosa.  In sera from cystic fibrosis patients, there was a significantly increased prevalence of precipitins against E. coli (76%), B. fragilis (38%) and P. aeruginosa (63%), and the mean number of precipitins against each of these bacteria was 3 (range: 1-12), 1.4 (range: 1-4), and 16 (range: 1-60), respectively.  Increased numbers of precipitins against P. aeruginosa were correlated with chronic lung infection caused by this species and with poor prognosis, whereas such associations were not revealed as regards precipitins against the two other bacterial species.  Increased numbers of precipitins against E. coli and B. fragilis were significantly associated with increased numbers of precipitins against P. aeruginosa.  It is suggested that this association is due to immune reactions in the intestinal mucosa, resulting in increased absorption of antigens from the gut.',\n",
       " '79004': 'Exocrine pancreatic insufficiency, small intestinal dysfunction and protein intolerance.  A chance occurrence or a connection?.CELIAC-DISEASE: co.  CYSTIC-FIBROSIS: co.The coexistence of cystic fibrosis (CF) and coeliac disease (CD) is reported in eight children, the odds against this occurring in the same child being 1:2 million to 1:5.9 million.  In Sweden, it would be around 1:3 million (incidence of CF 1:3000 and of CD 1:1000). The coexistence of these two diseases is thought to be chance, although CF might predispose to the development of CD.  In a 10-year period (with 33405 live births), we observed three children with exocrine pancreatic insufficiency and small intestine dysfunction.',\n",
       " '79005': 'Increased intracranial pressure in infants with cystic fibrosis [letter].CYSTIC-FIBROSIS: pp.  INTRACRANIAL-PRESSURE.Although the mechanism proposed by Dr Katznelson for the increased intracranial pressure observed in three infants with cystic fibrosis cannot be discounted, another explanation is possible.  It has been reported previously that a deficiency of vitamin A may predispose to development of increased intracranial pressure and bulging fontanelles in cystic fibrosis.  Finally, it is somewhat difficult to understand how such marked airway obstruction which produced increased intracranial pressure could occur with preservation of arterial blood gases. - Vitamin A and carotene blood levels were not determined in our cases and therefore obviously this possibility cannot be excluded, at least in two of the cases.  Dr Taussig\\'s suggestion that the improvement in the intracranial pressure in our cases was really the result of the \"unknowing\" associated administration of vitamin A and not to the improvements in the pulmonary status, as I proposed, fails to note the clinical observation that there had been a \"rise and fall\" in the bulge of the fontanel concomitantly with the increase and decrease of respiratory obstruction signs.  As to the question of the severity of airway obstruction, the clinical reversible picture of severe tachypnea with poor air entry, clear lung fields on X-ray with overdistended lungs and small heart appear most suggestive of airway obstruction in C.F.',\n",
       " '79006': 'Precipitating antibodies against Haemophilus influenzae and Staphylococcus aureus in sputum and serum from patients with cystic fibrosis.ANTIBODIES-BACTERIAL: an.  CYSTIC-FIBROSIS: mi. HAEMOPHILUS-INFLUENZAE: im.  PRECIPITINS: an.  SPUTUM: mi. STAPHYLOCOCCUS-AUREUS: im.Serum and sputum sol phase from 23 patients with cystic fibrosis (CF) were examined for occurrence and titres of precipitins against Haemophilus influenzae and Staphylococcus aureus by means of crossed immunoelectrophoresis with intermediate gel. The patients had from four to nine H. influenzae precipitins in serum and in most cases fewer precipitins in sputum, but, on an average, there was no difference between the titres of the antibodies in serum and sputum. Most of the antibodies were cross-reactive with other species, notably those of the Haemophilus genus. S. aureus precipitins were generally found in higher numbers in serum than in sputum, but, on an average, the titre of the precipitins in sputum was higher than in serum. Three of the precipitins were detectable only in sputum and not in serum, and one of these is a S. aureus-specific precipitin. Most of the antibodies were cross-reactive with other species, and these antibodies were often present in sputum in much higher titres than in the corresponding sera. Antibodies against teichoic acid of the S. aureus cell wall could not be demonstrated in sputum, while they were present in 22 sera. The possible role of the local pulmonary humoral immune response in protective immunity and in the pathology of the lung disease in CF is discussed.',\n",
       " '79007': 'IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.CYSTIC-FIBROSIS: im.  IGA.  IGG.  PSEUDOMONAS-AERUGINOSA: im. SPUTUM: im.Eleven cystic fibrosis (CF) patients chronically infected in the lungs with mucoid Pseudomonas aeruginosa and presenting multiple precipitins in serum against this bacterium (CF + P) and 10 CF patients without P. aeruginosa infection (CF-P) had their serum and sputum sol phase specimens examined for antibodies of the IgA and IgG classes against surface antigens of P. aeruginosa by means of an indirect immunofluorescence technique. Both the IgA and IgG antibody titres demonstrated in serum and sputum of the CF + P patients were significantly higher than in those of the CF-P patients (p less than 0.01). The titre of IgA antibodies in the sputum was higher than in serum in 3 cases indicating local pulmonary production of specific IgA antibodies. The role of the demonstrated antibodies in the local pulmonary immune defense mechanisms and the possible patogenesis of the pulmonary tissue damage in CF patients is discussed.',\n",
       " '79008': 'Activated complement in the sputum from patients with cystic fibrosis.COMPLEMENT-ACTIVATION.  COMPLEMENT.  CYSTIC-FIBROSIS: im.  SPUTUM: im.14 cystic fibrosis (CF) patients chronically infected with mucoid P. aeruginosa and presenting multiple precipitins in serum against this bacterium (CF + P) and 13 CF patients without P. aeruginosa infection (CF-P) had their plasma and sputum sol phase examined for albumin, Clq. C3/C3c, C4 and C5 by means of electroimmunoassays. Their sputum sol phase was examined also for factor B by rocketimmunoelectrophoresis. C3c was demonstrated in the sputum sol phase but significantly more frequent (p less than 0.01) among the CF + P patients than among the CF-P patients. Factor B was also demonstrated in the sputum sol phase, but no significant difference in frequency could be demonstrated between the CF + P and the CF-P patients. None of the results indicated that a local pulmonary production of complement factors took place. Complement activation was significantly (p less than 0.01) associated with inflammation expressed as increased (formula: see text). The results show the importance of complement mediated inflammation in the pathogenesis of pulmonary tissue damage in patients with CF and support the concept of chronic P. aeruginosa lung infection as an immune complex disease in CF patients.',\n",
       " '79009': 'Autoantibodies in serum and sputum from patients with cystic fibrosis.AUTOANTIBODIES: an.  CYSTIC-FIBROSIS: im.  SPUTUM: im.Sera from 89 patients with cystic fibrosis (CF) and 88 control persons were examined for the occurrence of rheumatoid factors (RF) of the IgG, IgA and IgM classes by an indirect immunofluorescence method and by the latex fixation slide test. The prevalence of RF-IgG was significantly higher (88%) (p less than 0.0005) among the CF patients than among the control persons (7%), while no difference was found between the two groups with regard to RF of the IgA or IgM classes. Fifty-five of the CF patients had chronic Pseudomonas aeruginosa infection in their lungs and two or more precipitins against these bacteria in their sera determined by crossed immunoelectrophoresis. These CF patients did not differ from the 34 CF patients without chronic P. aeruginosa infection, neither with regard to prevalence nor titer of RFs, but there was a positive correlation between the number of P. aeruginosa precipitins in the 55 chronically infected CF patients and their titers of IgG-RF. Nineteen CF patients were examined also for RFs, antinuclear antibodies (ANA) and anti-DNA antibodies in their sputum sol phase and corresponding sera. RFs were demonstrated in the sputum sol phase from 6 of the patients by the latex fixation test, whereas their sera were negative in this test, possibly indicating a local production of RF. Positive reactions for ANA and anti-DNA antibodies were found in 7 and 10 of the sputa respectively, and in higher titers than in the corresponding sera, also suggesting a local production. Titers of autoantibodies in sputum were low and no difference was found between patients with chronic P. aeruginosa infection and patients without P. aeruginosa infection. The possible role of autoantibodies in the patogenesis of pulmonary tissue damage in CF patients is discussed.',\n",
       " '79010': 'Chronic obstructive lung disease.LUNG-DISEASES-OBSTRUCTIVE.This chapter deals with the problems of chronic obstructive lung disease in children by first considering an approach to the evaluation, diagnosis and management of various forms of chronic obstructive lung disease with emphasis on history, physical and laboratory data.  A brief overview of therapeutic principles that can be applied to most forms of chronic obstructive lung disease are included.  The second part of this chapter consists of reviews of some of the more common diseases producing chronic airway obstruction in infancy and childhood.  Patient evaluation topics discussed include history and physical examination and laboratory studies. Therapeutic principles in the management of chronic obstructive lung disease, pediatric precursors of chronic obstructive lung disease, and chronic obstructive lung disorders (asthma, cystic fibrosis, bronchopulmonary dysplasia, aspiration pneumonitis, atelectasis, bronchomalacia and tracheomalacia, immunodeficiency, bronchiectasis, chronic bronchitis, and chronic upper airway obstruction with hypoventilation) are examined.',\n",
       " '79011': 'Meconium in health and in disease.INFANT-NEWBORN-DISEASES: pa.  INTESTINAL-OBSTRUCTION: pa. MECONIUM: an.Meconium is the first gastrointestinal excretion normally expelled by the neonate.  This review discusses the composition of meconium: proteins, lipids, steroid and sterols, bile pigments and bile acids, glycoproteins, mineral composition, and enzymes.  The major complications relating to meconium are serious: they include aspiration pneumonia, which may prove fatal and is not related to cystic fibrosis, the \"meconium plug syndrome\" and meconium ileus. Screening for cystic fibrosis is also examined.',\n",
       " '79012': 'The effect of oral zinc supplementation on plasma levels of vitamin A and retinol-binding protein in cystic fibrosis.CYSTIC-FIBROSIS: me.  RETINOL-BINDING-PROTEINS: me.  VITAMIN-A: bl. ZINC: pd.Oral zinc supplementation with 100 mg zinc sulfate over an 8-week period in 36 patients with cystic fibrosis and 17 siblings did not affect the vitamin A transport system, as evidenced by an absence of consistent and significant quantitative changes in plasma levels of vitamin A, retinol-binding protein, and zinc, nor did the exogenous zinc appear to stimulate growth or exert any clinical benefit to the cystic fibrosis patients. The lack of response to zinc supplementation might be explained by the fact that the group of cystic fibrosis subjects studied was fairly healthy in regard to clinical status and certain blood parameters, including zinc.',\n",
       " '79013': 'The fecal microflora and bile acids in children with cystic fibrosis.ANTIBIOTICS: tu.  BILE-ACIDS-AND-SALTS: me.  CYSTIC-FIBROSIS: me, mi. FECES: an, mi.Fecal fat, bile acids, and the rectal microflora were studied in seven control children and in three groups of patients with cystic fibrosis (CF).  Seven were off antibiotics, ten on oral cloxacillin, and six on i.v. triple therapy (cloxacillin, gentamycin, and carbenicillin) for at least 2 weeks.  Controls had lower concentrations (milligrams per gram dry stool) of both fat (P < 0.005) and vile acids (P < 0.025) than CF children off antibiotics. Antibiotics had little or no effect on fat but led to a striking decrease (P < 0.01) of bile acids in the triple therapy group. Concomitantly, there was reduced deconjugation of bile acids (P < 0.01) and formation of secondary bile acids (P < 0.005).  This was associated with a 5-fold increase in the percentage of bile acids found in the aqueous phase of stools and with a marked reduction (P < 0.001) of the anaerobic flora (log counts per gram wet stool) in children on triple therapy (4.3 plus or minus 1.9) when compared to controls (9.8 plus or minus 0.1), CF off antibiotics (9.1 plus or minus 0.1) and CF on cloxacillin (9.6 plus or minus 0.2).  The close relationship between the anaerobic flora, the extent of bile acid microbial transformation, and fecal bile acid concentrations suggest that reduction of the anaerobic flora decreases adsorption of bile acids to dietary residues and microbes, favors bile acid absorption, and leads to a decreased fecal loss of bile acids in CF.',\n",
       " '79014': \"Serum glycine-conjugated bile acids in pediatric hepatobiliary disorders.BILE-ACIDS-AND-SALTS: bl.  CYSTIC-FIBROSIS: bl. INFANT-NEWBORN-DISEASES: bl.  INTESTINAL-DISEASES: bl. LIVER-DISEASES: bl.Measurements of serum bile acids (glycine conjugates of cholic, chenodeoxycholic, deoxycholic, and lithocholic acids) by radioimmunoassay in a variety of pediatric hepatobiliary disorders showed elevations in neonatal hepatitis syndromes, cholestasis, and hepatitis of extrahepatic or intrahepatic origin. Measurements of individual serum bile acids failed to differentiate between the various neonatal hepatitis syndromes. In one patient with cholestasis, the increased levels of bile acids observed returned to normal following therapy with cholestyramine and phenobarbital. In chronic active hepatitis the serum bile acid values correlated well with the bilirubin and SGOT in response to therapy with corticosteroids. These data confirm suggestions that serum cholylglycine and chenodeoxycholylglycine levels are a sensitive indicator of disturbed hepatic function and can be used in monitoring the course, activity, and therapeutic response in various hepatitis syndromes. In Reye's syndrome and protracted diarrhea of infancy, elevations in serum bile acids were detected without associated hyperbilirubinemia and provided additional evidence of disturbed hepatic function.\",\n",
       " '79015': 'Comparison of the chloride electrode and gravimetric chloride titration sweat tests.CHLORIDES.  CYSTIC-FIBROSIS: di.  SWEATING.The chloride electrode sweat test and gravimetric chloride titration technic are compared. The two technics gave comparable mean values, ogives, equivalent points, and overlap for patients with cystic fibrosis and healthy subjects. As a single test with either technic has an unacceptable risk for false-positive or false-negative results, tests should always be done in pairs. A statistical interpretation technic based on prevalence and technical variability of the two tests will decrease the number of undiagnosed subjects and will define probability of cystic fibrosis in the undiagnosed group.',\n",
       " '79016': 'Comparison of the errors due to the use of gauze and the use of filter paper in the gravimetric chloride titration sweat test.CHLORIDES.  CYSTIC-FIBROSIS: di.  SWEATING.Potential sources of error in the Gibson and Cooke method of sweat testing using gauze and filter paper as collection media as described. The absolute chloride content of gauze was higher than that of filter paper; however, the variability of chloride contents between the two was insignificant. Complete chloride elution from filter paper requires more time than elution from gauze. A method of determining probability of a clinically acceptable measurement based on sweat sample size, chloride determination, and variability of chloride in collection media is also described.',\n",
       " '79017': 'Cystic fibrosis with acute hypoelectrolytemia and metabolic alkalosis in infancy.ALKALOSIS: et.  WATER-ELECTROLYTE-IMBALANCE: et.We describe two infants with previously undiagnosed cystic fibrosis who had electrolyte depletion, metabolic alkalosis, and dehydration in the winter and three infants known to have CF in whom similar manifestations developed.  We confirm previous reports that salt depletion and metabolic alkalosis do occur throughout the year in the northern United States and England.  When metabolic alkalosis and hypoelectrolytemia in infancy are not explained on the basis of other clinical conditions, CF should be suspected.  Pediatricians should measure serum electrolyte values promptly and consider early parenteral fluid and electrolyte therapy as a preventive measure for infants with CF with persistent vomiting and/or diarrhea.',\n",
       " '79018': 'Demineralization in cystic fibrosis detected by direct photon absorptiometry.BONE-AND-BONES: me.  BONE-DISEASES: et.  CYSTIC-FIBROSIS: co. GROWTH-DISORDERS: et.  MINERALS: me.Bone mineral content, bone width, and their ratio were measured in patients with cystic fibrosis (CF) using monoenergetic photon absorptiometry. Serial measurements of the radius and ulna were made in 27 patients with CF and were compared with 968 age-matched controls. Demineralization was found in 37% of the boys and 63% of the girls. Patients under age 10 years had normal bone mineral content and nine of 15 patients aged 13 or older were demineralized (P less than .01). Demineralization correlated with the extent of weight reduction in patients (P less than .001). Patients most likely to be demineralized were adolescent girls. To our knowledge, this is the first report of bone mineral status of children with CF, and the results indicate that a sizable proportion of these patients may be demineralized without overt rickets.',\n",
       " '79019': 'Psychosocial support for adults with cystic fibrosis: a group approach.CYSTIC-FIBROSIS: px.  SELF-HELP-GROUPS.This article describes the first time-limited psychosocial support group for adults with cystic fibrosis (CF).The chronology of the group is traced, focusing on issues of importance for health professionals who work with patients with CF. Some of the issues raised by patient members include doubts about the competence of nonpediatricians to adequately treat CF; resentment towards \"normals\" (those without CF), including health professionals; and the desire to control as many areas of their lives as possible. Covert (ie, unrecognized) issues, the role of staff, risks, and outcome are detailed as a guide for others who may wish to conduct such groups. The literature on groups for medical patients and a rationale for the beneficial effects on the group are given.',\n",
       " '79020': 'Cystic fibrosis in adults.  75 cases and a review of 232 cases in the literature.CYSTIC-FIBROSIS: co.  INTESTINAL-OBSTRUCTION: et. LUNG-DISEASES-OBSTRUCTIVE: et.Cystic fibrosis is now the most common cause of chronic obstructive pulmonary disease (COPD) and of pancreatic insufficiency in the first three decades of life in the United States.  In this report we describe 75 patients with cystic fibrosis aged 18 to 47 years and review another 232 cases reported in the literature.  All of these 307 patients had elevated sweat chloride and sodium levels, which proved excellent discriminants for cystic fibrosis even in patients in the older age group.  COPD, present in 97 per cent, was the major cause of morbidity and mortality, and differed from COPD of other etiologies.  The progressive downhill course in these patients was punctuated by recurrent symptomatic exacerbations of chronic bacterial bronchitis caused by Pseudomonas aeruginosa and Staphyloccocus aureus, and terminated in pulmonary insufficiency, cor pulmonale and death.  COPD was complicated by minor hemoptysis in 60 per cent, massive hemoptysis in 7 per cent and pneumothorax in 16 per cent, problems rare in children.  Sinusitis was present in all those examined roentgenographically, and 48 per cent had nasal polyposis.  Pancreatic insufficiency was present in 95 per cent of the patients, but in contrast to younger patients it was seldom symptomatic although steatorrhea and azotorrhea were still massive. Intussusception and meconium ileus equivalent (fecal accumulation) are frequent in adults (21 per cent) but rare in children, and they require immediate diagnostic and therapeutic intervention with enemas of diatrizoate sodium.  Glycosuria, biliary cirrhosis, cholelithiasis and aspermia were among other complications.  Height and weight were usually within the lower limits of normal, but 17 per cent of the men were above 180 cm in height and 7 per cent were overweight.  Therefore, a high index of suspicion is needed to make the diagnosis, because older patients with cystic fibrosis may look quite well.',\n",
       " '79021': 'Genetic counseling and prenatal diagnosis of cystic fibrosis [letter].CYSTIC-FIBROSIS: fg.  GENETIC-COUNSELING.  PRENATAL-DIAGNOSIS.Turner and associates cited cystic fibrosis as an example of the application of the judicious use of genetic counseling and prenatal diagnosis.  The reader who is unfamiliar with genetic disorders, prenatal diagnosis, and genetic counseling may have taken the \"cystic fibrosis example\" as fact rather than a model, as intended.  Cystic fibrosis is a recessive disorder for which prenatal diagnosis and heterozygote detection are not yet possible.  Currently, because of the present inability to detect the heterozygous state, genetic counseling of individuals with a family history of cystic fibrosis frequently means a statistical prediction is given, rather than a precise recurrence risk.',\n",
       " '79022': 'Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants.CYSTIC-FIBROSIS: pa.  PANCREAS: pa.The development of the exocrine pancreas has been determined quantitatively in 31 infants with cystic fibrosis (CF) both  with and without meconium ileus and in 29 control infants. In the normal pancreas, the ratio of acinar to connective tissue volume is 0.5 at 32 weeks postconceptional age (PCA) and increases linearly to 2.0 at 52 weeks PGA. In cystic fibrosis infants, with or without meconium ileus, the ration is 0.5 at 35 weeks PCA  anddecreases linearly to 0.3 at 52 weeks PCA. The volume of acinar and duct lumens is greater in CF than control infants but is independent of age or acinar volume. The development of the exocrine pancreas in infants with CF with and without meconium ileus diverges from the normal pattern: There is consistent lack of exocrine tissue before or a full-term birth, which persists throghout the age range of this study. CF infants above 42 weeks PCA can be discriminated from controls on the basis of the quantitative assessment of acinar volume.',\n",
       " '79023': 'A comparative study of inhaled atropine sulfate and isoproterenol hydrochloride in cystic fibrosis.ATROPINE: du.  CYSTIC-FIBROSIS: pp.  ISOPROTERENOL: du. RESPIRATION: de.To investigate the contribution of vagal tone to the obstructive airway disease in cystic fibrosis, we evaluated the pulmonary function response to administration of 0.1 mg of atropine sulfate per kg of body weight, 0.05 mg of isoproterenol hydrochloride per kg of body weight, or isotonic saline (control solution) administered by nebulization on 3 different days to each of 10 patients with cystic fibrosis in a single blind study.  The doses of atropine sulfate and isoproterenol hydrochloride were based on published dose-response characteristics of the drugs.  Each day, thoracic gas volume and airway resistance were measured in a volume displacement body plethysmograph, and maximal expiratory flow-volume curves were performed before and at 15, 30, and 60 min after the inhalation. After inhalation of saline, group mean values for all pulmonary functions indicated greater airway obstruction at 15, 30, and 60 min when compared to pretreatment values.  After inhalation of isoproterenol and atropine, significant improvement (P < 0.05) was noted in maximal expiratory flows at 60 per cent of total lung capacity, specific airway conductance, thoracic gas volume, and residual volume.  Inhalation of atropine also significantly improved maximal expiratory flow at 25 per cent of vital capacity. Isoproterenol increased the mean flows by 8 to 46 per cent above baseline, and decreased thoracic gas volume and residual volume by 11 to 16 per cent with the maximal response at 15 or 30 min. Atropine increased mean flows by 15 to 77 per cent and decreased thoracic gas volume and residual volume by 16 to 25 per cent with the maximal effect at 30 to 60 min.  The mean response to atropine, expressed as a percentage of baseline, was always greater than or equal to that for isoproterenol.  We conclude that vagal tone, which may reflect increased irritant receptor activity, contributes to the obstructive pulmonary function in cystic fibrosis.  Inhalation of atropine sulfate will decrease the pulmonary function abnormality, but side effects prohibit its clinical usefulness.',\n",
       " '79024': 'The pulmonary circulation: remodeling in growth and disease.  The 1978 J. Burns Amberson lecture.PULMONARY-ARTERY: pa.This account draws on studies of young and mature lung, on normal and morbid anatomic features, on normal adaptations as in growth, and remodeling by disease.  Qualitative analysis of the vascular bed, development of the pulmonary circulation, right ventricular hypertrophy or cor pulmonale, remodeling in disease, and experimental studies are discussed.  Pulmonary hypertension offers us a complex pattern of structural and functional interaction; we are just beginning to realize how complex it is.  Information on normal structure, its modification and remodeling by growth and disease, and appropriate techniques are available that will enable us to formulate our questions with due regard for anatomic precision and functional implication.  And so research will lead to understanding and, it can be expected, to control of the undesirable aspects of pulmonary hypertension.',\n",
       " '79025': 'Aspergillosis and atopy in cystic fibrosis.ASPERGILLOSIS-ALLERGIC-BRONCHOPULMONARY: et.  CYSTIC-FIBROSIS: co.Forty-six patients with cystic fibrosis (CF) were studied for colonization and sensitization by Aspergillus organisms. The fungus was cultured from 21 of 37 (57%) patients who produced sputum. The non-CF sputum isolation rate was 6.5%. Sputum hyphae were seen in 95% of patients with positive cultures. Sputum eosinophilia accompanied colonization by Aspergillus. Aspergillus precipitins were found in 37% of CF patients; positive immediate skin tests were found in 39%. \"Atopy\" defined by skin test criteria was found in 46%. All of these findings were more common in patients with more severe disease (p less than 0.05). CF patients had predominant mold sensitivity in contrast to predominant pollen sensitivity in a control group of asthmatic subjects. Serum IgE concentrations were increased in 22% of CF patients. CF patients who had increased serum concentrations of IgE were more likely to have a family history of atopy. Wheezing was more common in those who were atopic, especially the group with predominant mold sensitivity who had more severe disease. Four patients fulfilled the diagnostic criteria for allergic bronchopulmonary aspergillosis (ABPA) during the time of study and follow-up. A fifth patient had ABPA diagnosed before the study. The incidence of ABPA during a 2-yr period in our CF population was 11%.',\n",
       " '79026': 'Maximal expiratory flows after postural drainage.BRONCHITIS: th.  CYSTIC-FIBROSIS: th.  RESPIRATION.Flows measured from maximal expiratory flow-volume (MEFV) curves were used to evaluate the efficacy of postural drainage in improving ventilatory function acutely. Maximal expiratory flow-volume curves were obtained for 9 cystic fibrosis subjects and 10 subjects with chronic bronchitis before and 5, 15, and 45 min after a 30-min session of postural drainage with percussion, vibration, and coughing. Forced vital capacity (FVC) was significantly increased 45 min after drainage for the combining group. Flows at high lung volumes were different for the 2 subgroups. Subjects with cystic fibrosis demonstrated a significant increase in peak expiratory flow rates 45 min after drainage and an increase in forced expiratory volume in one sec at all time intervals. The subjects with chronic bronchitis had a decreased peak expiratory flow rate 5 min after drainage, but by 45 min, it had returned to baseline. There was no significant change in one-sec forced expiratory volume at any time interval for the chronic bronchitis subgroup. Changes in flows at low lung volumes were similar for the 2 subgroups. Forty-five min after drainage there was an increase in flow rates near 50 per cent of FVC. Flows near 25 per cent of FVC were increased 15 and 45 min after drainage. This study demonstrated that postural drainage with coughing resulted in significant improvement in flows at low lung volumes. Changes in flows at high lung volumes were less consistent.',\n",
       " '79027': 'Relationship between response to exercise and allergy in patients with cystic fibrosis.CYSTIC-FIBROSIS: co.  EXERTION.  HYPERSENSITIVITY: co.Responses to treadmill exercise of 36 patients with cystic fibrosis were studied to evaluate their usefulness in identifying those with atopy. Ten of 36 patients with cystic fibrosis (28%) had an abnormal response to exercise but had no more frequent atopic characteristics than those who had normal exercise responses. Response to treadmill exercise alone cannot identify patients with atopic disease among those with cystic fibrosis.',\n",
       " '79028': 'Radioimmunoassay of trypsin.  A new aid in the assessment of pancreatic function.PANCREAS: en.  PANCREATIC-DISEASES: di.  TRYPSIN: an.This review describes the development and application of a novel test to determine levels of human immunoreactive trypsin, an enzyme produced solely by the pancreas, in biological fluids. Being organ- specific, the assay of immunoreactive trypsin should be an ideal marker of pancreatic function, and this is supported by the results of a number of clinical and research investigations. Use of this assay in studies of chronic pancreatitis, juvenile-onset diabetes, and cystic fibrosis has yielded much valuable data, and it is expected that further research will lead to an improved understanding of these and other conditions associated with the pancreas in health and disease.',\n",
       " '79029': 'Endobronchial balloon tamponade of hemoptysis in patients with cystic fibrosis.CATHETERIZATION: mt.  CYSTIC-FIBROSIS: co.  HEMOPTYSIS: th. HEMOSTATIC-TECHNICS.  TAMPONS.The flexible bronchoscope with Fogarty balloon and irrigating catheters is used effectively to manage and treat hemoptysis in a series of patients with cystic fibrosis.  This procedure is well suited to such patients, who are prone to recurrent hemoptysis, and may also be indicated in any inoperable patient with poor cardiopulmonary reserve.',\n",
       " '79030': 'Antimicrobial susceptibilities of rough, smooth, and mucoid colony types of Pseudomonas isolated from cystic fibrosis patients.ANTIBIOTICS: pd.  CYSTIC-FIBROSIS: mi.  PSEUDOMONAS: de.Minimal inhibitory concentrations of carbenicillin, chloramphenicol, tetracycline, gentamicin, tobramycin, and trimethoprim- sulfamethoxazole were determined for rough, smooth, and mucoid Pseudomonas sp. isolates from sputa collected from 40 cystic fibrosis patients.  Ninety-four percent of the minimal inhibitory concentrations obtained by using mixed inocula of colonies of different morphological types fell within one serial dilution of the most resistant minimal inhibitory concentration obtained when each colony type was tested separately.',\n",
       " '79031': 'Results of 10 years of screening of newborn infants for inherited metabolic diseases in the province of Limburg (Belgium).METABOLISM-INBORN-ERRORS: oc.In the province of Limburg, all newborn babies are screened for metabolic anomalies: for amino acidopathies since 1968, for galactosemia since 1974 and for mucoviscidosis since 1978.  On 127,676 newborns, there were 12 cases of phenylketonuria and 3 other inherited anomalies.  A meaningful policy of the government on neonatal screening necessarily requires a good organization, to put together the screening data, diagnosis, treatment and follow-up.',\n",
       " '79032': 'Comparative trial of manual and mechanical percussion technique with gravity-assisted bronchial drainage in patients with cystic fibrosis.CYSTIC-FIBROSIS: th.  DRAINAGE.  PHYSICAL-THERAPY: mt.Chest physiotherapy still remains one of the most important aspects in the treatment of chest complications of cystic fibrosis. A mechanical device that allows the patient with cystic fibrosis to do his own chest physiotherapy will be of great benefit if it is as effective as manual percussion. 14 patients with cystic fibrosis using mechanical and manual percussion physiotherapy were studied by measuring sputum volumes, and FEV and FVC. Results with mechanical percussor were as good as with the manual percussor and, therefore, it would be reasonable for the older patient to use the former on his own.',\n",
       " '79033': 'Paediatric Research Society.  Plymouth, 15 and 16 September 1978: Abstracts.ASTHMA: th.  CYSTIC-FIBROSIS: me.  PEDIATRICS.Abstracts are given for articles on abnormalities of the complement system in children with liver disease, hepatic collagen synthesis and its modification by colchicine is a rat model of cirrhosis of the liver, postprandal total serum bile acid concentrations in cystic fibrosis, release of endogenous secretin in children with cystic fibrosis, bronchial allergy in children with cystic fibrosis, and other topics.',\n",
       " '79034': 'Screening for cystic fibrosis in the newborn by meconium analysis.CYSTIC-FIBROSIS: pc.  MASS-SCREENING: mt.  MECONIUM: an.During a 4-year routine screening programme for cystic fibrosis (CF) 15 464 specimens were examined for raised meconium albumin levels by a test strip method and by electroimmunoassay. The incidence of false- positive results was about 5 per 1000 specimens in either test. This could be reduced by 90% by determining the ratio of albumin : alpha-1- trypsin inhibitor (a ratio below 2.0 being considered as a negative result), and it could be reduced to zero by determining the ratio in subsequent faecal specimens. Three of 12 meconium specimens from infants with proved CF gave false-negative results in all 3 tests. The other 9 specimens had greater than 100 mg albumin/g dry weight and albumin: alpha-1-trypsin inhibitor ratios of greater than 3.0; in subsequent faecal specimens the ratios were over 4.0. 176 meconium specimens from elsewhere in the UK were examined and these included 23 from infants who were subsequently proved to have CF. Six of these 23 CF specimens gave false-negative results, the other 17 being strongly positive. The origins of meconium serum protein suggest that infants with CF in whom meconium gives false-negative results have normal pancreatic functions at birth. The specificity of current meconium tests therefore cannot be improved as they depend on pancreatic dysfunction.',\n",
       " '79035': 'Pulmonary candidiasis in cystic fibrosis.CYSTIC-FIBROSIS: co.  LUNG-DISEASES-FUNGAL: et.  CANDIDIASIS: et.A child with cystic fibrosis and asthma developed pulmonary candidiasis. Predisposing factors in this patient were prolonged antibiotic therapy, high-dose corticosteroids, and intravenous catherisation. A diagnosis was made by lung puncture and confirmed by rapid response to 5-fluorocytosine.',\n",
       " '79036': 'Intestinal bile salts in cystic fibrosis: studies in the patient and experimental animal.BILE-ACIDS-AND-SALTS: me.  CYSTIC-FIBROSIS: me.  DUODENUM: me. INTESTINAL-SECRETIONS: me.The quantitative and qualitative distribution of bile salts in the duodenal juice of 13 patients with cystic fibrosis (CF) was studied after a test meal. The effects of triolein (TO), bovine serum albumin (BSA), and ricinoleic acid (RA) on the absorption of taurocholate (TCA) in the distal ileum of the rat in vivo was also studied. The mean (and ranges) of total bile salt concentrations, glycine: taurine conjugate ratios, and percentage of dihydroxy bile salts in the patients with CF and pancreatic insufficiency were 3.5 (1.3--6.6) mmol/l, 8.6 (greater than 10-3.1), and 37 (10--60) compared with control values of 7.4 (3.0--16.0) mmol/l, 3.0 (1.3--4.5), and 61 (52-- 70) respectively. The differences between the control and CF values were statistically significant (P less than 0.01--P less than 0.001). Three of the 13 CF patients had total bile salt concentrations less than 2 mmol/l, 8 had much higher glycine: taurine ratios, and 8 had a reduced percentage of dihydroxy bile salts. In 2 patients with normal pancreatic enzyme activities, duodenal bile salts were both quantitatively and qualitatively normal. TO (10 and 30 mmol/l), BSA (3%), and RA (5 mmol/l) had no inhibitory effect on the ileal absorption of TCA. These results show pronounced abnormalities of duodenal juice bile salts in CF with pancreatic insufficiency consistent with a broken enterohepatic circulation (EHC); such abnormalities may contribute to defective lipid absorption in CF. The data in the experimental animal do not support the suggestion that unhydrolysed dietary substrates play a role in the pathophysiology of the broken EHC.',\n",
       " '79037': 'Possible hazard of timed-release aspirin in a patient with pancreatic insufficiency.ASPIRIN: ae.  CYSTIC-FIBROSIS: co.  HEMORRHAGE-GASTROINTESTINAL: ci.An episode of severe small intestinal hemorrhage occurred in a cystic fibrosis patient having pancreatic insufficiency and receiving timed- release aspirin therapy for disabling hypertrophic pulmonary osteoarthropathy. The increased acidity of small intestinal contents due to decreased bicarbonate secretion observed in patients with pancreatic insufficiency may alter the luminal environment and result in mucosal erosions and/or ulcerations in association with the presence of aspirin. Thus, physicians should be aware of the possibility that timed-release aspirin causes small intestinal hemorrhage in such patients.',\n",
       " '79038': 'Cystic fibrosis with brain abscess.BRAIN-ABSCESS: co.  CYSTIC-FIBROSIS: co. STREPTOCOCCAL-INFECTIONS: co.A 21-year-old patient with cystic fibrosis developed bilateral brain abscesses due to anaerobic Streptococcus. This rare association presents an interesting etiologic study.',\n",
       " '79039': 'Cystic fibrosis and hearing loss.CYSTIC-FIBROSIS: co.  HEARING-LOSS-CONDUCTIVE: et. HEARING-LOSS-PARTIAL: et.  HEARING-LOSS-SENSORINEURAL: et.The mucosal epithelium of the middle ear and Eustachian tube is in direct continuity with the upper respiratory tract. Since the otolaryngological aspects of cystic fibrosis (CF) are dominated by involvement of the paranasal sinuses, it might be assumed that children with CF would be expected to have a higher than usual incidence of middle ear disease. Eighty patients who were afflicted with CF had audiological evaluations, which consisted of hearing threshold levels (250 to 8,000 Hz) and speech and impedance audiometry. We found no greater incidence of a conductive or sensorineural hearing loss in patients with CF when compared with a normal age-adjusted population.',\n",
       " '79040': 'Vocational development and adjustment of adolescents with cystic fibrosis.ATTITUDE.  CAREER-CHOICE.  CYSTIC-FIBROSIS: rh.  DECISION-MAKING. GOALS.Adolescents with cystic fibrosis were compared with normal adolescents of the same age and educational grade on several measures of vocational development and adjustment. The cystic fibrosis group in ages 12--16 and in grades 7, 8, and 9 scored lower than their normal counterparts in measures of vocational and educational plans, and were less realistic than normals in considering their limitations and financial constraints. In contrast, the cystic fibrosis group at nearly all age and grade levels scored significantly higher on strength of commitment to vocational choice, work values, and awareness of occupational information. Compared to 4 additional handicapped groups already studied, adolescents with cystic fibrosis scored favorably. They not only plan to work but also hold strong work values compared to normals. Rehabilitation programs should emphasize preparation for a career and the development of educational and vocational plans while the adolescent is still in high school.',\n",
       " '79041': 'Pharmacokinetics of azlocillin in children with cystic fibrosis.CYSTIC-FIBROSIS: me.  PENICILLINS: me.6-E1(R)-2-(oxo-imidazolidine-1-carboxamido)-2-phenyl-acetamido]- penicillanic acid sodium salt (azlocillin, Securopen) was given in doses of 100 and 200 mg/kg body weight to children with cystic fibrosis. After intravenous bolus infections, the serum half-life was 0.82 +/- 0.12 h after the lower dose and 0.98 +/- 0.18 h after the higher dose. This was consequent to a dose limited elimination kinetics due to limitation in both renal and non-renal processes of elimination. Upon doubling of the dose from 100 to 200 mg/kg, the total body clearance dropped from 13.93 to 5.10 1/h. Evaluation of data presented in other publications indicate that a dose limited elimination kinetics is the normal situation for azlocillin. Besides, the serum concentrations of patients with cystic fibrosis were considerably lower than seen in the healthy state. The reason is faster elimination by the renal route in cystic fibrosis.',\n",
       " '79042': 'Dying children need help too.CHILD-HOSPITALIZED.  CYSTIC-FIBROSIS: th.  TERMINAL-CARE.The control of symptoms in dying children is often sadly neglected. This neglect is reflected in a review of the case notes of two children who died of cystic fibrosis within three years of each other.  The girls were under the care of the same consultant, who in the interval between the two cases was introduced to the concern of proper terminal care for children.',\n",
       " '79043': 'Cystic fibrosis: is it relevant to family practitioners?.CYSTIC-FIBROSIS: di.  FAMILY-PRACTICE.There has been a major change in the outlook for children with cystic fibrosis during the last 20 years. Provided the diagnosis is made before serious irreversible lung disease has occurred, most patients can expect to reach adult life without very serious disability. Inhibition of Tamm-Horsfall glycoprotein induction of alkaline phosphatase in cystic fibrosis fibroblasts by medium conditioned by normal cells.ALKALINE-PHOSPHATASE: me.  CELLS-CULTURED: me.  CYSTIC-FIBROSIS: me. FIBROBLASTS: me.  GLYCOPROTEINS: pd.It is confirmed that the level of alkaline phosphatase in fibroblasts derived from cystic fibrosis patients can be induced many-fold by growing the cells in the presence of Tamm-Horsfall glycoprotein. It is further shown that normal fibroblasts produce a \"CF corrective factor\" which markedly inhibits this phenomenon. These observations support a previous hypothesis on the nature of the metabolic defect in cystic fibrosis.',\n",
       " '79045': 'Antibody responses to influenza virus vaccine in patients with cystic fibrosis.ANTIBODIES-VIRAL: im.  CYSTIC-FIBROSIS: im.  INFLUENZA-VACCINE: im.Patients with cystic fibrosis were immunized with subunit influenza vaccine and their haemagglutination-inhibiting (HI) antibody responses were compared with responses in young healthy adults. There was no significant difference in the antibody levels reached after immunization and no evidence of any impairment of responses in the patient group.',\n",
       " '79046': 'Biological activities of cystic fibrosis serum.  III.  CF serum induced uptake of 45Ca++ by rabbit tracheal explants.CALCIUM: me.  CYSTIC-FIBROSIS: bl.Cystic Fibrosis (CF) serum and its isolated component IgG fraction produce an increased uptake of 45Ca++ in rabbit tracheal explants when compared to control serum and its isolated IgG fraction. Heterozygote serum also produced an increased uptake of 45Ca++ but not to the same extent as CF serum.  The calcium channel blocker D600 inhibited the CF serum induced uptake of 45Ca++ indicating that CF serum may be acting on the plasma membrane to produce changes in calcium permeability in rabbit tracheal explants.',\n",
       " '79047': 'Differential concanavalin A binding of cystic fibrosis and normal liver alpha-L-fucosidase.CONCANAVALIN-A: me.  CYSTIC-FIBROSIS: en.  FUCOSIDASE: me.  LIVER: en.A novel technique has been employed to demonstrate that alpha-L- fucosidase purified from cystic fibrosis and control livers exhibits differential binding to the lectin Concanavalin A.  The concentration of alpha-CH3-mannoside necessary to prevent 50% binding of alpha-L-fucosidase to Concanavalin A is considerably lower for the cystic fibrosis enzyme (13.5 vs. 33.3 mM).  Comparable results were found when binding studies were done on crude supernatant alpha-L-fucosidase from 8 cystic fibrosis and 8 control livers (5.6 plus or minus 0.4 mM and 13.2 plus or minus 3.4 respectively), without any overlap of values between the cystic fibrosis and control livers.  These results suggest that comparative lectin binding studies on cystic fibrosis and normal glycoproteins from readily available tissues might result in an assay for detecting the cystic fibrosis genotype.',\n",
       " '79048': 'Enzyme immunoassay of albumin as an aid to the diagnosis of cystic fibrosis in the newborn human [proceedings].CYSTIC-FIBROSIS: di.  SERUM-ALBUMIN: an.One of the symptoms of cystic fibrosis (mucoviscidosis) is pancreatic insufficiency.  The reduced proteolytic activity in the gut of children with the disease results in an elevated concentration of protein, especially serum albumin, in the meconium.  This feature is used in the diagnosis of the disease in the newborn, and we decided to examine the utility of enzyme immunoassay for the measurement of albumin in meconium samples from normal and cystic fibrosis infants. Normal samples were found to have apparent albumin concentrations in the range 0.05-0.26 mg/g dry wt., whereas cystic fibrosis samples had concentrations in the range 60-230 mg/g dry wt.  The assay provides a cheap and relatively rapid method of differentiating cystic fibrosis positive and negative meconium samples.',\n",
       " '79049': 'Induction of alkaline phosphatase in cultured human fibroblasts. Comparison of normal cells and those from patients with cystic fibrosis.ALKALINE-PHOSPHATASE: bi.  CYSTIC-FIBROSIS: en.  FIBROBLASTS: en.The membrane glycoprotein enzyme, alkaline phosphatase was induced in cultured human fibroblasts by dibutyryl cyclic AMP, sodium butyrate, the serum glycoprotein fetuin, the Tamm-Horsfall urinary glycoprotein, and by a number of inhibitors of DNA synthesis. The uninduced basal enzyme activity increased at later stages of growth when the cells became confluent. Induction by dibutyryl cyclic AMP or fetuin was most effective when the agents were added after the cells had reached stationary phase and was maximal after at least two days of exposure. The levels of induction resulting from the addition of pairs of the agents, dibutyryl cyclic AMP, n-butyrate and fetuin were additive indicating that these have different modes of action. The inhibitors of DNA synthesis, cytosine arabinoside, hydroxyurea, and methothrexate were less effective inducers. Bromodeoxyuridine which also has non-DNA mediated effects induced to the same extent as dibutyryl cyclic AMP. Similar experiments with sex- and age-matched cell strains derived from patients with cystic fibrosis failed to detect differences in the levels of induction from those observed in normal cells. In addition, the combined inductive effects of Tamm- Horsfall glycoprotein, isoproterenol and theophylline, were similar with normal and cystic fibrosis cells.',\n",
       " '79050': 'Plasma membrane lipids of human diploid fibroblasts from normal individuals and patients with cystic fibrosis.CYSTIC-FIBROSIS: me.  MEMBRANE-LIPIDS: an.The lipid composition of isolated plasma membranes of human skin fibroblasts is described for the first time. Plasma membranes from a number of strains of fibroblasts from patients with cystic fibrosis and matched normals were isolated by a recently described procedure and analysed for major phospholipid classes, cholesterol and fatty acids. No differences in the quantities of these compounds were detected between cells of the two different origins. The fetal calf serum used to supplement the growth medium contained relatively more palmitoleate and oleate but less stearate than the membranes. There were also no consistent differences between cystic fibrosis and normal membranes in terms of the fatty acid compositions of their individual phospholipid classes. Consistent with this lack of chemical change in the lipids of membranes of cystic fibrosis cells, the degree of fluorescence polarization of diphenylhexatriene, an index of fluidity, was also unchanged.',\n",
       " '79051': '2. Theories of genetic causation in human disease.GENETICS-MEDICAL.  HEREDITARY-DISEASES.The central problem of the mid-20th century genetic counselor has been to determine the place of the genes in the origin of complex human characteristics - such as neural tube defects, cleft palate, diabetes, and congenital heart disease - in short, the major malformation and polygenic syndromes which make up the bulk of what we call birth defects.  Of comparable importance in terms of genetic counseling is understanding the origin and incidence of the newly recognized genetic heterogeneity lying behind what had previously been regarded as simple, single-gene determined diseases.  Topics include dealing with genetic heterogeneity, phenotypes and genotypes, where genetic causation defies simple analysis, and sources of variation.  Behavior disorders with presumptive single-gene causation (Lesch-Nyhan disease), presumptive sex-linked causation (aggressivity), and presumptive polygenic causation (alcoholism) are also discussed.',\n",
       " '79052': 'Bronchial artery embolization in the control of massive haemoptysis.BRONCHIAL-ARTERIES.  EMBOLIZATION-THERAPEUTIC.  HEMOPTYSIS: th.Bronchial artery embolization is a useful palliative treatment for life-threatening haemoptyses where surgery is contra-indicated. Patients presenting with haemoptyses complicating cystic fibrosis and aspergilloma have been embolized. Control of haemoptysis was achieved in the former, but late recurrence of haemoptysis in the latter led to asphyxiation.',\n",
       " '79053': 'Cystic fibrosis in adults [editorial].CYSTIC-FIBROSIS: co.Cystic fibrosis is the commonest semilethal genetic disorder in Caucasians.  The biochemical sequence that leads to widespread dysfunction of exocrine glands has yet to be determined.  Cystic fibrosis in adults has been the subject of extensive review.  We still do not know the cause of the changes in the lungs.  Pancreatic insufficiency was recorded in 95% of the patients, but the older ones needed little dietary restriction and some seemed to thrive without pancreatic replacement.  Ninety-five per cent of males have aspermia due to failure of development of the vas deferens, epididymis, and seminal vesicles.  Despite the obvious handicap and emotional and social strains in all four series, adolescent and adult patients with cystic fibrosis not only did well at school and at work but managed to fit in well in their social framework.',\n",
       " '79054': \"New mechanical aid to physiotherapy in cystic fibrosis.CYSTIC-FIBROSIS: th.  PERCUSSION: is.  PHYSICAL-THERAPY: is.The force of impact and frequency of percussion by physiotherapists and parents of children with cystic fibrosis were analysed on a special test rig and incorporated in a prototype percussor. In adult volunteers and cadavers a maximum intrathoracic pressure could be achieved by a critical frequency of mechanical percussion which was higher than that reached by physiotherapists and parents. Consequently the percussor was redesigned to operate at this optimum frequency. It was then discovered that if the percussor was pressed firmly enough against the chest, this maximum intrathoracic pressure could be indicated by quivering of the voice. In a continuing study of intrathoracic pressures obtained mechanically and manually the Salford percussor's produced higher pressures than the physiotherapists' and maintained them constantly, while the physiotherapists' efforts and results varied from one to another. Hospital and domiciliary use of the percussor have shown it to help in the first stage of the physiotherapy routine for patients with cystic fibrosis. The percussor should enable adolescents and adults to treat themselves and encourage twice-daily and more effective chest treatments. It is easy to apply and its speed and efficiency should enable parents to improve the quality of their chest therapy for younger children at home. Its long-term benefits are difficult to assess because of the nature of the disease.\",\n",
       " '79055': 'Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis.BREATHING-EXERCISES.  CYSTIC-FIBROSIS: th.Sixteen patients with cystic fibrosis were treated with conventional physiotherapy aided by an assistant. The results were compared with those produced by physiotherapy using the forced expiration technique cleared more sputum in less time than conventional physiotherapy. A sputum in less time than conventional physiotherapy. A second study showed that an assistant did not further improve the results obtained by the patient performing the forced expiration technique himself. These findings mean that patients with cystic fibrosis who have had to rely on the help of others for their home treatment may now perform more effective treatment without help. The forced expiration technique might also be helpful for patients with chronic bronchitis, asthma, or bronchiectasis.',\n",
       " '79056': 'Dying children need help too.CHILD-CARE.  TERMINAL-CARE.The control of symptoms in dying children is often sadly neglected. This neglect is reflected in a review of the case notes of two children who died of cystic fibrosis within three years of each other.  The girls were under the care of the same consultant, who in the interval between the two cases was introduced to the concept of proper terminal care for children.  These two cases show that illness can cause physical, emotional, and spiritual pain to family and staff.  In retrospect these areas of distress were not clearly defined in either case and opportunities to alleviate suffering were missed.  The principles of controlling symptoms need to be remembered as much during distressing treatment as during the distress of dying.',\n",
       " '79057': 'Nocturnal elemental diet for retarded growth in a patient with cystic fibrosis.CYSTIC-FIBROSIS: co.  FOOD-FORMULATED.  NUTRITION-DISORDERS: dh.The combination of chronic pulmonary sepsis and pancreatic insufficiency in children with cystic fibrosis may lead to malnutrition.  We describe our experience of the long-term use of continuous nocturnal infusion of elemental diet in a patient with cystic fibrosis.  Our patient tolerated the long-term nocturnal elemental diet well, and it enabled her to continue normal everyday activity and eat normal meals.  The periods of nutritional support coincided with periods of increased body weight and total body potassium, indicating that the lean body mass was increased. We think that these results show a need for further studies of home treatment in children with cystic fibrosis.',\n",
       " '79058': 'Lung function abnormalities in cystic fibrosis and changes during growth.CYSTIC-FIBROSIS: pp.  LUNG: pp.Static lung volumes (VC, TLC, FRC, RV), elastic recoil pressure of the lungs (Pst(1) at 100, 90, and 60% of TLC), static lung compliance [Cst(1)], specific airway conductance at FRC level (Gaw/TGVex), forced expiratory volume in the first second (FEV1), maximal expiratory flows (Vmax.) at 25 and 50% of VC and at 60% of TLC, and \"upstream\" airway conductance (Gus) at 60% of TLC were studied in 28 patients with cystic fibrosis, 5 to 25 years old, over a period of 1 to 5 years. The data were compared individually with normal values, related to body height in the form of regression equations and expressed in percentage of predicted values. From the indices assessing airway function, Vmax. at low lung volumes, Gus at 60% TLC, RV and RV/TLC were the functional parameters most consistently abnormal. Among the indices characterizing lung elasticity, Pst(1) at 60% TLC was the most abnormal. Generally, the values of the majority of lung function indices [VC, TLC, FRC, Pst(1)] declined during growth. Vmax. at all lung volumes and Gus at 60% TLC did not deteriorate with growth probably due to the great abnormality of these parameters already in young patients. It was also observed that lung function did not change significantly over a period of 1 to 5 years corresponding to a 10 cm increase in body height. However, over that period, lung function improved in some of the subjects, did not change in over 50% of the cases and deteriorated in the others.',\n",
       " '79059': 'The role of nutritional status, airway obstruction, hypoxia and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis.AIRWAY-OBSTRUCTION: bl.  ANOXIA: bl.  CYSTIC-FIBROSIS: bl.  EXERTION. LIPIDS: bl.  NUTRITION-DISORDERS: bl.This study investigated the roles of hypoxia, pulmonary mechanics, nutritional status and serum fatty acid composition in limiting exercise tolerance in cystic fibrosis.  Twenty children with CF of carrying severity performed two progressive exercise tests on a cycle ergometer, once while breathing air, once while breathing O2. The children with the lower maximal mid-expiratory flow rates tended to have very little respiratory reserve at the final work load.  We conclude that nutritional status and airway obstruction are closely correlated with exercise tolerance in CF and that, unlike the adult with chronic obstructive pulmonary disease, exercise limiting dyspnoea occurs in the presence of normal end-tidal CO2.',\n",
       " '79060': 'One breath at a time: a family teaching program for children with cystic fibrosis.CYSTIC-FIBROSIS: rh.  PARENTS: ed.  PATIENTS: ed. PATIENT-EDUCATION.We have found patients who have cystic fibrosis to be very special people; they have to overcome apparently insurmountable odds.  Our teaching program comes from a basic belief that with support, encouragement and affection, information and a focus on the positive aspects of life, a person with CF can live well, even if only one breath at a time.',\n",
       " '79061': 'Noninvasive radionuclide assessment of right ventricular performance in man.HEART-VENTRICLE: ri.  RADIONUCLIDE-IMAGING: mt.This chapter focuses on the application of radionuclide angiocardiography to assessment of right ventricular ejection fraction and the relationship between right and left heart performance demonstrated by this technique.  Prior to discussion of the clinical applications, the functional geometry of the two ventricles will be reviewed.  In addition, the first-pass radiotracer techniques will be compared to other radionuclide imaging approaches of the right heart.  First-pass radionuclide angiocardiographic techniques are now suitable for clinical application.  They have been validated and standardized and can be relied upon for accurate, reproducible noninvasive assessment of right and left ventricular performance.  They already have been applied to the study of patients with cardiopulmonary disease; future directions will include earlier evaluation of myocardial infarction, application to children and adults with a variety of congenital cardiac abnormalities (primarily those affecting the right heart), and assessment of the effects of physiologic stress upon right ventricular function.  With this background valuable clinical and investigative insights should become available during the coming years.',\n",
       " '79062': 'In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.AMINOGLYCOSIDES: pd.  CEPHALOTHIN: pd.  COLISTIN: pd. PENICILLINS: pd.  PSEUDOMONAS: de.Of 97 well-defined strains of Pseudomonas, isolated from sputum of patients with cystic fibrosis (CF), the minimum inhibitory concentration (MIC) of several antibiotics was determined with a broth dilution method. The majority of the strains were resistant to ampicillin and cephalothin, moderately susceptible to carbenicillin (70% to 100 microgram/ml) and highly susceptible to piperacillin (100% to 25 microgram/ml, 88% to 6.25 microgram and 60% to 3.12 microgram/ml). If the pharmacological properties of piperacillin are comparable with those of carbenicillin, it can be expected that the sputum level of this drug will be adequate to treat Pseudomonas pulmonary infections. At the lowest concentration tested (0.78 microgram/ml) 3% of the strains were susceptible to kanamycin, 85,5% to amikacin, 95% to gentamicin, 98% of tobramycin, and 80% to colimycin. With regard to clinically attainable concentrations, 98.9% of the strains were susceptible to gentamicin and tobramycin 97.9% to amikacin, 96.9% to colimycin, 88.6%  to piperacillin, 38% to carbenicillin, 25.7% to kanamycin, 12.3% to ampicillin, and 1% to cephalothin.',\n",
       " '79063': 'Echocardiographic profiles of the long-term cardiac changes in cystic fibrosis.CYSTIC-FIBROSIS: co.  ECHOCARDIOGRAPHY.  HEART-DISEASES: di.In this echocardiographic study, assessment of the heart in children with cystic fibrosis has shown that changes occur in not only the right ventricle but also in the left ventricle and aorta, as compared with normal. Echocardiograms could be successfully performed in 34 of 37 patients. The thickness of the right ventricular anterior wall and the dimension of the right ventricular cavity  were abnormal, even in patients with mild disease (National Institutes of Health [NIH] score for severity of disease of 85 or greater). Larger, older children with lower NIH score had disproportionately larger right ventricular anterior walls and cavities. The thickness of the septal wall, the thickness of the left ventricular posterior wall, and the aortic dimensions were increased in those with severe disease. The dimensions of the left ventricular cavity for the population were slightly but significantly smaller than normal in systole and in diastole throughout the course of the disease. This study demonstrates that echocardiography is an effective noninvasive means of assessing the long-term changes in children with cystic fibrosis. These changes occur in both sides of the heart and appear to worsen as the disease progresses.',\n",
       " '79064': 'Lymphocytic acid-hydrolases and response to mitogens in cystic fibrosis.ACID-PHOSPHATASE: bl.  CYSTIC-FIBROSIS: en.  GLYCOSIDE-HYDROLASES: bl. LYMPHOCYTES: en.  MITOGENS: pd.In the present study, we compared the levels of a series of cultured lymphocytic acid-hydrolase enzymes in cystic fibrosis homozygotes, heterozygotes and controls; compared the effects of three different mitogens on these levels; and studied the effect of CF vs control serum in the culture medium.  Our observations provide an entirely new interpretation for the apparent changes occurring in lymphocytic enzymes during culture of lymphocytes with mitogens, and suggest that a serum factor is present in cystic fibrosis serum that mimics mitogens in this regard.  Lymphocytic acid-hydrolases and total protein are present in higher concentrations in lymphocytes cultured for 48 hours without mitogen when CF homozygous or heterozygous serum is present in the culture media.  This appears to result from a CF serum factor that has mitogen-like activity and prevents loss of cell protein during culture.  Responsiveness of the cellular proteins to mitogens is blunted when CF serum is present in the culture media, either because the cell proteins are already maximally stimulated by the CF serum factor, or the factor blocks or modifies the action of mitogens on lymphocyte protein content.  This phenomenon is useful for detection of CF heterozygosity, and appears to reflect the genetic abnormality causing cystic fibrosis.',\n",
       " '79065': 'Measurement of regional lung function by tetrapolar electrical impedance plethysmography.PLETHYSMOGRAPHY-IMPEDANCE: mt.  PULMONARY-CIRCULATION. RESPIRATORY-FUNCTION-TESTS: mt.This study demonstrates the clinical feasibility of atraumatically measuring dynamic regional lung function with tetrapolar electrical impedance plethysmography (EIP) in the pediatric age group. A tetrapolar electrode system was used because of its ability to detect local baseline and pulsatile impedance changes, minimal electrode- tissue impedance interference, and uniform current distribution. Studies performed on 4 children 4 to 15 years old with various pulmonary diseases are presented. The information obtained on their regional ventilation and pulsatile perfusion by EIP was found to agree closely with pulmonary ventilation and perfusion scans. In one case, EIP detected pulsatile perfusion abnormalities which were not apparent in the non-pulsatile perfusion scan but were demonstrated by cineangiography. It is concluded that tetrapolar EIP can provide safe, reliable regional information about ventilation and perfusion in diseased lungs, and because of its atraumatic approach, is technically most suitable for use in children.',\n",
       " '79066': 'Evaluation of the single-breath diffusing capacity in asthma and cystic fibrosis.ASTHMA: di.  CARBON-MONOXIDE: du.  CYSTIC-FIBROSIS: di. PULMONARY-DIFFUSING-CAPACITY.To explain why the single-breath carbon monoxide diffusing capacity (Dsb) was, on the average, elevated in 163 asthmatic subjects and 175 patients with cystic fibrosis, we simulated this elevation in ten normal subjects by having them perform the test for Dsb through an inspiratory obstruction. This resulted in an 18 percent increase in Dsb corrected for pulmonary volume. Inhalation of a bronchodilator drug was associated with relief of obstruction and a fall in the corrected Dsb in 31 asthmatic subjects but did not change either the obstruction or the corrected Dsb in 17 patients with cystic fibrosis. We suggest that elevated Dsb in asthma and cystic fibrosis is partly due to maximal inspiration against obstructed airways. This requires abnormally negative intrathoracic pressures, increasing the pulmonary capillary blood volume, and, thereby, increasing the Dsb.',\n",
       " '79067': 'Echocardiographic abnormalities in patients with cystic fibrosis.CYSTIC-FIBROSIS: pp.  ECHOCARDIOGRAPHY.  HEART: pp.An echographic study was undertaken to evaluate left (LV) and right ventricular (RV) function in 30 patients with cystic fibrosis. Echographic recording of the pulmonary and aortic valve echogram permitted measurement of the phases of right and left ventricular systole. The ratio of the LV preejection period/LV ejection time (LPEP/LVET) and shortening of the LV internal dimension %SID was employed to reflect LV function, while RV preejection period/RV ejection time (RPEP/RVET) has excellent correlation with pulmonary artery diastolic pressure. RPEP/RVET and two other echographic measurements, right ventricular wall (RVW) and internal dimension (RVD) were compared with pulmonary function tests and clinical scores. RPEP/RVET correlated well with percent vital capacity(%VC), r = -0.73, percent residual volume (%RVol) r = +0.72, and clinical score, r = -0.77. Multilinear regression of RPEP/RVET, RVD, and RVW improved correlation for %VC (r = -0.80), %RVol, r = +0.82, and clinical score, r = -0.84. Patients in overt right heart failure exhibited elevated RPEP/RVET (mean = 0.48) when compared to patients not in right heart failure (mean = .33). Marked diminution of LV function was present in two patients. A variety of cardiovascular abnormalities were demonstrated echographically and were valuable in assessing the degree of cardiac involvement in patients with cystic fibrosis.',\n",
       " '79068': 'Response to bronchial provocation and exercise in children with cystic fibrosis.ASTHMA: et.  BRONCHIAL-PROVOCATION-TESTS.  CYSTIC-FIBROSIS: co.Ten of fifteen cystic fibrosis children with positive skin prick tests to common antigens gave an immediate bronchial reaction to the antigen inhaled, five of them also gave a late reaction; however only one gave a history of asthma. The antigen most commonly eliciting a positive skin reaction in cystic fibrosis patients is Aspergillus fumigatus. In six children tested to this antigen the bronchial response varied, two were negative, one gave an immediate reaction and three gave a dual (immediate and late) reaction. None of the children showed the characteristic pattern of response to exercise seen in asthmatic patients, an initial rise in Peak Expiratory Flow Rate followed by a fall of greater than 14% below the resting level. Two patients showed an abnormal rise in Peak Expiratory Flow Rate during exercise, a pattern described previously in cystic fibrosis. The results suggest that bronchial allergy, immediate or late does completely explain susceptibility to asthma, and that other factors including perhaps the type of bronchial reactivity shown by bronchoconstriction after exercise may be required. However the majority of the children tested had bronchial allergy and anti- allergy therapy such as inhaled sodium cromoglycate may have a place in the management of selected patients with cystic fibrosis.',\n",
       " '79069': 'IgE mediated hypersensitivity to pancreatic extract (PE) in parents of cystic fibrosis (CF) children.CYSTIC-FIBROSIS: co.  DRUG-HYPERSENSITIVITY: im. HYPERSENSITIVITY-IMMEDIATE: ci.  PANCREATIC-EXTRACTS: ae.  PARENTS.On exposure to pancreatic extract (PE), four parents of cystic fibrosis (CF) children developed immediate hypersensitivity-like symptoms: i.e. rhinoconjunctivitis, asthma, and/or anaphylaxis. IgE to PE was demonstrated in the subjects by skin testing, leucocyte histamine release and radioallergosorbent test (RAST). No serum precipitating antibodies were found. Bronchial challenge caused an immediate asthmatic response. No delayed asthmatic response or hypersensitivity pneumonitis-like reaction occurred. The responsible antigen for PE induced asthma is unknown; trypsin failed to inhibit PE-RAST and is therefore not responsible in these subjects. Caution should be exercised in using PE for skin testing and bronchial challenge in subjects with suspected hypersensitivity to PE. Certain measures were found useful in preventing the occurrence of symptoms in the four subjects.',\n",
       " '79070': 'A study of erythrocyte fatty acids, adenosinetriphosphatase and acetylcholinesterase in cystic fibrosis.ACETYLCHOLINESTERASE: bl.  ADENOSINE-TRIPHOSPHATASE: bl. CYSTIC-FIBROSIS: bl.  ERYTHROCYTES: me.  FATTY-ACIDS-UNSATURATED: bl.1. The proportions of both saturated and polyunsaturated fatty acids were measured in the erythrocytes in Cystic Fibrosis (CF) patients along with two membrane bound enzymes ATPase and acetylcholinesterase. Linoleic acid was found to be significantly decreased and arachidonic acid increased in CF patients. The proportion of saturated fatty acids were not significantly different from the controls. Only adenosinetriphosphatase activity was found to be reduced and not acetylcholinesterase in CF patients.',\n",
       " '79071': 'Measurement of 4-hydroxyphenylacetic aciduria as a screening test for small-bowel disease.INTESTINAL-DISEASES: di.  MANDELIC-ACIDS: ur.We evaluted measurement of urinary 4-hydroxyphenyl acetic acid as a potential screening method for small-bowel disease and bacterial overgrowth syndromes in 360 unselected acutely ill infants and children. Control data were obtained on 120 healthy children, ages 1.5 to 15 years, from a general medical practice, 48 healthy infants, ages one to five years, from local day nurseries, and 150 healthy babies, ages less than one to eight days. Comparative data were from 300 acutely ill hospitalized babies and children, ranging in age from less than one day to 15 years and without clinical evidence for small- bowel disease and bacterial overgrowth syndrome. No false-negative results and only 2% false-positive results were observed. Among the 10 patients whose urinary excretion of the analyte was considered to be abnormal were patients with Giardia lamblia infestation, ileal resection with blind loop, and other diseases of the small intestine associated with bacterial overgrowth. We conclude that measurement of 4-hydroxyphenylacetic acid excretion is useful in screening for such diseases.',\n",
       " '79072': 'Quality of sweat test performance in the diagnosis of cystic fibrosis.CYSTIC-FIBROSIS: di.  SWEATING.The sweat test, correctly performed, appears to be reliable, but results were found to be unreliable about half the time in 84 small community hospitals assessed. The reasons are inexperienced and untrained technicians, the infrequency of test performance, the use of unstandardized equipment, and the lack of appropriate standards. It behooves all clinical laboratory directors to re-examine and standardize their procedures and use the recommendations of the Cystic Fibrosis Foundation. Physicians should be made aware of the current situation and send their patients only to laboratories that perform the test reliably.',\n",
       " '79073': 'Secretion of beta-N-acetylglucosaminidase isoenzymes by cultured cystic fibrosis fibroblasts.ACETYLGLUCOSAMINIDASE: se.  CYSTIC-FIBROSIS: en.  GLUCOSAMINIDASE: se. ISOENZYMES: se.Secretion of the lysosomal enzyme beta-N-acetylglucosaminidase (EC 3.2.1.30) by normal and cystic fibrosis fibroblasts has been compared. In contrast to an earlier report, no differences were found in either the rate of secretion, or in the molecular forms of the enzyme secreted by normal fibroblast cultures and cultures initiated from patients with cystic fibrosis. The B isoenzyme of beta-N- acetylglucosaminidase from cystic fibrosis fibroblasts was converted to a more negatively charged form during preincubation for 3 h at pH 5.0 and 37 degrees C. The enzyme from normal fibroblasts was unaffected by this treatment.',\n",
       " '79074': 'Glycosidases in serum of cystic fibrosis patients.CYSTIC-FIBROSIS: en.  GLYCOSIDE-HYDROLASES: bl.In a study of eight glycosidases in serum samples from 72 cystic fibrosis patients, 85 cystic fibrosis parents and 34 healthy and diseased controls, significant elevations of mean alpha-glucosidase levels were found in cystic fibrosis patients. All other glycosidases did not show any significant change. Mean alpha-glucosidase levels in obligate heterozygotes were the same as in control individuals. Moreover, alpha-glucosidase levels in cystic fibrosis patients correlated with the degree of clinical impairment as measured by the Schwachman score.',\n",
       " '79075': 'Carboxypeptidase B activity of cultured skin fibroblasts and relationship to cystic fibrosis.CARBOXYPEPTIDASES: me.  CYSTIC-FIBROSIS: en.Enzyme activity against hippuryl-L-arginine was studied in cultured skin fibroblasts from controls and cystic fibrosis patients. The enzyme had a lysosomal distribution and an acid optimum of pH 4.5 with little or no activity present above pH 7.0. Dithiothreitol was required for full activity and the kinetics of thiol activation were different for the control and cystic fibrosis enzyme. The properties and lysosomal distribution of the enzyme indicated that it was a carboxypeptidase B. Substrate affinity, thermolability, pH stability, the fall and rise in activity with subculture, the cyclical pattern of activity through serial passage and the level of activity were similar for the control and cystic fibrosis enzyme.',\n",
       " '79076': 'Decreased sialic acid and altered binding to lectins of purified alpha 2-macroglobulin from patients with cystic fibrosis.ALPHA-MACROGLOBULINS.  CYSTIC-FIBROSIS: bl.  LECTINS. SIALIC-ACIDS: an.Purified preparations of plasma alpha 2-macroglobulin from patients with cystic fibrosis are shown to have normal amounts of total hexose but as much as 40% decrease in their sialic acid content. The binding of these preparations to concanavalin A and wheat-germ agglutinin was markedly reduced as compared to normal values in controls. Intermediate values were found in obligate heterozygotes. These results suggest a possible alteration in the carbohydrate moiety of alpha 2-macroglobulin in cystic fibrosis, presumably due to a defective posttranslational process.',\n",
       " '79077': 'Abnormal distribution of alpha-L-fucosidase in cystic fibrosis: decreased activity in serum.CYSTIC-FIBROSIS: bl.  FUCOSIDASE: bl.The activity of alpha-L-fucosidase is decreased in the serum of cystic fibrosis patients when compared to age-matched controls. This result, combined with the elevated activity in skin fibroblasts, supports the concept of an abnormal intracellular and extracellular distribution of alpha-L-fucosidase in cystic fibrosis.',\n",
       " '79078': 'Electrolytes and norepinephrine levels in blood of patients with cystic fibrosis.CYSTIC-FIBROSIS: bl.  ELECTROLYTES: bl.  NOREPINEPHRINE: bl.Young adults with cystic fibrosis in good to excellent condition have reduced plasma sodium and chloride and elevated plasma potassium compared to a group of healthy young adult control subjects. Blood pressure was also lower in the patients with cystic fibrosis. However, plasma norepinephrine and dopamine-beta-hydroxylase and their response to standing and isometric hand grip were normal in the cystic fibrosis patients.',\n",
       " '79079': 'Primary amniotic fluid cell, skin fibroblast and liver alpha-L-fucosidase and its relation to cystic fibrosis.CYSTIC-FIBROSIS: en.  FUCOSIDASE: me.Cultured skin fibroblast and primary amniotic fluid cell alpha-L- fucosidase had a double optimum of pH 5.0 and 6.0. Alpha-L-fucosidase was largely bound as a single peak to DEAE-cellulose at pH 6.6. Sucrose density isoelectric focusing revealed up to seven components with pI values of 4.9, 5.2, 5.4, 5.8, 6.1, 6.5 and 7.1 with their apparent KM values (77--500 mumol/l) being higher than that (57 mumol/l) of the unfocused enzyme. Liver, skin fibroblast and amniotic fluid cell alpha-L-fucosidase was separated into two peaks by gel filtration. Peak one was more active and stable at low pH and more thermostable at 50 degrees C than peak two, while both peaks had an apparent KM of 52 mumol/l. Apart from the different proportions of the peaks separated by gel filtration, the results for the three tissues were similar. The properties of alpha-L-fucosidase studied were similar for control and cystic fibrosis liver or skin fibroblasts.',\n",
       " '79080': 'Allergy in cystic fibrosis.CYSTIC-FIBROSIS: im.  HYPERSENSITIVITY-IMMEDIATE: et.Forty-four patients with cystic fibrosis, sixty-seven parents, and thirty-nine controls were compared with regard to their immediate cutaneous hypersensitivity, total and specific serum IgE and serum IgG4 concentrations. The patients had increased prick test reactions and specific IgE to Aspergillus fumigatus. The development of reactions to A. fumigatus correlated with the severity of the disease. There were no other significant differences when serum total IgE, specific IgE and IgG4 concentrations or skin test reactivity were compared in the patients, parents and controls.',\n",
       " '79081': 'Heterozygote advantage in cystic fibrosis: mosquito tests.CYSTIC-FIBROSIS: fg.  INSECT-BITES-AND-STINGS.  MOSQUITOES.Tests to demonstrate a preference by mosquitoes for stinging controls as opposed to obligate heterozygotes for Cystic Fibrosis proved negative. If a heterozygote advantage caused a lower malarial incidence in carriers in South West Africa, it must have worked through the malarial parasite being adversely affected by a serum factor. This remains to be tested.',\n",
       " '79082': 'Deficiency of serum carboxypeptidase B-like (anaphylatoxin inactivator, carboxypeptidase N) activity in sera from patients with cystic fibrosis.CARBOXYPEPTIDASES: df.  CYSTIC-FIBROSIS: en. ARGININE-CARBOXYPEPTIDASE: df.Serum from 95 patients with cystic fibrosis and 47 control subjects without cystic fibrosis was analyzed for carboxypeptidase B-like activity in the presence of optimal concentrations of Co2+ ion, hippuryl-L-lysine and serum.  Fourteen of the cystic fibrosis patients had no steatorrhea and therefore minimal pancreatic dysfunction.  Patients with cystic fibrosis and controls were of comparable age.  Serum carboxypeptidase B-like activity was significantly decreased in cystic fibrosis patients including cystic fibrosis patients without steatorrhea.  Significantly low values were found in both male and female cystic fibrosis patients when compared with controls of similar sex.  Although values were unaffected by age in the control population, values in older patients with cystic fibrosis were significantly lower than values in younger patients.  No correlation was obtained between serum carboxypeptidase B-like activity and pulmonary or hepatic function. Serum carboxypeptidase B-like activity therefore falls with progression of the disease and may limit the ability to degrade circulating peptides in older patients with cystic fibrosis. Deficient serum carboxypeptidase B-like activity is less likely, however, to be a factor in the development of the early manifestations of the disease.',\n",
       " '79083': 'False-positive 111In-labeled leukocyte scan in cystic fibrosis.CYSTIC-FIBROSIS: ri.  INDIUM: du.  RADIOISOTOPES: du.A false-positive 111In-labeled leukocyte scan was obtained in a girl with cystic fibrosis and infection. There was focal accumulation of 111In activity in the abdomen and marked pulmonary uptake. Surgical exploration and postmortem examination revealed no abdominal abnormality. The abnormal activity was apparently due to swallowed sputum which contained labeled leukocytes. Broader clinical implications are discussed.',\n",
       " '79084': 'Study of the oligosaccharide units from mucus glycoproteins of meconium from normal infants and from cases of cystic fibrosis with meconium ileus.CYSTIC-FIBROSIS: me.  MECONIUM: an.  MUCOPROTEINS. OLIGOSACCHARIDES: an.1. The mucus glycoproteins in meconium from normal infants and from infants having cystic fibrosis with meconium ileus have been studied. 2. Whereas normal meconium contained about 50% protein-bound carbohydrate, the meconium from cystic fibrosis contained only about 10%. 3. Glycopolypeptides were prepared from the mucus of glycoproteins. The oligosaccharide units from this material were released and fractionated. The fractions ranged widely in size and composition. 4. The fractions from cystic fibrosis specimens had a significantly higher content of fucose than those from normal specimens.',\n",
       " '79085': 'Pseudomonas aeruginosa infection: pathogenesis and therapy.PSEUDOMONAS-INFECTIONS: th.Infection with the gram-negative bacillus, Pseudomonas aeruginosa, is less common than infections with Escherichia coli, Klebsiella pneumoniae, and Proteus sp; however, the mortality associated with pseudomonas sepsis exceeds that found with the more commonly isolated gram-negative bacilli by a considerable margin.  While explanations exist for this increased virulence of pseudomonas, including secretions of toxic exoproducts and a high degree of antibiotic resistance, the precise reasons for such unfavorable clinical experience with this organism are uncertain.  The current interest in pseudomonas infection is partly due to the ever-increasing numbers of immunosuppressed and granulocytopenic patients seen in clinical practice.  The organism, pathogenesis, clinical presentations (burn patients, nosocomial infections, immunosuppressed patients, cystic fibrosis), and therapy are discussed.',\n",
       " '79086': 'Lipids in cystic fibrosis.CYSTIC-FIBROSIS: dh.  DIETARY-FATS.There are certain aspects of the symptomatology of cystic fibrosis that bear a resemblance to those of essential fatty acid deficiency. We fed a group of patients essential fatty acids orally since intravenous administration is not a practical method for long term treatment.  Results of the study were varied.  Although some response was noted in all patients, there were no consistent clinical changes seen in every patient.  The oral EFA therapy effected no change in sputum cultures.  After one year of EFA, the sweat sodium concentration was lower in all but one patient.  The clinical aspect of our study is small, but promising.  The results suggest a role for EFAs in the care of CF.  Whether EFA is a factor in the etiology of CF or merely a manifestation of malabsorption requires further investigation.',\n",
       " '79087': 'Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.CYSTIC-FIBROSIS: pp.  LUNG: pp.In 28 patients with cystic fibrosis aged 5--24 years the values of maximum expiratory flow rates (Vmax) at lower volume levels were assessed, as well as the \"specific\" conductance of the respiratory pathways (Gaw/TGV), the vital capacity (VC), total lung capacity (TLC), residual volume (RV), functional residual capacity (FRC), RV/TLC and FRC/TLC ratios and the one-second forced expiration of the vital capacity (FEV1) to evaluate obstruction of the respiratory pathways. Most markedly and most frequently abnormal were the values of Vmax, RV and of the RV/TLC ratio. These findings revealed that in almost all patients with CF there was already during the initial examination an obstruction of the peripheral respiratory pathways and hyperinflation of the lungs. During repeated measurement of the above values of lung function in 15 patients with cystic fibrosis during a period of 1--5 years when the patients increased in height by 10 cm on average, the above values did not deteriorate on average. There was, however, an individual variability of the investigated values during this period. The comprehensive treatment provided in our country prevented in patients with CF a deterioration of obstruction of the respiratory pathways during the period of investigation.',\n",
       " '79088': \"Prenatal diagnosis of cystic fibrosis [letter].CYSTIC-FIBROSIS: di.As far as I know, no test for the prenatal diagnosis of cystic fibrosis has yet been shown to be reliable, but several experimental studies on prenatal diagnosis of cystic fibrosis are being carried out.  Deficient protease activity, assayed by 4-methylumbelliferyl guanidinobenzoate, an active site titrant of serine proteases, has been reported in plasma and cultivated skin fibroblasts from patients with cystic fibrosis.  Another prenatal diagnostic test for cystic fibrosis involves the observed resistance of patients' skin fibroblasts to dexamethasone (a synthetic glucocorticoid) toxicity, in comparison to normal fibroblasts.  Specific induction of alkaline phosphatase with Tamm Horsfall glycoprotein, isoproterenol and theophylline has been recorded in skin-derived fibroblasts from affected patients.\",\n",
       " '79089': 'Clinical pharmacology in a paediatric hospital.DRUG-THERAPY: st.  HOSPITALS-PEDIATRIC.  HOSPITALS-SPECIAL. PEDIATRICS.  PHARMACOLOGY.Despite the critical role played by a clinical pharmacologist, there are only three in Canada who specialize in paediatrics.  The role of paediatric clinical pharmacologists in the promotion of safer and more effective drug use, in research, in teaching, and in service are discussed, as well as contributions from clinical pharmacology. Protease deficiency in plasma of patients with cystic fibrosis. Reduced reaction of 4-methylumbelliferylguanidinobenzoate with plasma of patients with cystic fibrosis.CYSTIC-FIBROSIS: en.  HYMECROMONE: bl.  PEPTIDE-HYDROLASES: df. UMBELLIFERONES: bl.Protease activity in plasma is assayed using 4- methylumbelliferylguanidinobenzoate. The assay is modified by carrying out the reaction in the presence and absence of benzamidine, a competitive inhibitor of trypsin-like proteases. The parameters of the assay are described in detail. Using this assay, our earlier demonstration of a deficiency of protease activity in plasma of patients with cystic fibrosis is confirmed. The activity, corrected for the nonspecific hydrolysis of 4- methylumbelliferylguanidinobenzoate by benzamidine, is expressed as nanomoles of 4-methylumbelliferone released per milliliter plasma. Under standard conditions, the activity in plasma activated with chloroform-ellagic acid was 127.2 +/- 23.1 in 7 controls, 70.4 +/- 11.7 in 11 obligate heterozygotes, and 48.7 +/- 16.6 in 12 patients with cystic fibrosis. Identical results were obtained when unactivated plasma was used. These data demonstrate that the judicious use of specific inhibitors such as benzamidine might be useful in assaying low levels of protease activity in crude systems.',\n",
       " '79091': 'Evaluation of long term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: dt.  LUNG-DISEASES: dt. TOBRAMYCIN: tu.To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was achieved in all but one patient. Objective parameters (chest X-ray, pulmonary function tests) changed to a lesser extent. In only one patient was Pseudomonas eradicated from the sputum but reappeared after discontinuation of therapy. In the rest of the patients Pseudomonas was significantly suppressed or replaced by other pathogens. Four patients showed rises of antibody titres to Candida and two to Aspergillus fumigatus. No nephrotoxic side effects were observed, but vestibular function was reversibly impaired in one patient without corresponding clinical symptoms. No bacterial resistance to tobramycin was observed during therapy.',\n",
       " '79092': \"Cystic fibrosis: decreased thermostability of alpha-mannosidase in crude extracellular fluids of patients and carriers.CYSTIC-FIBROSIS: en.  EXTRACELLULAR-SPACE: en.  MANNOSIDASES: me. SKIN: en.We wish to demonstrate that an abnormal thermostability has been found in crude extracellular fluids for alpha-mannosidase.  More extensive studies involving several of the 'leaky' hydrolases are under way and they indicate that the observed thermolabilities can be exploited to develop the urgently needed simple diagnostic tools for cystic fibrosis.\",\n",
       " '79093': 'Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis.CYSTIC-FIBROSIS: pp.  LUNG-VOLUME-MEASUREMENTS.Clinical and radiological findings, quantified by special scores, in 36 patients with cystic fibrosis are compared with lung function measurements, including the ratio of RV/TLC and FEV/VC and the arterial blood gases at rest and during exercise. Although respiratory function tests were found to correlate well with both the pulmonary finding score and the chest radiographic score, distinction of three severity groups was possible only by a vector calculation of the blood gases in PaO2-PaCO2-diagram, at rest and during exercise. Thus, measurements of pO2 and pCO2 at rest and on exercise appear to be a helpful adjuvant to routine spirometry for the individual appraisal of the degree of lung involvement, performance and care level.',\n",
       " '79094': 'Complement in cystic fibrosis.COMPLEMENT-3: an.  CYSTIC-FIBROSIS: im.Quantitative and functional assessments were made of both the classical and alternative pathways of complement activation in sera from 23 patients with cystic fibrosis. The classical pathway functioned similarly in patients and controls as measured by CH50 titre. Alternative pathway function, initiated in patient sera by incubation with inulin, was equal to that of controls as determined by cleavage of Factor B and C3, and by the consumption of terminal components. Factor B, however, was more readily activated in patient than in control sera. This rapid alteration of Factor B did not lead to accelerated or more extensive activation of the terminal complement components via the alternative pathway when assessed by C3 cleavage and the consumption of terminal components. Thus, a complement deficiency was not found. The importance of the easily activated Factor B is undefined.',\n",
       " '79095': 'Substance P plasma levels in pregnancy and in various clinical disorders.PREGNANCY.  SUBSTANCE-P: bl.Using radioimmunoassay, immunoreactive SP (iSP) has been measured in the plasma of 162 hospital patients with various disorders and in the plasma of 67 pregnant women. In pregnancy, iSP was undetectable in 40% women as compared to 12% in other hospital patients. The mean iSP plasma level in pregnancy was 37.8 +/- 4.6 (SEM) as compared to 77.1 +/- 4.9 (SEM) pg/ml in other hospital patients. The results support earlier observations based on bioassay, suggesting that the blood of pregnant women contains higher concentrations of a SP-inactivating factor. Of the hospital patients, elevated levels of iSP were found in patients with chronic leukaemia, in one patient with a basaloid carcinoma of the anus, and in one patient with toxic liver damage and pancreatic insufficiency. No correlation was found between thyroid function and iSP plasma levels. ISP plasma levels in various gastrointestinal disorders were similar to those found in normal subjects.',\n",
       " '79096': 'The effect of serum from patients with pancreatic disease on the short circuit current of rat jejunum.BIOLOGICAL-ASSAY: mt.  JEJUNUM: ph.  PANCREATIC-DISEASES: bl.The short circuit current rat jejunum bioassay, first employed in an attempt to discern the cystic fibrosis (CF) serum \"factor,\" was evaluated using sera from patients with pancreatic disease.  The data suggest other pancreatic diseases, specifically genetic diabetes and alcoholic pancreatitis, also present with a serum \"factor\" (or \"factors\") which reduce the short circuit current of rat jejunum, an effect very similar to that of the CF serum \"factor.\"  A large number of sera from presumed normal subjects also exhibited a significant reduction in short circuit current; these (false positives) represent a yet to be defined mechanism, however, they do decrease the likelihood that the observed effect is merely due to pancreatic destruction.  Detailed procedure and equipment specifications for the bioassay system are included.',\n",
       " '79097': 'Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.ANTIGENS-BACTERIAL: im.  CYSTIC-FIBROSIS: im. ENTEROBACTERIACEAE: im.  LYMPHOCYTE-TRANSFORMATION. PSEUDOMONAS-AERUGINOSA: im.In vitro lymphocyte responses to Pseudomonas aeruginosa have been found to be impaired in cystic fibrosis patients with advanced clinical disease. The responses to Klebsiella pneumoniae, Serratia marcescens, and Proteus mirabilis were studied in a similar group of cystic fibrosis patients and normal individuals. Cystic fibrosis patients found to be unresponsive to pseudomonas were also unresponsive to klebsiella, serratia, and proteus. Responsiveness to Staphylococcus aureus was not impaired in cystic fibrosis patients. We postulate that in vitro lymphocyte responses to several gram- negative bacteria require the function of a lymphocyte subpopulation which may be impaired in some cystic fibrosis patients.',\n",
       " '79098': 'High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.ANTIBIOTICS: ad.  CYSTIC-FIBROSIS: co.  PSEUDOMONAS-INFECTIONS: dt. RESPIRATORY-TRACT-INFECTIONS: dt.  TOBRAMYCIN: ad.The bacteriological effect of chemotherapy against mucoid strains of Pseudominas aeruginosa in the lower respiratory tract of patients with cystic fibrosis is reported. A comparison of the effect of high doses of tobramycin (10 mg/kg/24 h) given alone or in combination with carbenicillin showed a significant difference in favour of the combination therapy. In 74.5% of the initially successful courses the patients were recolonized within one month. Fifty-three patients were examined by audiometric and vestibular tests. Only in one patient was it possible to register a transient, high tone hearing impairment at 8000 Hz bilaterally, that might be attributed to the tobramycin treatment. It is concluded that high dose tobramycin treatment in children and adolescents with normal kidney function implies only a minimal clinical risk of adverse ototoxic effects, even after repeated courses of treatment. No nephrotoxic side-effects were found in this material.',\n",
       " '79099': 'The immotile-cilia syndrome and other ciliary diseases.CILIA: pp.It is the purpose of this review to present evidence for a disorder which is believed to be caused by defective cilia and to review some data on the occurrence of abnormal cilia, evidently formed in response to environmental insults.  The cilium, human ciliated structures, the immotile-cilia syndrome and other inborn ciliary diseases, cystic fibrosis, and acquired disorders of ciliated structures are discussed.  Ciliary activity is not vital, but its loss will cause a great deal of discomfort.  The greatest problems relate to the lower respiratory tract, which is also a site of most of the cilia in the body.  It is striking that a certain degree of clearance can be maintained in the lungs in the absence of motile cilia by coughing, hawking, and other mechanisms.',\n",
       " '79100': 'Cystic fibrosis.CYSTIC-FIBROSIS: th.Cystic fibrosis is an hereditary disorder that affects infants, children, adolescents, and young adults.  Its genetic influence, signs and symptoms, diagnostic tests, nutritional management and diet therapy, respiratory infection, and growth retardation are discussed.',\n",
       " '79101': 'Tobramycin ototoxicity.  Repeated courses of high dosage treatment in children with cystic fibrosis.ANTIBIOTICS: ae.  CYSTIC-FIBROSIS: co.  EAR-DISEASES: ci. PSEUDOMONAS-INFECTIONS: dt.  RESPIRATORY-TRACT-INFECTIONS: dt. TOBRAMYCIN: ae.Fifty-three patients with cystic fibrosis were treated with large doses of tobramycin sulphate, 10 mg/kg/24 h.  Patients received an average of 3.2 courses, each lasting 10 to 14 days.  The patients were examined with audiometric and vestibular tests, and in one patient, a 10-year-old girl, we found a transient high tone loss at 8000 Hz bilaterally that might be attributed to the tobramycin treatment.  All patients had normal kidney function.  High dose tobramycin treatment in children with normal kidney function gives minimal clinical risks of adverse ototoxic effects, even after repeated courses of treatment.',\n",
       " '79102': 'Round table discussion--treatment of lower respiratory tract infections with co-trimoxazole.RESPIRATORY-TRACT-INFECTIONS: dt.  SULFAMETHOXAZOLE: tu. TRIMETHOPRIM: tu.Over one thousand patients with acute and chronic chest infections have been treated with a combination of trimethoprim and sulphamethoxazole.  The patients may be divided into four groups and the results are summarised in this presentation.  Much of the work is published elsewhere.',\n",
       " '79103': 'Epidemiology of cystic fibrosis: a review.CYSTIC-FIBROSIS: oc.Three main reasons have been advanced for the degree of ignorance and confusion surrounding epidemiologic measures of the incidence and prevalence of Cystic Fibrosis. (CF)  Relatively recent recognition of CF as a specific disease entity.  Wide range of clinical manifestations, presentation as a multisystem disease, and great natural variation in the severity of involvement of various organs.  Past difficulty in establishing a diagnosis based on sound laboratory evidence, this being largely due to the lack of a screening test that had gained wide acceptance among diagnosticians, and inaccuracies in the performance and interpretation of the sweat test.  In addition to these factors, there are a number of methodological deficiencies and questionable assumptions in several of the papers that have here been reviewed.  It may be noteworthy that the two sets of authors whose research design most closely matched being aimed at providing multiple ascertainment of cases and cross-checks of validity, have arrived at nearly the same estimated incidence of this particular disorder (1/3700 and 1/3800 respectively).  The issue of selection and diagnostic criteria is one that has important implications for epidemiologic studies of cystic fibrosis.  Particularly in a disease like CF, where the spectrum of clinical manifestations and severity of involvement is so broad, estimates of incidence will vary according to the criteria by which cases are ascertained and included.  A greater degree of uniformity in standards than has been employed in previous studies is necessary before comparisons can meaningfully be made.  There are good grounds for regarding most estimates of CF incidence to be minimum confirmed figures, and this is particularly so where the research design ensures that multiple ascertainments of the same case will be identifiable.  Higher estimates are made where several sources of error (respondent bias, generalization of hospital data to the wider population, multiple ascertainments of the same patient) are not recognised.',\n",
       " '79104': \"The impact of grief: a retrospective study of family function following loss of a child with cystic fibrosis.CYSTIC-FIBROSIS: px.  DEATH.  FAMILY.  GRIEF.The impact of the death of a cystic fibrosis child on subsequent family function was evaluated in a retrospective study of 16 families.  In findings similar to that reported for another model of fatal childhood illness, leukemia, there was a high incidence of emotional and medical problems in the parents.  There was an unexpectedly high incidence (7/16) of incomplete mourning, i.e., maintenance of the child's room as a shrine or weekly grave visit for more than six months.  Siblings had less difficulty in adjusting to the loss than that reported for the siblings of leukemic children.  It is suggested that the prolonged course of a disease with a hopeless prognosis prepares the family for the child's death but also retards the mourning process.  The family may need counseling to ensure that mourning is completed.\",\n",
       " '79105': 'Synthesis of hemoglobin Aic and related minor hemoglobin by erythrocytes.  In vitro study of regulation.ERYTHROCYTES: me.  HEMOGLOBIN-A: bi.  HEMOGLOBINS: me.Factors that influence hemoglobin (Hb)Aic synthesis by intact erythrocytes were studied in vitro.  After incubation cells were lysed, and hemoglobins were separated by isoelectric focusing on polyacrylamide slab gels and quantitated by microdensitometry. HbAic increased with time, glucose concentrations (5-500 mM) and incubation temperature (4 degrees-37 degrees C).  Low temperatures allowed prolonged incubations with minimal hemolysis.  At 4 degrees C HbAic increased linearly with time for 6 wk; after incubation at the highest glucose concentration, HbAic comprised 50% of total hemoglobin.  Insulin (1 and 0.1 mU/ml) did not affect HbAic synthesis in vitro.  In addition to glucose, galactose and mannose, but not fructose, served as precursors to HbAic.  A good substrate for hexokinase (2-deoxy-glucose) and a poor hexokinase substrate (3-O-methyl-glucose), were better precursors for HbAic synthesis than glucose, suggesting that enzymatic phosphorylation of glucose is not required for HbAic synthesis.  Autoradiography after erythrocyte incubation with 32P-phosphate showed incorporation of radioactivity into HbAia1 and HbAia2, but not HbAib, Aic, or A. Acetylated HbA, generated during incubation with acetylsalicylate, migrated anodal to HbAic and clearly separated from it. Erythrocytes from patients with insulinopenic diabetes mellitus synthesized HbAic at the same rate as controls when incubated with identical glucose concentrations.  Likewise, the rate of HbAic synthesis by erythrocytes from patients with cystic fibrosis and congenital spherocytosis paralleled controls.  When erythrocytes from cord blood and from HbC and sickle cell anemia patients were incubated with elevated concentrations of glucose, fetal Hb, HbC, and sickle Hb decreased whereas hemoglobins focusing at isoelectric points near those expected for the corresponding glycosylated derivatives appeared in proportionately increased amounts.',\n",
       " '79106': 'Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.CYSTIC-FIBROSIS: mi.  PSEUDOMONAS-AERUGINOSA: cl.  SPUTUM: mi.A phenotypic characterization of Pseudomonas aeruginosa from single sputum samples of 21 typical cystic fibrosis patients indicated a high frequency of heterogeneity among isolates on the basis of differences in antibiotic resistance, colony morphology, pigmentation, and serotype.  Two or more isolates with different but stable susceptibilities to carnecillin, gentamycin, streptomycin, tetracycline, chloramphenicol, and sulfamethoxazole plus trimethoprim were detected in 38% of the sputa.  Differences generally were independent of the mucoid state of the strain.  O- antigen group determination with the Difco typing set showed that two or more serologically distinct strains were present in 10/21 sputum specimens.  Nonmucoid derivatives of mucoid isolates almost always retained both the antibiotic susceptibilities and serotype of their parent strain.  These data suggest that cystic fibrosis patients may be cocolonized/coinfected by difference strains of P. aeruginosa more frequently than generally believed.  Alternatively, phenotypically distinct strains from a single patient might arise as phenotypic dissociants from a single infecting strain.  Because of the frequency and multiplicity of phenotypically distinct P. aeruginosa isolates which we obtained from our cystic fibrosis patients, it is important to select multiple isolates from sputum cultures for antimicrobial susceptibility testing so as to assess adequately the susceptibility of this organism to antibiotic therapy in cystic fibrosis.  We recommend that several colonies of each distinguishable colony type of P. aeruginosa be pooled for the antibiogram.',\n",
       " '79107': 'Dietary problems associated with the care of chronically sick children.CHRONIC-DISEASE: dh.  DIET.The dietary problems associated with the care of chronically sick children can be considered under two broad headings.  First, there are the problems in those children for whom diet is an essential part of the treatment of their chronic disorder; and second there are nutritional complications which may occur in children with chronic diseases in which diet does not have a specific role in treatment, and is thus often neglected or considered only at a later stage of management.  Many of the problems are of course common to both situations.  This paper will review briefly some of the difficulties, illustrating these with specific examples; no attempt will be made to describe or discuss the treatment of any particular disorder.',\n",
       " '79108': 'Inborn errors of metabolism: the need for sugar.DIETARY-CARBOHYDRATES.  METABOLISM-INBORN-ERRORS: dh.Inborn errors of metabolism are conditions in which the body fails to metabolise certain chemicals due to an inherited enzyme deficiency. The inborn errors of metabolism considered in this paper are those which affect the metabolism of dietary nutrients and which require manipulation of the carbohydrate intake.  In these cases the need for sugar - either as a source of energy when other energy-supplying nutrients have to be suppressed, or for the control of hypoglycaemia - is vitally important.  Inborn errors of protein metabolism include phenylketonuria, maple-syrup urine disease, organic acidaemias, and hyperammonaemia.  Inborn errors of fat metabolism  include abetalipoprotinaemia, type I lipoprotein-lipase deficiency, and lymphangiectasia.  Inborn errors of carbohydrate metabolism include diabetes, galactosaemia, fructosaemia, and glucose-6-phosphate deficiency (type I glycogen storage disease).  Inborn errors of multiple nutrients include cystic fibrosis.  Dietary carbohydrate, psychological considerations, and dental caries are examined.',\n",
       " '79109': 'Therapeutic possibilities in Pseudomonas infections.PSEUDOMONAS-INFECTIONS: th.Acute pseudomonas infections require treatment with antibiotics producing a bactericidal effect. The most useful are gentamicin, tobramycin, sisomicin and polymyxin B. In resistant strains, amikacin is indicated in addition. Carbenicillin, ticarcillin, carfenicillin or azocillin should never be given alone but in combination with some of the above preparations. Other drugs, such as chloramphenicol, tetracycline or streptomycin, though effective in vitro, should be avoided. Chemotherapy may be complemented by passive immunization either with hyperimmune specific gama globulin or hyperimmune plasma. A programmatic item of combined treatment is active immunization, especially with toxoid vaccine. Chronic processes are not, perhaps with the exception of urinary infections, suitable for antibiotic therapy. For this reason effective polyvalent vaccines should be developed from appropriate strains. It is now certain that in infections caused by mucous strains (most frequently encountered in cystic fibrosis) the vaccine should be prepared from these strains, since they have distinct functional and antigenic characteristics. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.CYSTIC-FIBROSIS: dt.  PSEUDOMONAS-AERUGINOSA: ip.Clinical isolates of Pseudomonas aeruginosa from patients with cystic fibrosis were studied in an effort to determine the unique characteristics of the infecting strains and to elucidate the pattern of colonization. Of 413 patients studied, 81% were chronically infected with P. aeruginosa. Patients from whom P. aeruginosa was never or only occasionally isolated were in better clinical condition than the chronically infected patients. Isolates were classified into six morphologic varieties: classic, rough, mucoid, gelatinous, dwarf, and enterobacter. Most patients had two or more of these varieties. Such multiple varieties from the same individual were of the same serotype but often differed in antibiotic susceptibility as determined by both the disk and the minimal inhibitory concentration methods. These differences were apparent when mucoid strains were compared with nonmucoid strains and when nonmucoid strains were compared with one another. Studies of antibiotic susceptibility should be performed on each morphologically different type of P. aeruginosa obtained from patients with cystic fibrosis.',\n",
       " '79111': 'Summary of a workshop on infections in patients with cystic fibrosis.BACTERIAL-INFECTIONS: co.  CYSTIC-FIBROSIS: et.Cystic fibrosis is currently the most common fatal hereditary disease of the Caucasian race.  The lack of effective oral antibiotics against Pseudomonas aeruginosa precludes either systemic treatment or suppression, in an outpatient setting, of the chronic pseudomonas bronchitis typically seen in CF patients.  Because of the central role of infection, and particularly pseudomonas infection, in the sequence of events that leads to respiratory failure and death in CF, currently available information regarding the pathogenesis of infections caused by P. aeruginosa was emphasized and discussed at a workshop on infections in patients with CF, sponsored by the National Institute of Allergy and Infectious Diseases in Bethesda, Md., on January 9 and 10, 1979.',\n",
       " '79112': 'Sulfhydryl-mediated depression of ciliary activity: an adverse effect of acetylcysteine.ACETYLCYSTEINE: ae.  CILIA: de.  SULFHYDRYL-COMPOUNDS: pd.Although N-acetyl-L-cysteine (Mucomyst) is an effective mycolytic, numerous investigations have failed to demonstrate a consistent improvement in pulmonary mechanics following its use. In order to determine whether its beneficial mucolytic activity might be counterbalanced by a deleterious direct effect on cilia, we studied its effect on the activity of ciliated epithelium in the ferret tracheal organ culture system. N-acetyl-L-cysteine consistently caused progressive time-dependent ciliostasis at concentrations clinically employed, with complete ciliary paralysis within 8 hr. The effect was only partially reversed by the removal of the drug. Control preparations retained full ciliary activity for 3 to 12 weeks. In order to determine the active site on the N-acetyl-L- cysteine molecule, we investigated the ciliostatic effects of five of its chemical analogs. Isomolar N-acetyl-L-alanine was not ciliostatic, indicating the necessity of a sulfhydryl group for activity. Ciliostasis was independent of isomeric structure, acetylation, and chain length, as evidenced by the similar ciliostatic effects of L-cysteine, D-cysteine, 2-mercaptoethylamine, and N-acetyl-L-homocysteine. We conclude that N-acetyl-L-cysteine induces partially reversible ciliostasis of tracheal epithelium via its sulfhydryl group; prolonged use of this drug may impair mucociliary clearance.',\n",
       " '79113': 'Adult cystic fibrosis: a new therapeutic challenge for the primary care physician.CYSTIC-FIBROSIS: th.In this article, we will examine the reasons for the prolonged survival of individuals with cystic fibrosis as well as discuss the pathogenesis, diagnosis and treatment of this multisystemic disease. The reasons for the improved prognosis in CF are multiple: improved antibiotic therapy, early diagnosis, specialized care centers, and aggressive treatment regimens.  This presents the primary care physician with a new and challenging patient population, requiring the coordinated effort of the health care team, including specialists, nurses, therapists, etc., to achieve effective therapy for this truly multisystemic disease.',\n",
       " '79114': 'Cystic fibrosis in Northern Ireland.CYSTIC-FIBROSIS: oc.In a retrospective study of cystic fibrosis in Northern Ireland for 1961 to 1971, the incidence was 1 in 1857 livebirths, which is comparable to figures from Great Britain and the Republic of Ireland.',\n",
       " '79115': 'Cutaneous necrotizing venulitis in patients with cystic fibrosis.CYSTIC-FIBROSIS: co.  PHLEBITIS: pa.  PURPURA: pa.  SKIN: bs.Palpable purpura was noted to occur late in the course of some patients with cystic fibrosis. Skin biopsy specimens showed necrotizing venulitis characterized by a perivenular infiltrate composed of neutrophilic leukocytes, fibrin, hypogranulated mast cells, and endothelial cell necrosis. Circulating immune complexes were detected. Recurrent pulmonary infections and the chronic administration of therapeutic agents provide sources of potential antigens.',\n",
       " '79116': 'HLA determinants in families with more than one member with cystic fibrosis [letter].ANTIGENIC-DETERMINANTS.  CYSTIC-FIBROSIS: fg.  HLA-ANTIGENS.Attempts to identify the carrier state for cystic fibrosis (CF) or to make a prenatal diagnosis of CF have been unsuccessful.  One approach to this problem is to look for associations between known genetic markers and the locus for CF.  In general these studies have looked at the frequency of HLA types in patients with CF and have failed to demonstrate a strong association.  We attempted to look for linkage between HLA haplotypes and CF in families with more than one affected member.  The segregation of HLA in these affected sibpairs vary little from the expected.  Although the sample size is small, it is unlikely that a close linkage exists between the HLA loci and the CF locus.',\n",
       " '79117': 'Episodic arthritis in children with cystic fibrosis.ARTHRITIS: co.  CYSTIC-FIBROSIS: co.Five children 2 to 10 years of age with cystic fibrosis developed transient episodic arthritis.  Although polyarticular in distribution, only one joint might be involved during each attack. No laboratory or radiologic evidence of juvenile chronic arthritis was present and no permanent joint limitation was noted.',\n",
       " '79118': 'Failure to thrive, anemia, and anasarca.CYSTIC-FIBROSIS: co.  FOOD-HYPERSENSITIVITY: co.  MILK: ae. PROTEIN-LOSING-ENTEROPATHIES: et.A 5-month-old white girl was admitted to an Infant Intensive Care Unit of Jackson Memorial Hospital.  According to her mother, the baby had been in \"her usual state of health\" until one week before admission, when she began to \"spit up\" after feedings and her lower extremities became puffy.  Vomiting increased in frequency until it occurred after every meal; eventually the baby refused all feedings; there was no diarrhea.  Ultimately, the family\\'s physician, when consulted, recommended that she be admitted to the hospital.  On the fourth day she developed renal failure with anuria and rising creatinine concentration despite adequate fluid intake; peritoneal dialysis was begun.  However, she soon became hypothermic and developed pulmonary edema, and she died a few hours later.  A discussion of the case is presented.',\n",
       " '79119': \"Bronchial hyperreactivity in cystic fibrosis [letter].BRONCHIAL-SPASM: co.  CYSTIC-FIBROSIS: co.Mitchell and co-workers conclude that bronchial hyperreactivity is common in cystic fibrosis (CF) but is different from that in asthma. Their data were interesting, but I do not agree with their conclusion.  One can interpret these data as suggesting a common reversible component in both patient groups, and perhaps a common denominator in mechanism.  Because of certain problems with baseline measurements and withholding of medication, it seems that the conclusion of Mitchell et al may not be well supported. - We felt justified in studying those patients with a low baseline FEV (forced expiratory volume in one second), since a subject's bronchial response to methacholine remains stable even if these is moderate fluctuation both in initial specific airway conductance and in the severity of the disease.  We feel that withholding the drug for a longer period would not have affected the comparisons.  Although there might be a common underlying mechanism in bronchial hyperreactivity in asthma and cystic fibrosis, our data showed a number of differences between the two groups of patients.  Although these differences would not exclude a common mechanism in bronchial hyperreactivity in the two diseases, the existence of the differences should lead to caution in concluding that there is a common underlying mechanism in the bronchial hyperreactivity in the two diseases.\",\n",
       " '79120': 'A peroral test of pancreatic insufficiency with 4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic fibrosis.P-AMINOBENZOIC-ACID: du.  AMINOBENZOIC-ACIDS: du. CYSTIC-FIBROSIS: di.We report on the examination of stimulated pancreatic secretion using 4-(N-acetyl-L-tyrosyl)aminobenzoic acid in children with cystic fibrosis.  In controls the urinary excretion of 4-aminobenzoic acid amounted to 54.8 +/- 11.7% with 19.6% as the lower limit of normal during six hours, and 74.7 +/- 10.8% and 40.5% during eight hours. In children with cystic fibrosis the mean values were 5.6% in the six-hour test and 13.7% in the eight-hour test.  Both values are significantly different in comparison with controls.  It may be assumed that both 4-(N-acetyl-L-tyrosyl)aminobenzoic acid and 4-(N-benzoyl-L-tyrosyl)aminobenzoic acid are suitable for indirect determination of exocrine pancreatic secretion in children.',\n",
       " '79121': 'The effect of cimetidine on maldigestion in cystic fibrosis.CIMETIDINE: tu.  CYSTIC-FIBROSIS: co.  GUANIDINES: tu. MALABSORPTION-SYNDROMES: dt.Ten patients (6 to 27 years of age) who had severe pancreatic exocrine insufficiency due to cystic fibrosis were studied to determine whether cimetidine would improve dietary fat and nitrogen absorption. When a constant diet was consumed and oral pancreatic enzymes were administered, the addition of cimetidine (150 or 200 mg taken orally one-half hour before meals) signficantly reduced fecal fat excretion from 25.3 +/- 2.9 to 17.3 +/- 2.1 gm/24 hours and fecal nitrogen excretion from 4.5 +/- 0.6 to 3.4 +/- 0.5 gm/24 hours (P less than 0.05). Lower doses of cimetidine resulted in less significant reductions of steatorrhea and azotorrhea. Cimetidine may be a useful adjunct to oral pancreatic enzyme therapy in patients with cystic fibrosis who continue to have steatorrhea and azotorrhea with enzyme therapy alone.',\n",
       " '79122': 'Normal neutrophil and monocyte chemotaxis in patients with cystic fibrosis.CHEMOTAXIS-LEUKOCYTE.  CYSTIC-FIBROSIS: bl.The prominent role of infection in the clinical course of cystic fibrosis has led to considerable investigation of possible immune deficiency in these patients.  Leukotaxis of circulating phagocytic cells and the ability to generate chemotactic factors are important in host defenses against bacterial invasion.  These properties were investigated in patients with clinically stable cystic fibrosis to determine if they possess dysfunctional inflammatory responses which would predispose them to severe infection.',\n",
       " '79123': \"Hyperuricemia in cystic fibrosis [letter].CYSTIC-FIBROSIS: bl.  URIC-ACID: bl.Davidson et al report hyperuricemia in cystic fibrosis patients ingesting large quantities of pancreatic extracts.  This article and others emphasize the considerable purine content of these preparations as causal to the increased serum and urine uric acid levels in patients who consume them.  This may find clinical application, since uric acid production from RNA might be decreased by an inhibitor of ribonuclease.  While itself a purine chain, polyadenylic acid added to pancreatic extracts may prevent the hydrolysis of mixed-base ribonucleic acid to uric acid precursors, while allowing the beneficial effects of the other pancreatic enzymes to prevail. - A number of weaknesses to the proposal bears stressing before we begin giving polyadenylic acid to our patients.  No one knows whether nucleic acids are malabsorbed in cystic fibrosis.  If polyadenylic acid produces only 70% inhibition of pancreatic ribonucleases at a one-to-one ratio of substrate and inhibitor, a relatively enormous amount of polyadenylic acid would have to be fed with the pancreatic extracts.  If there were an intestinal enzyme capable of cleaving polyadenylic acid, the treatment would add to, not subtract from, the purine load.  Finally, Stapleton et al's results suggest that more than 75% of the purine load in the pancreatic extracts would probably be absorbed anyway.\",\n",
       " '79124': 'Bronchial artery embolization in cystic fibrosis; technique and long-term results.BRONCHIAL-ARTERIES.  CYSTIC-FIBROSIS: co.  EMBOLIZATION-THERAPEUTIC. HEMOPTYSIS: th.Severe bronchial hemorrhage in 13 patients with cystic fibrosis was treated by catheter embolization of bronchial arteries. Indications were either excessive bleeding persisting for several days, or bleeding serious enough to interfere with pulmonary drainage and recurring over weeks or months. In follow-up ranging from one to 30 months, cessation of major bleeding was achieved in 12 of 13 patients (93%), although 5 of 13 patients (40%) did have recurrence of minor hemoptysis. No neurologic or other major complications were encountered. However, there are potential risks and this approach at present should be limited to patients with life-threatening bleeding and carried out only by experienced angiographers.',\n",
       " '79125': 'Reliability of sweat test in cystic fibrosis [letter].CYSTIC-FIBROSIS: di.  SWEAT: an.The report by Huff, Huang, and Arey again calls attention to the heterogeneity of cystic fibrosis and to the fact that a properly performed sweat test in the normal or borderline range does not rule out cystic fibrosis.  This may occur in approximately 1% of patients we classify as having cystic fibrosis and confirms our original impression that the sweat test has a reliability of between 98% and 99%.  One must pay close attention to the clinical picture, the family history, and especially the pulmonary or gastrointestinal findings, and provide rational treatment until more acceptable evidence of the disease can be documented.  In the same issue is a report on a false positive sweat test in a Canadian patient with the Mauriac syndrome.  The authors list a variety of conditions that have been reported as yielding elevated sweat electrolytes.  The manner of the collections can greatly influence the result. - In patients with transient abnormal sweat electrolytes, sodium values were consistently higher than chloride values.  Perhaps the finding of sodium values in excess of chloride in the abnormal range suggests a false positive test.',\n",
       " '79126': '25-Hydroxycholecalciferol levels in patients with cystic fibrosis.CYSTIC-FIBROSIS: bl.  HYDROXYCHOLECALCIFEROLS: bl.Assessment of the status of circulating vitamin D in cystic fibrosis patients was investigated by determining serum levels of 25-hydroxycholecalciferol.  The majority of the patients with CF and pancreatic insufficiency had levels of 25-OH-D within the normal range.  Clinical symptoms or pathologic signs resulting from deficiencies of vitamins A and E in patients with CF have been repeatedly documented.  In contrast, a paradoxical lack of vitamin D deficiency signs has been observed in CF patients.  This is especially puzzling since rickets had been commonly associated with most other forms of steatorrhea.  We can only speculate why rickets was formerly rarely reported in association with CF.  Perhaps because of voracious appetites and the selective absorption of vitamin D via the lymphatics without requiring esterification, these individuals were spared clinical rickets.',\n",
       " '79127': 'Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis.CALCIUM: bl.  CYSTIC-FIBROSIS: bl.  HYDROXYCHOLECALCIFEROLS: bl.Vitamin D and mineral metabolism were studied in 21 adolescents and young adults with cystic fibrosis and the results were compared to those in 21 matched controls. All CF patients had been maintained on standard multivitamin supplements in combination with pancreatic enzyme replacement. Despite this supplementation, relative to control subjects the CF patients had a 36% reduction in serum 25- hydroxyvitamin D concentration, a slight but significant reduction in serum calcium concentration, evidence of calcium malabsorption with secondary hyperparathyroidism, and a 14% decrease in bone mass measured by the photon absorption technique. Currently accepted modes of pancreatic enzyme replacement and vitamin D supplementation are often inadequate to maintain normal mineral homeostasis in CF patients; additional measurements may be required to reduce the risk of clinically significant osteopenia concomitant with prolonged survival in CF.',\n",
       " '79128': 'Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with cystic fibrosis.CYSTIC-FIBROSIS: bl.  DIHYDROXYCHOLECALCIFEROLS: bl. HYDROXYCHOLECALCIFEROLS: bl.Steatorrhea is a prevalent gastrointestinal manifestation of cystic fibrosis.  Although deficiencies of vitamins A, E, and K have been described in patients with this disease, vitamin D deficiency and rickets have rarely been reported.  The major form of vitamin D, cholecalciferol (vitamin D3), is produced by ultraviolet irradiation of 7-dehydrocholesterol in the skin.  Ergocalciferol (vitamin D2) is a product of plant ergosterol.  We studied the vitamin D status of patients with cystic fibrosis by measurement of the serum concentrations of the major circulating metabolites of vitamin D: 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D.  The mean serum concentrations of total 25OHD, 25OHD3, and 24,25(OH)2D and 25OHD3/25OHD ratios in patients with cystic fibrosis were similar to values recorded in control subjects.  The present study demonstrates that the serum concentrations of the major metabolites of vitamin D in patients with cystic fibrosis are similar to those in healthy subjects.',\n",
       " '79129': 'Atypical cystic fibrosis of the pancreas with normal levels of sweat chloride and minimal pancreatic lesions.CHLORIDES: an.  CYSTIC-FIBROSIS: di.  SWEAT: an.This paper presents additional evidence of the variability and independence of the involvement of the sweat glands in cystic fibrosis.  A case report of an infant girl, who died at age 9 years of progressive pulmonary disease, is presented.  The case indicates that fatal cystic fibrosis, or a variant thereof, can exist with normal levels of sweat chloride and that the pulmonary disease develops independently of the functional abnormality of the sweat glands.',\n",
       " '79130': 'Noninvasive evaluation of ventricular function in cystic fibrosis.CYSTIC-FIBROSIS: pp.  HEART-VENTRICLE: pp.The cardiac function of 21 patients with cystic fibrosis was studied using radionuclides and M-mode echocardiography. The patients (mean age 13.2 years, range 4 to 27) had a wide range of clinical and pulmonary function abnormalities (mean Shwachman-Kulczycki score 62.1). Decreased right ventricular ejection fraction was found in 13 of 18 patients (72%); an additional four patients had abnormal septal motion on ECHO. Left ventricular ejection fraction was abnormal at rest in four patients (19%); an additional four patients had borderline low LVEF. The LV pre-ejection period to ejection time ratio increased significantly (i.e., worsening LV performance) with deterioration of S-K score, chest radiograph score, and forced expiratory volume in 1 second. Three of eight patients with normal LVEF at rest had an abnormal response to supine bicycle exercise: LVEF fell in two patients and was unchanged in one. Thus evidence of LV dysfunction was observed in seven of 21 (33%) of the patients; four at rest and in three only during exercise.',\n",
       " '79131': \"Aminoglycoside clearance in patients with cystic fibrosis [letter].AMIKACIN: me.  CYSTIC-FIBROSIS: me.  KANAMYCIN: aa.  KIDNEY: me.We have been utilizing a patient's individual pharmacokinetic profile to plan and monitor aminoglycoside therapy, and we have often noted what appeared to be an extremely rapid elimination rate of gentamicin in our patients with cystic fibrosis.  The patients with cystic fibrosis had significantly greater renal and total clearances than those without cystic fibrosis.  If this observation could be extended to other drugs (such as the aminoglycosides), which are not normally subject to renal secretion, it would prove intriguing evidence for a possible primary renal defect in these patients.\",\n",
       " '79132': 'A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis.AMBULATORY-CARE.  CEPHALEXIN: tu.  CYSTIC-FIBROSIS: co.The effects of oral administration of cephalexin were evaluated in a double-blind, placebo-controlled, crossover study in 17 patients with mild to moderate pulmonary disease due to cystic fibrosis.  For two years, four-month periods with cephalexin were alternated with four-month placebo periods.  Thus, patients served as their own control subjects.  Fungal vulvovaginitis occurred in two patients during cephalexin therapy.  During the 2 years of study, the rate of colonization with mucoid strains of Pseudomonas aeruginosa increased and disease severity deteriorated in patients initially colonized with P. aeruginosa.  Short-term courses of sputum culture-specific antibiotics improved the course of some patients with mild to moderate pulmonary disease due to cystic fibrosis.  Treatment with cephalexin decreased the frequency of respiratory illnesses, respiratory illnesses requiring antibiotics, and hospitalizations for respiratory illnesses in patients initially colonized with Staphylococcus aureus and/or Haemophilus influenzae, and also reduced colonization with these organisms.  Improved weight gain in 16 of 17 patients was associated with periods of cephalexin therapy. Pulmonary function tests remained stable or improved in 10 or 14 patients.  Disease severity improved in patients not colonized with P. aeruginosa.',\n",
       " '79133': 'False positive sweat test, malnutrition, and the Mauriac syndrome.CHLORIDES: an.  DWARFISM: co.  HEPATOMEGALY: co. NUTRITION-DISORDERS: co.  SWEAT: an.Mauriac syndrome is characterised by hepatomegaly, glycogen infiltration of the liver, retarded sexual maturation, and short stature in diabetic children.  We report the first example of Mauriac syndrome, in a patient clinically malnourished and edematous, who had a transient false positive sweat test.  Malnourished children who have a positive sweat test should have repeated sweat tests once the malnourished state has been reversed.  This would eliminate error in the diagnosis of cystic fibrosis.',\n",
       " '79134': 'Cystic fibrosis in two black children with sickle cell anemia.ANEMIA-SICKLE-CELL: co.  CYSTIC-FIBROSIS: co.Sickle cell anemia and cystic fibrosis are the most frequent lethal inherited diseases in the black and white population, respectively. The occurrence of both diseases in the same individual has not been reported in the literature.  This report presents two such patients and poses questions concerning the possible clinical implications of the simultaneous occurrence of both diseases.',\n",
       " '79135': 'Cystic fibrosis and malnutrition.CYSTIC-FIBROSIS: co.  NUTRITION-DISORDERS: et.Cystic fibrosis as a specific disease entity has been known to be associated with malnutrition for almost half a century. The importance of the malnutrition in the disease process remains unknown, as does much information about specific nutritional deficiencies in CF. Supplements for children with CF should include extra energy as fat or carbohydrate, a form of linoleic acid that can be absorbed, hydrolyzed protein, fat-soluble vitamins with vitamins A and E in a water emulsion, vitamin B12, probably B vitamins and vitamin C, and trace minerals. Routine measurements of nutritional status, particularly in children with growth failure, should be made at regular intervals and should include a three-day diet record and a simultaneous 72-hour stool fat determination. If fat malabsorption is not controlled by pancreatic enzymes, the use of antacids or cimetidine should be considered. The true role of nutrition in patients with CF will not be known until the appropriate studies are completed.',\n",
       " '79136': 'Preatherosclerotic aortic lesions in cystic fibrosis.AORTA: pa.  ARTERIOSCLEROSIS: pa.  ATHEROSCLEROSIS: pa. CYSTIC-FIBROSIS: pa.Patients with cystic fibrosis have fat malabsorption, providing an experimental model for evaluation of the hypothesis that a low-fat intake may prevent atherosclerosis. We studied the frequency and extent of aortic precursor lesions (fatty streaks, early fibromusculoelastic lesions, late fibromusculoelastic lesions) found at autopsy in this disease as well as in other patients with debilitating disorders but with no apparent impairment of fat absorption. Fatty streaks were less common in the cystic fibrosis group, as were the late fibromusculoelastic lesions. There was no significant difference in the frequency, length, or thickness of the early fibromusculoelastic lesions. The findings suggest that fat may be responsible for progression but not initiation of the fibromusculoelastic precursor lesions, and support the concept that early restriction of dietary fat may prevent, delay, or otherwise modify atherosclerosis in the adult.',\n",
       " '79137': 'PABA-test for diagnosis of exocrine pancreatic insufficiency [letter].P-AMINOBENZOIC-ACID: du.  AMINOBENZOIC-ACIDS: du. CYSTIC-FIBROSIS: di.We have also found a significant difference between the 6-hour urinary PABA recovery in healthy controls and CF patients, with no overlap of the ranges, and a good correlation with fecal chymotrypsin activity.  We can stress the usefulness of the test in this age group.  In studying a group of healthy newborn infants, however, the results were quite different: The PABA recovery was smaller and showed greater variations and overlap with results in CF patients occurred.  It is clear that the test is not applicable in newborn infants when performed in the described manner.  One possible explanation is the physiologically limited glomerular filtration rate in the newborn infant, which could have delayed the PABA excretion.',\n",
       " '79138': 'Brain abscess and cystic fibrosis.BRAIN-ABSCESS: et.  CYSTIC-FIBROSIS: co.Brain abscess has only recently been considered a complication of cystic fibrosis. Three patients are reported here and a fourth cited from the literature. All of our patients were young adults with advanced pulmonary disease. The bacteria involved were mouth organisms and were found in the sputum culture in only one of the patients. Resistance was present to previously given antibiotics. As patients with cystic fibrosis survive into adulthood, the risk of developing a brain abscess appears to increase.',\n",
       " '79139': 'Meconium ileus: laparotomy without resection, anastomosis, or enterostomy.INFANT-NEWBORN-DISEASES: su.  INTESTINAL-OBSTRUCTION: su. MECONIUM.During the 14 yr from 1965 through 1978, 49 infants presented shortly after birth with intestinal obstruction due to impacted meconium. Three of these patients did not have fibrocystic disease. Eight patients were cured by a Gastrografin enema. There were 18 patients who had complications that included associated atresia, volvulus, and/or peritonitis. Various operations were done including resection with either primary anastomosis or enterostomy or varieties of the foregoing. Twenty-three babies had the simple uncomplicated form of meconium ileus. Eleven of these underwent resection and six patients died. Twelve patients were treated by laparotomy, ileotomy through a purse-string suture and prolonged irrigations using acetylcysteine. Of this group only one succumbed. This latter course of management is recommended for patients with simple uncomplicated meconium ileus as it involves no resection, no enterostomy, nor any primary anastomosis.',\n",
       " '79140': \"The effect of histamine, metiamide and cystic fibrosis factor on the electrophysiological properties of the frog's gastric mucosa [proceedings].CYSTIC-FIBROSIS: bl.  GASTRIC-MUCOSA: de.  HISTAMINE: pd. METIAMIDE: pd.  THIOUREA: aa.The total active transport of Cl ions across the frog's gastric mucosa can be considered as: net Cl- flux (serosa to mucosa) = H+ + SSC (short-circuit current), all terms expressed as micromole cm-2 hr-1.  The net chloride flux (Hogben, 1955; Durbin & Heinz, 1958) may be divided into two fractions: an acidic one which is equivalent to the acid secreted and an electromotive one which accounts for the gastric electromotive force.  The changes in SCC can accordingly be used as a partial index to the activity of the chloride pump. Experiments were designed to investigate the effects of histamine, metiamide (H2 receptor antagonist), cystic fibrosis (CF) and non-CF plasma on the above parameters using the frog's isolated gastric mucosa.  The SCC and the resistance of the mucosal preparation is measured by means of an automatic SCC apparatus (de Jesus, 1977). The H ion secretion is measured by pH meter.  Results obtained (expressed as mean change (delta) plus or minus S.E. of mean) for histamine (10-4 M) (n = 10) show an initial increase of the SCC by 36.94 plus or minus 2.95 microA cm-2 and a parallel small increase in H+ output by 0.045 plus or minus 0.003 micromole cm-2 hr-1.  This initial increase in SCC is followed by a drop to a steady-state level of 23.62 plus or minus 2.23 microA cm-2 and also by a large increase in H+ secretion 2.26 plus or minus 0.22 micromole cm-2 hr-1.  These results support the work of Rehm (1961) in that histamine has an effect first on the Cl- pump and then on the H+ secretion.  Metiamide (10-4 M) (n = 12) caused a drop in the SCC by 20.16 plus or minus 2.32 microA cm-2 and also reduced the acid secretion by 2.21 plus or minus 0.14 micromole cm-2 hr-1, thus suggesting an effect on the Cl- pump as well as on the H+ secretion. Significant differences are shown (P < 0.001) between CF and non-CF plasma results.  The CF plasma (n = 8) increased the SCC by 17.25 plus or minus 2.94 microA cm-2 and H+ secretion by 2.38 plus or minus 0.43 micromole cm-2 hr-1.  Non-CF plasma caused a slight increase in SCC by 5.17 plus or minus 1.1 microA cm-2 and had little effect on the H+ secretion, 0.34 plus or minus 0.01 micromole cm-2 hr-1 (n = 8).  The effect of the CF plasma on the Cl- and H+ mechanism is of interest since in cystic fibrosis there is an abnormal increase of Cl- and Na+ in the sweat of patients (di Sant Agnese, Darling, Perera & She, 1953).\",\n",
       " '79141': 'The chronically ligated submandibular salivary duct of the rabbit as a possible model for cystic fibrosis [proceedings].CYSTIC-FIBROSIS: pp.  SUBMANDIBULAR-GLAND: pp.Schulz (1969) showed that the raised Na concentration in the sweat of children suffering from cystic fibrosis  was due to a defect in Na reabsorption in the duct epithelium, but somewhat surprisingly the transepithelial potential difference (p.d.) is the same as that in normal controls.  Na transport is also reduced in the chronically ligated salivary duct of the rabbit submandibular gland (Fraser & Smaje, 1978), and because p.d. is unaffected, the ligated gland may be a useful model of this aspect of cystic fibrosis.  Here we would like to report a further similarity to cystic fibrosis; duct ligation leads to goblet cell hyperplasia which also occurs in the salivary glands in cystic fibrosis (Lev & Spicer, 1965).  Sections of the salivary duct 6 microm thick were taken at 60 microm intervals from ducts which had been ligated for between 1 and 5 weeks and from their contralateral controls following fixation by immersion.  Ligation resulted in an increase in luminal diameter by distension of the previously convoluted epithelium, but there was no significant change in epithelial surface area.  The number of cell layers appeared to have increased however and there was a proliferation of goblet cells.  The mucus in these cells was stained by alcian blue at pH 1 indicating the presence of sulphomucin.  The mean goblet cell density rose from 7.62 plus or minus 4.73 mm-2 (mean plus or minus S.E. of the mean, n = 6) in controls to 114 plus or minus 49.6 in ligated ducts.  The transepithelial Na flux in the same ducts was reduced from 10.1 plus or minus 0.79 n-mole cm-2 sec-1 to 1.6 plus or minus 0.84 while p.d. remained at -22 mV, similar to those results previously reported.  There was no significant correlation between the degree of diminution of Na transport and the density of goblet cells but there was a positive correlation (r = 0.90) between the number of goblet cells in the control and contralateral ligated ducts.',\n",
       " '79142': 'Sweat tests [letter].CYSTIC-FIBROSIS: di.  SWEAT: an.I agree that sweat tests are frequently not performed reliably, but I wonder why the clinical chemist has been singled out as being responsible when most hospital laboratories are still directed by pathologists and not by professional clinical chemists.  In addition to our laboratory, I know of many other hospital clinical chemistry laboratories in which the test is being performed properly. Furthermore, the Pediatric Committee of the American Association for Clinical Chemistry is working on a review article for the journal, Clinical Chemistry, regarding the correct way the sweat test should be run.  Clearly, clinical chemists do not \"lack interest.\"',\n",
       " '79143': 'The sweat test for cystic fibrosis [letter].CYSTIC-FIBROSIS: di.  SWEAT: an.The major issue is not the \"lack of interest of clinical chemists,\" but the actual performance of the test.  Neither the pathologist nor the clinical chemist, in all likelihood, actually performs the test. Rather, it is the medical technologist or technician who carries out the actual procedure.  It is a major part of our roles as educators and laboratory administrators to ensure that these people are adequately trained for the task and that the test meets high enough performance standards to provide a clinically relevant answer.',\n",
       " '79144': 'Immunoreactive serum trypsin in diseases of the pancreas.PANCREATIC-DISEASES: en.  TRYPSIN: bl.Immunoreactive serum trypsin was measured with a double antibody radioimmunoassay in normal subjects and patients with various diseases of the pancreas. The normal range is 115-350 ng/ml with a geometric mean of 212 ng/ml. No trypsin was found in serum after total duodenopancreatectomy, in about 75% of patients with cystic fibrosis and in a few patients with pancreas carcinoma or chronic pancreatitis. Reduced serum trypsin levels between 10 and 100 ng/ml were measured in the remaining 25% of cystic fibrosis and in one third of the patients with chronic pancreatitis. Serum trypsin was increased to 700-17,000 ng/ml in all patients with acute pancreatitis or during the acute phase of chronic pancreatitis. Absent or reduced serum trypsin is a reliable indicator of total or partial exocrine pancreatic insufficiency whereas considerably increased serum trypsin concentration do indicate acute pancreatitis.',\n",
       " '79145': 'Differential pathology of nasal polyps in cystic fibrosis and atopy.CYSTIC-FIBROSIS: co.  HYPERSENSITIVITY-IMMEDIATE: co. NASAL-POLYPS: pa.Nineteen nasal polyps from 13 patients were examined histologically. Nine polyps from seven cystic fibrosis (CF) patients could be positively identified by a triad of observations: delicate, barely visible basement membrane of surface epithelium without submucosal hyalinization, lack of extensive infiltration of eosinophils (Giemsa stains), and a preponderance of acid mucin in glands and cysts of the polyp and in its surface mucous blanket (Alcian Blue-periodic acid- Schiff stains). Two polyps from two patients with CF and atopy showed the characteristic findings of CF without modification. Eight polyps from four atopic patients without CF were identified by the reverse triad of changes: extensive thickening of the epithelial basement membrane and its extension into the submucosa as an irregular hyaline membrane, high stromal eosinophil count, and mainly neutral mucin in mucous glands, cysts, and mucous blanket. Hyperplastic mucous glands, mucous cysts of variable sizes, focal metaplasia of surface epithelium, and acid mucin in goblet cells were considered nonspecific lesions.',\n",
       " '79146': 'Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.CYSTIC-FIBROSIS: di.  TRYPSIN: bl.An immunoreactive-trypsin assay uses small dried-blood spots (diameter 1.25 mm) and is therefore suitable for incorporation in established neonatal screening schemes. Blood specimens from neonates with cystic fibrosis had trypsin levels greater than those in control subjects, thus confirming earlier findings. Trypsin levels were below normal in several older patients with cystic fibrosis.',\n",
       " '79147': \"Detection of cystic fibrosis with plasma hydrolases [letter].ACID-PHOSPHATASE: bl.  CYSTIC-FIBROSIS: di.  MANNOSIDASES: bl.Dr Hosli and Mrs Hosli reported that differential thermolability of plasma alpha-mannosidase and plasma acid phosphatase allowed discrimination between normal people, cystic fibrosis carriers, and patients.  We have repeated these experiments, paying special attention to the technical details given in the Hoslis's paper.  In a separate series of experiments we used larger volumes of plasma for each assay, which was performed either with or without non-fluorescent paraffin oil.  In both cases the blood samples were processed exactly as outlined in Hosli and Vogt's paper.  There were no significant differences in the heat stability of plasma alpha-mannosidase and acid phosphatase between the three groups.\",\n",
       " '79148': 'Dried blood spot screening for cystic fibrosis [letter].CYSTIC-FIBROSIS: di.  TRYPSIN: bl.We have measured immunoreactive trypsin IRT activity in dried blood spot samples and have found abnormally high levels in infants with cystic fibrosis (CF).  We agree with Crossley et al. that this test deserves further investigation as a screen for CF in the newborn. The low value for the 94 week infant is consistent with their finding that, in children with low pancreatic enzyme output, the increased IRT results are restricted to the first few months of life.  It remains to be proved whether older CF patients with residual pancreatic enzyme secretion do indeed continue to have increased IRT levels.  If they do, the IRT test would also deserve further investigation as a tool, to be used in conjunction with stool pancreatic enzyme activity, in smaller centres who have had problems with inaccurate sweat tests.',\n",
       " '79149': 'Age dependence of serum angiotensin-converting enzyme activity [letter].KININASE-II: bl.We examined the age dependence of serum angiotensin-converting enzyme (SACE) activity in healthy controls.  While we found no age dependence in controls older than 20 years, those under 20 had much increased SACE values.  We feel that it is inappropriate to evaluate SACE activity in patients under 20 years old with diagnostic criteria determined in adults. - Dr Romer and colleagues reported high activities of SACE in 3 patients out of 10 with chronic granulomatous disease (CGD) and concluded that \"CGD is associated with increased levels of SACE\".  Unfortunately, Romer et al. did not study an adequate paedeatric age control group, and their mean values are compared primarily with that in 5 children with cystic fibrosis.  Our most recent studies confirm our earlier observation that children under the age 19 years definitely have higher mean SACE values than do adults.  Cystic-fibrosis patients should not be used for comparison since they tend to have lower SACE levels than comparable aged controls.  In my opinion patients with CGD, according to the data published by Romer et al., show no increase in SACE levels for their age.',\n",
       " '79150': 'Methylumbelliferyl-guanidinobenzoate reactive proteases and prenatal diagnosis of cystic fibrosis [letter].AMNIOTIC-FLUID: en.  CYSTIC-FIBROSIS: di.  PEPTIDE-HYDROLASES: an.For several reasons the supernatant fraction of amniotic fluid is not often used in the prenatal detection of inborn errors of metabolism. In early pregnancy the bulk of the protein in amniotic fluid is derived from the maternal circulation, and this can obscure the more critical contribution from the fetus needed for prenatal diagnosis. 10 - 30% of amniotic fluids are significantly contaminated with maternal blood, and if the enzyme in question is present in this blood (as 4-methylumbelliferyl guanidinobenzoate [MUGB] protease is), this can further distort diagnostic conclusions.  For this reason we have examined the variation of MUGB protease in a heterogenous collection of amniotic fluids.  No significant differences in titre between individual weeks in the second trimester were observed.  A further 104 second-trimester amniotic fluids from pregnancies with abnormal outcome were also investigated.  The means of the four groups were not significantly different from that of the normals and the ranges were very similar.  We have not yet had the opportunity to examine an amniotic fluid from a known case of cystic fibrosis. Diagnosis of cystic fibrosis could probably be further refined by coupling amniotic-fluid protease titration and isoelectric focusing on polyacrylamide gel.',\n",
       " '79151': 'Screening for cystic fibrosis [letter].CYSTIC-FIBROSIS: en.  PEPTIDE-HYDROLASES: bl.Our cystic-fibrosis  children usually either have severe lung disease with mild steatorrhea or severe maldigestion with lesser pulmonary problems.  We therefore measured serum-proteases in cystic-fibrosis patients and controls to see if there was any support for the following hypothesis: since lack of antitrypsin is associated with lung damage, plasma-trypsin in excess of antitrypsin might be responsible for the lung damage in cystic fibrosis.  General protease and trypsin levels were measured spectrophotometrically using a modification of the method of Erlanger, Kojowsky and Cohen.  Our result showed no significant difference between protease and trypsin levels in cystic-fibrosis patients and controls.  The difference between our results and those of Crossley et al. may be explained by the differing measuring technique used.  Our trypsin levels were measured spectrophotometrically and theirs by radioimmunoassay.',\n",
       " '79152': 'Serum-angiotensin-converting-enzyme in chronic granulomatous disease [letter].GRANULOMATOUS-DISEASE-CHRONIC: en.  KININASE-II: bl.We have studied serum-angiotensin-converting-enzyme (SACE) in sarcoidosis and other granulomatous disorders.  We have measured SACE in 10 randomly chosen, consecutive patients with chronic granulomatous disease (CGD) and in some of their family members and in 5 children with cystic fibrosis and severe chronic pulmonary involvement.  SACE levels in the patient with CGD differed significantly from those of normal controls and those of family members and patients with cystic fibrosis.  Our preliminary studies show that CGD is associated with increased levels of SACE.',\n",
       " '79153': 'Dried-blood spot screening for cystic fibrosis in the newborn.BLOOD-STAINS.  CYSTIC-FIBROSIS: di.  TRYPSIN: bl.Serum-immunoreactive-trypsin (I.R.T.) was measured in children with cystic fibrosis (C.F.) and a variety of controls. In the first few months of life all C.F. children had a raised serum-I.R.T. A dried blood-spot assay for I.R.T. was established and has potential as a screening test for C.F. in the newborn.',\n",
       " '79154': 'Allergy and bronchial hyperreactivity in cystic fibrosis [editorial].ASTHMA: et.  BRONCHI: im.  CYSTIC-FIBROSIS: im.A little-known feature of cystic fibrosis is the frequent occurrence of positive skin-prick tests to environmental allergies.  In the normal population only about half those with positive prick tests actually have clinical allergic disease; so, are the positive skin-tests of cystic fibrosis clinically important?  In particular, do they mean a high prevalence of asthma, overt or hidden, amongst these patients?  A general clinical impression is that asthma is no more frequent amongst cystic fibrosis than in the normal population. The often positive skin tests, although of considerable immunological interest, do not necessarily imply additional clinical disease.',\n",
       " '79155': 'Serum-immunoreactive-trypsin concentrations in cystic fibrosis [letter].CYSTIC-FIBROSIS: di.  TRYPSIN: bl.We measured immunoreactive trypsin (IRT) concentrations in 32 patients with established cystic fibrosis and in 16 parents (heterozygotes) of patients with CF.  29 patients (91%) and 6 parents (38%) had abnormal trypsin concentrations.  We found that in only 3 out of the 29 patients with abnormal IRT was the concentration supranormal.  Our data suggest that low IRT concentrations are an excellent index of diminished pancreatic reserve in CF and that serum-IRT concentration would be a useful diagnostic test.  The fact that CF patients at birth invariably have very high IRT concentrations which fall with age and the progress of the disease, allied with the fact that heterozygotes have high concentrations, supports the previous suggestion that an uncontrolled hypersecretion of zymogen granules is the basic cellular defect in CF.',\n",
       " '79156': 'Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic fluid: possible marker for cystic fibrosis [letter].AMNIOCENTESIS.  AMNIOTIC-FLUID: en.  CYSTIC-FIBROSIS: di. HYMECROMONE: du.  PEPTIDE-HYDROLASES: an.  UMBELLIFERONES: du.Previous studies in our laboratory have demonstrated significant differences in the extent of protease reactivity with MUGB (4-methylumbelliferyl guanidinobenzoate, a sensitive active site titrant of many serine proteases) when plasma and cultivated skin fibroblasts from patients with cystic fibrosis (CF), obligate heterozygotes, and controls were compared.  Because of these observations, and the potential value of amniotic fluid for the prenatal detection of cystic fibrosis, these studies were extended to human amniotic fluid obtained by amniocentesis done for the intrauterine detection of genetic and other fetal abnormalities.  An amniotic-fluid sample obtained from a woman who was subsequently delivered of a baby with CF showed a much reduced level of MUGB reactivity similar to the relative deficiency observed in plasma and cultivated skin fibroblasts from patients with CF.  These observations suggest that amniotic-fluid protease activity may be a useful marker for the prenatal detection of CF.',\n",
       " '79157': 'Plasma hydrolases in cystic fibrosis [letter].CYSTIC-FIBROSIS: en.  HYDROLASES: bl.Dr Hosli and Esther Vogt reported that the alpha-mannosidase and acid phosphatase activities of cystic fibrosis plasma assayed at pH 5.4 are abnormally thermolabile at 41 degrees and 36.5 degrees C, respectively, and that the levels of residual activity after heat inactivation clearly distinguish between CF patients, CF carriers, and normal subjects.  We have repeated these experiments under identical conditions and found no differences between the three groups.',\n",
       " '79158': 'Mechanical chest physiotherapy [editorial].CYSTIC-FIBROSIS: th.  PERCUSSION: is.  PHYSICAL-THERAPY: mt. SPUTUM.Despite some critical debate lately about the usefulness of physiotherapy in certain chest conditions, the fact remains that many patients voluntarily undertake regular postural bronchial drainage to help their sputum.  A substantial number also find rapid chest percussion over affected lung segments useful in loosening the sputum.  Chest percussion by a mechanical device controlled by the patient himself seems worthy to trial.  Maxwell and Redmond have compared a commercial device with manual percussion during postural bronchial drainage.  The two techniques resulted in expectoration of similar quantities of sputum, although all but one patient felt subjectively that the machine delivered better-quality percussion. Before parents and others are advised to buy percussing machines, we need a formal study of postural drainage with and without chest percussion.',\n",
       " '79159': 'Detection of cystic fibrosis homozygotes and heterozygotes with plasma [letter].CYSTIC-FIBROSIS: di.  GENETIC-TECHNICS.  MANNOSIDASES: bl.Dr Hosli and Esther Vogt base their diagnosis of heterozygotes and homozygotes for cystic fibrosis on the thermal stability in plasma or extracellular fluids of alpha-mannosidase and/or phosphatase activity assayed at pH 5.4.  The activity of alpha-mannosidase in plasma and this pH is a composite one: both acidic alpha-mannosidase, which has a pH optimum of 4.25 and intermediate alpha-mannosidase, which has a pH optimum of 5.6 - 6.0, will contribute to the activity measured at pH 5.4.  These two forms of alpha-mannosidase are structurally and genetically distinct and have different kinetics and thermostabilities.  Therefore the total alpha-mannosidase activity at pH 5.4 and the physicochemical properties of this activity will depend upon the relative proportions of the two types of alpha-mannosidase in the sample.  The proportions of the two forms vary widely in normal plasma, especially in plasma from children. Although the data of Hosli and Vogt suggest that the total alpha-mannosidase at pH 5.4 does not differ significantly between controls, CF heterozygotes and CF homozygotes, they do not show whether the proportions of acidic and intermediate alpha-mannosidase have changed.  An increase in the proportion of the thermolabile intermediate alpha-mannosidase in CF would be manifested as a decreased thermostability of alpha-mannosidase at pH 5.4. Alternatively a mutation in the normally stable acidic alpha-mannosidase leading to a less stable form would also be reflected as a decreased stability in the activity at pH 5.4, especially if the proportion of acidic alpha-mannosidase was increased in CF.  These situations should also be considered as possible explanations of the observations, in addition to the one favoured by Hosli and Vogt.',\n",
       " '79160': \"Arginine esterase in amniotic fluid: possible marker for cystic fibrosis [letter].AMNIOTIC-FLUID: en.  CYSTIC-FIBROSIS: di.  ESTERASES: an.Following Rao and Nadlers' report of decrease arginine activity in the blood of patients with cystic fibrosis we have been trying to apply their findings to the prenatal diagnosis of cystic fibrosis. We were therefore most interested in the reports on the use of 4-methylumbelliferyl-rho-guanidinobenzoate (MUGB) for assaying arginine esterase activity in amniotic fluid.  Our results with MUGB are similar to those of Brock and Haywood but are substantially higher than those of Walsh and Nedler.  A sample of amniotic fluid that had been incubated with MUGB and then assayed with pro-phe-arg-4-methylcoumarinyl-7-amide (PPA-MCA) showed less than 20% of the activity of a similarly treated control sample that had not been incubated with MUGB.  The activity of arginine esterase towards PPA-MCA both in amniotic fluid and in cultures amniotic fluid cells is much greater than towards CBZ-Arg-AMC.  These levels of activity are high enough to warrant further investigation for use in an antenatal diagnosis.\",\n",
       " '79161': 'Detection of cystic fibrosis homozygotes and heterozygotes with plasma.ACID-PHOSPHATASE: bl.  CYSTIC-FIBROSIS: di.  MANNOSIDASES: bl.Evidence is accumulating which indicates that the basic defect in cystic fibrosis interferes with the formation of recognition markers on hydrolytic enzymes. As a result these hydrolases leak into the extracellular space and some of them display abnormal thermolabilities. By heat inactivation of plasma alpha-mannosidase at 41 degrees C and plasma phosphatase at 36.5 degrees C, both enzymes being assayed at pH 5.4, it is possible to differentiate normal people from cystic fibrosis carriers and patients.',\n",
       " '79162': 'Differential incorporation of 3H-thymidine into DNA in cultured skin fibroblasts derived from patients with cystic fibrosis and controls.CYSTIC-FIBROSIS: me.  DNA: me.Tritiated thymidine (3H-TdR) incorporation into DNA of the fibroblasts derived from subjects with cystic fibrosis (CF) and their controls was studied with scintillation counting and autoradiography.  3H-TdR incorporation at 24 hours postseeding was significantly less (p < 0.005) in CF strains in comparison with cells from controls.  The percentage of labeled fibroblasts was not significantly difference between the two strains (p > 0.1).  The cell cycle time and the duration of each phase were studied by a mitotic selection and scintillation counting technique.  There was no difference in cell cycle time between CF and control fibroblasts, however, the duration of the synthetic phase was significantly (p < 0.005) longer in CF subjects.',\n",
       " '79163': 'Animal model for cystic fibrosis: pulmonary clearance of Staphylococcus aureus in mice treated with reserpine.CYSTIC-FIBROSIS: pp.  LUNG: mi.  RESERPINE: pd. STAPHYLOCOCCUS-AUREUS.Since it has been demonstrated that chronic administration of reserpine to rats produces CF-like alterations, we have studied the lung resistance to bacterial infections in animals treated with reserpine.  Mice of the BALB/c inbred strain were injected subcutaneously with different doses of reserpine for 7 days; after, they were submitted to an infective aerosol containing Staphylococcus aureus in a nebulization chamber.  With each pair of exposed animals, an individual value of the uncleared bacteria ratio (UBR) at 4 hours was obtained.  Reserpinized animals showed a significant increase in UBR values when compared to control mice (p < 0.05 and p < 0.01 depending on the doses), suggesting an impairment of the lung antibacterial defenses.  Although pharmacological doses of reserpine produce catecholamine depletion, we can not conclude that this action upon the nervous system is the only cause of the CF-like response we detected.  In conclusion, the observed UBR decrease lends support to the concept of a reserpine- induced CF animal model.',\n",
       " '79164': 'Increased resistance to influenza as a possible source of heterozygote advantage in cystic fibrosis.CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  ORTHOMYXOVIRUS-INFECTIONS: im. PARAMYXOVIRUS-INFECTIONS: im.Cystic fibrosis is the most common lethal or semi-lethal genetic disease in Caucasians of Central European origin, among whom it is inherited as an autosomal recessive trait at a frequency approximately 10 times that expected from recurrent mutation alone. A decreased sialic acid content has been observed in cell surface glycoproteins on cystic fibrosis fibroblasts and in numerous soluble glycoprotein preparations from cystic fibrosis homozygotes. Sialic acid residues on cell surface glycoconjugates play an essential role in the binding and infectivity of myxoviruses and paramyxoviruses, including those causing pandemic influenza. It is suggested that increased resistance to these viruses conferred by similar but quantitatively smaller alterations in sialoglycoconjugate structure in cystic fibrosis heterozygotes may have provided a selective advantage to maintain the high frequency of the cystic fibrosis gene in Caucasian populations.',\n",
       " '79165': 'Pathogenesis of cystic fibrosis: possible importance of alteration in epithelial surface topography.CYSTIC-FIBROSIS: et.  LUNG: ul.As the pathogenesis in cystic fibrosis (CF) has been considered to lie in a disturbance in the behavior of secretions, particularly mucins, from exocrine glands, it has been proposed that an alteration in surface topography (form, number or distribution of microvilli or blebs) of epithelial cells lining ducts could impair distribution leading to retention of mucus leading to the clinical phenotype. Scanning electronmicroscopy of human epithelial suspension cultures now offers an opportunity to evaluate the role of plasmalemma topography in CF.',\n",
       " '79166': 'Alkaline phosphatase induction in cystic fibrosis fibroblasts [letter].ALKALINE-PHOSPHATASE: du.  CYSTIC-FIBROSIS: di.Lysosomal acid hydrolases and alkaline phosphatase cooperate in the intracellular digestion of natural polymers.  A stimulus for the induction of these enzymes is the retention of any kind of polymer inside the cell.  This stimulus is long-lasting and strong if polymers are intracellularly retained because of a lack of digestive enzymes.  In previous papers it has been demonstrated that the alkaline phosphatase (AIP) induction with Tamm Horsfall glycoprotein discriminates between fibroblasts of CF homozygotes on the one hand and normals and CF carriers on the other hand, and a hypothesis has been proposed to explain these observations.  As predicted, more efficient inducing mixtures have since been developed; these have been used in the present study.  The first writer familiarized himself with ultramicrotechniques and then carried out double blind studies on 20 fibroblast cultures from French patients.  These findings demonstrate the reproducibility of the AIP induction and of the methods used, and they particularly underline the importance of employing the present ultramicrotechniques for a successful AIP induction.  It is likely that amniotic fluid cells behave like skin fibroblasts in this test; if this proves to be so, then the induction of alkaline phosphatase should provide a useful technique for the prenatal diagnosis of cystic fibrosis.',\n",
       " '79167': \"Improved survival of patients with cystic fibrosis.CYSTIC-FIBROSIS: mo.The survival of 320 patients, who were born in and after 1958 with cystic fibrosis and managed by the Departments of Thoracic Medicine and Gastroenterology, Royal Children's Hospital, Melbourne, is reviewed. Eighty per cent of patients survived to 11 years of age, and 64% to 18 years. Of patients managed between 1973 and 1977, 91% survived to 12 years of age, and 80% to 17 years of age. In the same period, 79% of patients survived for 16 years after diagnosis. Forty- four per cent of the 240 patients currently being managed have no significant permanent lung disease, and only 9% have advanced disease.\",\n",
       " '79168': 'Alkaline phosphatase induction in cystic fibrosis fibroblasts [letter].ALKALINE-PHOSPHATASE: bi.  CYSTIC-FIBROSIS: en.Hosli has published a hypothesis relating to the primary cause of cystic fibrosis (CF) based on his observations that the level of alkaline phosphatase (ALP) in CF-derived skin fibroblasts, but not fibroblasts derived from normal individuals, could be increased several-fold by growing the cells in the presence of the urinary glycoprotein, Tamm-Horsfall protein (THP).  However, we have not been able to show, in Adelaide, any change or induction in the level of ALP activity in CF-derived skin fibroblasts when grown in the presence of locally prepared THP under what appear to be identical cell culture conditions to those used by Hosli.  It thus appears that under the conditions currently employed in our laboratory, there is no diagnostic discrimination between fibroblasts of CF homozygotes and normal individuals.',\n",
       " '79169': 'The short-term effects of chest physiotherapy on lung function tests in children with cystic fibrosis.CYSTIC-FIBROSIS: th.  LUNG: pp.  PHYSICAL-THERAPY.Chest physiotherapy is an important part of the treatment program of children with cystic fibrosis, but controlled studies of its effects are few.  27 children with cystic fibrosis, 20 being chronic sputum producers and 7 non-sputum producers, were studied in hospital with serial lung function tests on 3 consecutive days.  On the 1st day physiotherapy was performed twice; on the 2nd day no physiotherapy was performed; on the 3rd day the two periods of physiotherapy were preceded by an inhaled bronchodilator (Rimiterol).  Lung function tests included peak flow, forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1.0) and residual volume to total lung capacity ratio, and were measured at the beginning of each day and at similar intervals throughout the 3 days.  Sputum volume and cough frequency were noted on day 1 and day 3.  Physiotherapy resulted in significant improvement of peak flow in the sputum producers.  However, the FVC and FEV1.0, while improving after physiotherapy, also improved on the control day when no physiotherapy was performed.  This suggests that physiotherapy may be effective in removing sputum from central large airways with resultant improvement in peak flow, but has little added effect on the more peripheral airways, whose airflow improves through the day with normal activity.  No significant effect was shown in the non- sputum producers although there was a trend towards improvement in peak flow.  A bronchodilator before physiotherapy may be beneficial in those patients who demonstrate significant reduction in airflow obstruction at formal testing of bronchodilator response, but may lessen the beneficial effects of physiotherapy in those without a positive response.  The study illustrates the importance of examining difference methods of chest physiotherapy, to find ways of improving sputum clearance.',\n",
       " '79170': 'Effect of four physiotherapy schedules on pulmonary function in children with cystic fibrosis.CYSTIC-FIBROSIS: th.  LUNG: pp.  PHYSICAL-THERAPY.In 17 children (group A) with cystic fibrosis (CF) the effect of the following treatment schedules on pulmonary function has been studied in random order on 4 consecutive days: (1) clapping and postural drainage (CP); (2) CP after inhaling an aerosol of 5 ml 20% N-acetylcysteine by a Monaghan ultrasonic device; (3) as in 2 but with the addition of 0.5 mg isoprenaline to the aerosol; (4) as in 3 but with an IPPB device added to the nebulizer. Treatment was started at 9.30 a.m. and lasted for about 1 h.  Pulmonary function was measured prior to and 30 min after treatment (9.00 and 11.00 a.m., respectively).  In 8 children (group B) with CF (severity comparable to the previous group) pulmonary function was measured at 9.00 and 11.00 a.m. but without physiotherapy in between.  The following pulmonary function measurements have been included in the evaluation of the results: VC, FVC, FEV1, TLC (body box), TLC (helium dilution), TLCBb-TLCHe, RVBb, RVHe, maximal expiratory flows at 60% TLBBb, 25% FVC, maximal midexpiratory flow, airway conductance.  The technique of the determinations was carefully controlled and initial values were reproducible in most children.  In group B, mean values of pulmonary function were equal at 9.00 and 11.00 a.m.  In group A none of the treatment schedules caused a significant improvement of mean pulmonary function values.  In some of the children, however, pulmonary function improved, but in others it deteriorated. The significance of these findings was discussed. Relationship between clinical conditions, chest radiographic findings and respiratory function tests in cystic fibrosis.CYSTIC-FIBROSIS: di.We explored 44 children suffering from cystic fibrosis with predominant pulmonary involvement and followed in particular the course of illness of 30 of these patients during an average period of 4 years.  We were impressed by the enormous variability of the pulmonary symptomatology in these children.  The question arose whether this clinical impression is supported by the finding of the thorax radiograph and the results of the lung functions tests and the blood gas measures at rest and on exercise.  From the clinical point of view, there is a possibility to make a classification of severity in pulmonary aspects of this disease.  Because of the large ranges of the score values a clear distinction of the severity could only be possible if large groups of patients were to be compared.  For the interindividual comparison the cumulative evaluation of a clinical score, the chest radiograph and the lung function tests are indispensable.  Only the continuous follow-up of these examinations allows one to notice, in time, a progressive lung involvement with its degenerative changes.',\n",
       " '79172': 'A new percussion aid for cystic fibrosis patients.CYSTIC-FIBROSIS: th.  PERCUSSION.This paper is a report on the first part of a comprehensive research programme.  The aim is the development of a mechanical aid which will enable patients with cystic fibrosis to give themselves satisfactory physiotherapy.  The percussor, which can be used by patients, parents or relatives, is portable and lightweight.  The domiciliary trial showed that effective percussion could be self-administered to the front of the chest and to a lesser extent to the sides of the chest. The percussor was found to be very acceptable to adolescent patients and especially girls with early breast development.  Further research work has now been completed and as a result a system has been developed which enables patients to treat themselves with satisfactory chest percussion in the five preferred positions of postural drainage.',\n",
       " '79173': 'The mechanism of autogenic drainage studied with flow volume curves.CYSTIC-FIBROSIS: co.  LUNG-DISEASES-OBSTRUCTIVE: th.  SPUTUM.In 1977, we demonstrated the efficiency of autogenic drainage with two bronchorrheic children, who needed bronchography for diagnostic purposes.  This demonstration was made possible thanks to a radiocinematographic study after bronchography.  The examination also showed the inefficacy of coughing.  The object of the present study is to analyze the physiologic mechanism of autogenic drainage.  For children older than five, this method is very simple and efficient and as the effort or onset is not excessive and as expiration does not need to be complete, autogenic drainage is not exhausting and can be performed for a long time, which is indispensable since the progression of secretions is slow.',\n",
       " '79174': \"Intestinal lactase deficiency in newborns with cystic fibrosis--dietary consequences.CYSTIC-FIBROSIS: co.  INTESTINES: en.  LACTOSE-INTOLERANCE: dh.The problem of proper diet to children and infants with cystic fibrosis is continuously discussed.  This paper deals with the diet for CF infants younger than one year.  The basic view is that the diet should be as close to the 'normal baby' diet as possible, partly to ensure normal growth and development, and partly to avoid extra work for the families with CF infants.  Infants suffering from CF were given lactose-free diet until they reached the age of one year. The weight increased more rapidly than in CF patients given the traditional CF diet with low fat and high protein.  Furthermore, it was not necessary to give increased amounts of calories to the infants given lactose-free diet, nor did they receive additional fat-soluble vitamins. Ultrastructure of the bronchial epithelium in children with cystic fibrosis.BRONCHI: ul.  CYSTIC-FIBROSIS: pa.The ultrastructure of the bronchial epithelium in 3 children with cystic fibrosis was described.  In 2 of them a developed squamous metaplasia with many signs of pathological alteration of the epithelial cells was observed.  In the third patient severely injured pseudostratified epithelium with remnants of ciliary border is preserved.\",\n",
       " '79176': \"Recent research in cystic fibrosis.CYSTIC-FIBROSIS.  RESEARCH.This review emphasizes some of the positive accomplishments of cystic fibrosis research, some of the puzzles and some of the recent developments that have promise.  One of the major unresolved questions is the maintenance of this lethal gene at such a high frequency, perhaps because of a heterozygote advantage in the past, no longer operative at present.  Nothing is known of the chromosomal localization of the trait; except that chromosomes are morphologically normal, that it is autosomal, not sex linked and that there is no correlation with blood groups or major HLA loci.  One of the important achievements of the past many years is that we understand relatively well the pathogenesis of most clinical manifestations of CF.  The as yet unknown inherited basic defect or metabolic error of CF gives rise to two main anomalies: the electrolyte defect in exocrine sweat glands and the 'mucous secretion' abnormality.  While the results of tissue culture studies often have been conflicting and disparate, it does seem to be the consensus that the fibroblasts are affected by the basic metabolic error in some manner, and that they respond abnormally under different experimental circumstances.  Virtually all investigators have found some anomalies in biologic fluids of CF, although using different approaches and methods.  An abnormality in the function of the autonomic nervous system, which is so closely associated with the exocrine glands, has always been an attractive explanation for the generalized exocrinopathy of CF.  The search for a genetic animal model for CF has led to interesting findings.\",\n",
       " '79177': \"Relevance of second messengers in cystic fibrosis.ADENOSINE-CYCLIC-MONOPHOSPHATE: me.  CYSTIC-FIBROSIS: me. ISOPROTERENOL: pd.  RECEPTORS-ADRENERGIC.  RECEPTORS-ADRENERGIC-BETA.Water, electrolyte and macromolecular secretion, which is affected in cystic fibrosis, is regulated by neurotransmitters of the autonomic nervous system stimulating the cells by binding to alpha-adrenergic, beta-adrenergic and cholinergic receptors.  Therefore, a genetic disturbance in cyclic 3'5'-adenosine monophosphate (c-AMP) response could eventually explain some of the manifold expressions of labile biochemical changes observed in CF, specially in tissue culture.  We further characterized beta-receptors in cultured fibroblasts of CF patients and normal controls and investigated isoproterenol and prostaglandin E1-mediated c-AMP response using defined culture conditions.  No significant difference was found between the two phenotypes on basal c-AMP values.  With the exception of one cell line, CF strains had 25 to 180% increased c-AMP content.  This difference is highly significant (p < 0.0025).  This statistically significant difference in response can neither be attributed to differences in dose- or time-response curves nor to differential c-AMP escape into culture medium.  Since CF cells synthesize more c-AMP than controls only in response to isoproterenol but not to prostaglandin E1, the alteration which might be responsible for the observed phenomenon is probably located proximal of the adenylate cyclase at the cells border between intra- and extracellular space.\",\n",
       " '79178': \"Trace element malabsorption in exocrine pancreatic insufficiency.CYSTIC-FIBROSIS: me.  IRON: me.  MALABSORPTION-SYNDROMES: et. MANGANESE: me.  PANCREATIC-DISEASES: me.  ZINC: me.This paper presents preliminary results from metabolic balance studies of iron, zinc and manganese absorption and retention in children with cystic fibrosis and Shwachman's syndrome. Malabsorption of zinc, iron and manganese in exocrine pancreatic insufficiency has been demonstrated by these early studies.  A possible relationship between this and the associated features of CF has been briefly discussed, and indicates areas for further research. If such relationships are established then some form of trace element supplementation should be considered.\",\n",
       " '79179': 'Prostaglandins and cystic fibrosis.CYSTIC-FIBROSIS: me.  PROSTAGLANDINS-E: me.  SWEAT: me.We have investigated two aspects of prostaglandin function in cystic fibrosis: the response of platelets to PGE1, and the concentrations of PGE2 and PGE-alpha in the sweat.  Low concentrations of PGE1 have less effect on platelet agglutination in CF patients and heterozygotes than in normals, but no difference is observed when high PG concentrations are used.  Sweat PGE2 and PGE-alpha concentrations are similar in normals, CF patients and heterozygotes, but sweat PGE2 concentrations are proportional to Na/Cl levels in CF, but not in control children or heterozygotes.',\n",
       " '79180': \"Operational definition of cystic fibrosis.  I.CYSTIC-FIBROSIS: di.Recently, one of us suggested a new hypothesis concerning the 'basic defect' of cystic fibrosis.  The purpose of the present paper is to review this model and to critically discuss its eventual diagnostic applications.  With extensive studies, we collected experimental data which contribute five major arguments in favour of the proposition that CF may be an enzyme recognition site mutant.  With fibroblast cultures the three genotypes can be separated in the following way: CF homozygote, leaky for alkaline phosphatase (A1P) and lysosomal hydrolases/A1P is Tamm-Horsfall glycoprotein (THP) inducible; CF heterozygote, leaky for A1P and lysosomal hydrolases/A1P is not THP inducible; normal control, not leaky for A1P and lysosomal enzymes/A1P is not THP inducible.  With the exception of a second double-blind study, the THP induction as well as the leakage analysis seem to be statistically unequivocal: they strongly support our hypothesis concerning the basic defect in CF.\",\n",
       " '79181': 'Alpha-glucosidase in cystic fibrosis.CYSTIC-FIBROSIS: en.  GLUCOSIDASES: bl.Studies are presented on the serum level of several acid glycosidases in normal and cystic fibrosis subjects.  Levels of alpha-glucosidase found in serum from CF patients were significantly higher than from normals and heterozygotes.  The increase in alpha-glucosidase was directly related to the clinical gravity of the disease.  Levels of all other glycosidases studied in CF patients were in the normal range.',\n",
       " '79182': \"Postprandial total serum bile acid concentrations in cystic fibrosis.BILE-ACIDS-AND-SALTS: bl.  CYSTIC-FIBROSIS: bl.In recent years, several workers have reported that a single 2-hour postprandial total serum bile acid (TSBA) concentration, in a variety of liver disease states, is a more sensitive index of deranged liver function than are the 'conventional' serum liver function tests. This observation seemed to us to provide a challenging situation for the assessment of TSBA concentrations in cystic fibrosis.  The distribution of results for the CF patients (mean TSBA concentration 27.0 micromol/l) and for the age-matched controls (mean concentration 19.9 micromol/l) shows a wider range for the CF group.  Statistical analysis, however, of these two groups shows no significant difference between them.  Many factors affect both the size and distribution of the bile acid pool in CF, and a consideration of these factors may go some way towards explaining the rather unspectacular TSBA results.\",\n",
       " '79183': 'The cystic fibrosis gene, IgE and IgG4.CYSTIC-FIBROSIS: fg.  GENES.  IGE: an.  IGG: an.We decided to survey a geographically defined population of cystic fibrosis patients and parents living in Avon County, England.  By examining the obligate heterozygotes (the parents), we would be able to assess the influence of the CF gene without the presence of the disease.  There is an increase in immediate hypersensitivity to A. fumigatus in CF patients but not their parents.  This increased sensitivity is probably IgE-mediated and a secondary effect of lung damage.  There is no evidence that the CF gene produces a generalised increase in skin reactivity (atopy), serum IgE or serum IgG4 in the heterozygotes.  They are not therefore likely to develop asthma.',\n",
       " '79184': 'Bronchial reactivity in children with cystic fibrosis and other recurrent or chronic bronchopulmonary diseases.ASTHMA: et.  BRONCHITIS: et.  CYSTIC-FIBROSIS: co. RESPIRATORY-HYPERSENSITIVITY: et.In our efforts to standardize the evaluation of bronchial reactivity we performed investigations into the threshold dosage of acetylcholine-induced bronchospasm in patients with various recurrent and chronic bronchopulmonary diseases.  A significantly decreased threshold value of acetylcholine and thus an increased bronchial reactivity could be proven in patients with cystic fibrosis in comparison with healthy children.  The cause of bronchial hyperreactivity in patients with CF may be due to proteases deriving from leucocytes of the purulent sputum.  Furthermore, we investigated the influence of terbutaline on the bronchial obstruction induced by acetylcholine in patients with bronchial asthma and cystic fibrosis. The groups were comparable, especially with regard to the degree of the initial bronchial obstruction.',\n",
       " '79185': 'Increased serum TSH response to TRH in cystic fibrosis.CYSTIC-FIBROSIS: pp.  THYROID-GLAND: pp. THYROTROPIN-RELEASING-HORMONE: du.  THYROTROPIN: bl.The aim of the present study is to reassess the peripheral pattern of thyroid function in subjects with cystic fibrosis with special reference to their responsiveness to thyrotropin-releasing hormone (TRH) stimulation.  In all the CF patients the basal levels of serum T4, T3, and TBG were within the normal range.  Mean values in CF patients and in control children were not significantly different. In CF patients there is no correlation between the TSH response area and the basal level of serum T4, or with grading according to Shwachman and Kulczycki.  We found no relation with therapy.  In basal conditions, our data show a completely normal pattern of the serum concentration of T4, T3, TBG and TSH in subjects with CF in absence of iodide therapy.  Thyroid status should be examined in patients with CF specially when they receive iodide therapy or other drugs which can enhance the impairment of thyroid function.',\n",
       " '79186': \"Factors influencing the frequency of cystic fibrosis in South West Africa.CYSTIC-FIBROSIS: oc.Drift, chance effect in a small community and consanguinity have resulted in South West Africa's high cystic fibrosis incidence. Isolated communities generations ago in Europe, e.g. Bad Gastein, where this congress was held, surrounded by its Alpine peaks, could have resulted in gene enrichment, which together with the increased fertility of the heterozygote could still be responsible for most of the CF seen wherever Europeans live today.\",\n",
       " '79187': \"The effect of cystic fibrosis and non-cystic fibrosis plasma on electrophysiological responses in isolated frog gastric mucosa.CYSTIC-FIBROSIS: bl.  GASTRIC-MUCOSA: ph.An alternative method for assaying the cystic fibrosis factor could be on the electrophysiological responses of isolated living tissues. The ability of the frog's gastric mucosa to secrete hydrochloric acid and maintain a negative potential difference is well known.  This potential difference across the secretory (mucosa) to the nutrient (serosa) side coupled with its property of transporting chloride and hydrogen ions against an electrochemical gradient could therefore serve as a useful model for investigating any induced changes in the presence of CF and non-CF plasma.  From the results obtained the short circuit current and H+ secretion responses in the presence of CF (whole) plasma show significant increases compared to the control. These findings show that in the presence of CF plasma, whole or plasma fraction B, there is a marked increase in the actively transported Cl- and H+.  The effect of CF plasma in increasing net Cl- flux is important considering the elevation of this electrolyte in the sweat of CF patients and deserved further investigation.\",\n",
       " '79188': \"Fatty acid supplementation in cystic fibrosis.CYSTIC-FIBROSIS: dt.  FAT-EMULSIONS-INTRAVENOUS: tu.Elliott's works, together with the previous works of several authors reporting low essential fatty acid concentrations in the serum lipids of patients with cystic fibrosis, stimulated us to make a pilot study treating older CF patients with Intralipid for 1 year.  We found no side effects in treating older CF patients with Intralipid for 1 year.  On the other hand the objective benefit was very limited and today confusing, i.e., only a slight but significant improvement in the renal sodium excretion after an oral sodium load was found.  The relevance of this is speculative.\",\n",
       " '79189': 'Bronchial provocation tests in cystic fibrosis.ASTHMA: di.  CYSTIC-FIBROSIS: co. RESPIRATORY-HYPERSENSITIVITY: di.Patients with cystic fibrosis have a higher incidence of positive skin prick tests than normal; this may be the result of defective antigen handling at mucosal surfaces.  Our aim was to investigate bronchial allergy in a group of children with CF and positive skin tests.  We studied 15 children aged 7 to 16 years with mild to moderate respiratory disease.  Only 1 child gave a history of wheezing not associated with chest infections and this study supports the hypothesis that clinical asthma is a product of bronchial allergy and broncholability.  The responses to bronchial provocation with Aspergillus suggest that allergy to this antigen may play a part in the pathogenesis of lung disease in some patients with CF.',\n",
       " '79190': 'The local immune status in cystic fibrosis.BRONCHI: im.  CYSTIC-FIBROSIS: im.We focused our study on concentration of immunoglobulins, lysozyme, lactoferrin, some antiproteolytic fractions and acute phase proteins in bronchial secretion of children with various pulmonary diseases, especially with cystic fibrosis.  Secretory IgA is decreased in all studied groups of patients having chronic or recurrent infections of the respiratory tract (when compared to the group of healthy children).  Groups which were characterized by the infection of the lower part of the respiratory tract had increased lysozyme level. The results obtained in the group of CF children are similar to those obtained in groups with bronchiectasis and chronic bronchitis, which suggests that the observed differences are characteristic for chronic infection rather than for CF.  Although in CF as well as in bronchiectasis massive bacterial infection results in increased concentration of immunoglobulins, antiproteolytic fractions and acute phase proteins, the results seen in both groups are somewhat different.  These differences may indicate some difference in the reactivity to infection of the respiratory tract in CF in comparison to patients with bronchiectasis.  It seems conceivable that among children with CF who have very low S-IgA, chronic respiratory tract infections occur earlier and IgG response to permanent exposition to variety of antigens is less vigorous.  The presented results raise also a possibility that the bacterial infection in CF does not stimulate defence mechanisms to the same extent as in bronchiectasis.',\n",
       " '79191': 'Complement activation and pulmonary inflammation in CF patients.COMPLEMENT-3: an.  CYSTIC-FIBROSIS: im.  LUNG: im.  PNEUMONIA: im.This study examined whether biologic activation of C3 with subsequent pulmonary inflammation takes place in the lungs of patients with cystic fibrosis.  Plasma complement C3 levels were all normal. Eleven of the patients with the C3 split product C3c were from the group of 14 patients suffering from chronic infection with mucoid strains of Pseudomonas aeruginosa and 2 were from the group of 14 CF patients without P. aeruginosa infection.  This difference was significant (p < 0.002).  A comparison of albumin ratios between the 13 patients with the C3 split product C3c and the remaining other 15 patients showed a significant higher ratio in the former group (p < 0.01) on an average 4.1 versus 1.4 per cent.  The significantly higher albumin ratio demonstrated in the patients with C3c in their sputum sol phase supports the concept of complement-induced inflammation with subsequent transudation of plasma proteins in these patients.  This study thus shows that complement-mediated inflammatory reactions may play an important role in the pathogenesis of pulmonary tissue damage in patients with CF, even when the plasma C3 levels are normal, and it supports the concept of chronic P. aeruginosa lung infection as an immune complex disease in CF patients.',\n",
       " '79192': 'Protein, IgA, secretory IgA, IgG and electrolytes as parameters of parotid gland function in children with cystic fibrosis.CYSTIC-FIBROSIS: pp.  ELECTROLYTES: me.  IGA: an.  IGA-SECRETORY: an. IGG: an.  PAROTID-GLAND: pp.  PROTEINS: an.  SALIVA: an.To study the parotid gland function in children with cystic fibrosis we investigated parotid saliva specimens of 18 such patients.  We compared the results with a control group of 12 healthy children of the same age and sex.  Furthermore, children with bronchial asthma and chronic bronchitis were examined.  The flow rate of the parotid and the protein output without stimulation were nearly the same for the four groups.  In patients with CF the protein output after stimulation was significantly lower.  An increased level of sodium was observed in the stimulated secretion and the unstimulated saliva as well.  In CF children we found a significant higher output of sodium in both stimulated parotid saliva and unstimulated parotid saliva.  The IgG output of the gland after stimulation was found to be slightly reduced in patients with CF in comparison to healthy children.  The output of the gland for IgA after stimulation was observed to be strongly reduced for the group with CF and for the group with bronchial asthma.  The decreased output of the gland for secretory IgA after stimulation was demonstrated again in CF and in bronchial asthma in comparison with healthy persons.  The increased sodium concentration in parotid saliva may be caused in a similar way as the electrolyte abnormality of sweat in CF patients, namely by a decreased net reabsorption of sodium.  Due to the result of an increased electrolyte output and decreased immunoglobulin output of parotid gland we can suppose that the molecular magnitude plays its role in this disturbance.',\n",
       " '79193': 'Precipitating antibodies against E. coli, B. fragilis, and P. aeruginosa in CF patients and normal persons determined by means of crossed immunoelectrophoresis.ANTIBODIES-BACTERIAL: an.  BACTEROIDES-FRAGILIS: im. CYSTIC-FIBROSIS: im.  ESCHERICHIA-COLI: im. PSEUDOMONAS-AERUGINOSA: im.Wallwork and co-workers have proposed that increased absorption of antigens takes place across the mucosal membranes of the gut and respiratory tract possibly due to a transient defect in the production of secretory IgA.  As a consequence of this hypothesis, one would expect cystic fibrosis patients to produce a pronounced antibody response against the intestinal bacterial flora.  The present work was therefore carried out to investigate the antibody response in CF patients and in normal persons against Escherichia coli and Bacteroides fragilis which are present in the gut in large numbers and against the respiratory pathogen P. aeruginosa.  A significantly higher prevalence of precipitins against each of the 3 bacterial species was found in CF patients compared to normal persons, and the prevalence of precipitins against each of these bacteria increased significantly with age.  As regards P. aeruginosa precipitins, the prevalence and number was significantly higher in CF patients who have subsequently succumbed compared to CF patients who are still alive.  Such a correlation between the antibody response and the prognosis of the patients was not found as regards E. coli or B. fragilis.  Considering the hypothesis of Wallwork and co-workers concerning increased absorption of antigens from the gut, it seems more attractive to suppose that increased absorption of antigens from the gut flora occurs predominantly in CF patients with P. aeruginosa lung infection with a pronounced antibody response against P. aeruginosa.',\n",
       " '79194': 'Screening for cystic fibrosis in the newborn.CYSTIC-FIBROSIS: pc.In an 8-year period, a programme of screening for cystic fibrosis has been conducted over an extensive part of Wales.  The screening method used is based on the detection of a high level of albumen (greater than 20 mg%) in the meconium.  During the course of the investigations several different tests have been used.  Because of the high incidence of false-negative results (34%) the detection of protein in meconium is not an ideal screening test, but is the most satisfactory presently available, in the newborn period.  Because of its relative simplicity, low cost, absence of direct involvement of the parent or patient, and a high yield of positive cases, its use on a wider scale may be justified.',\n",
       " '79195': 'Sulphated glycoproteins in the pancreas.CYSTIC-FIBROSIS: me.  GLYCOPROTEINS: me.  PANCREAS: me. SULFATES: me.Several reports have indicated the presence of abnormally high amounts of sulphate in the mucous glands of patients with cystic fibrosis.  Bearing these facts in mind, we suspected that abnormal, over-sulphated, and strongly anionic, glycoproteins might be involved in the pathogenesis of CF.  The present study was carried out to determine whether sulphated blood-group substances occur in normal pancreatic tissue.  The distribution of sulphate over the exocrine part of pancreas does coincide with the distribution of blood-group substance previously observed by fluorescent microscopy.  We therefore find it very likely that the sulphate and blood-group substance are associated with the same glycoprotein molecule.  Since blood-group substance has been demonstrated in many secretions in man, and since high amounts of sulphate have been found in the mucous glands in CF, such a mechanism is possible in many locations and may thus offer an explanation for the multiorgan involvement in CF.',\n",
       " '79196': \"An evaluation of the meconium 'lactase test' for the detection of cystic fibrosis in the newborn.BETA-GALACTOSIDASES: an.  CYSTIC-FIBROSIS: di.  GALACTOSIDASES: an. MECONIUM: an.Recently, Antonowicz et al. proposed a simple test for cystic fibrosis that could be used to verify the Boehringer-Mannheim meconium test result and thus reduce the false-positive incidence. The test is based on the detection of lactase activity in meconium. The 'lactase test' may be of some value as a confirmatory test when used with the BM-mec test although its specificity in this study was not as good as previously reported.\",\n",
       " '79197': 'Two children with cystic fibrosis and myocardial fibrosis.CYSTIC-FIBROSIS: co.  MYOCARDIAL-DISEASES: et.Usually cardiac affection in cystic fibrosis is secondary to progressive affection of the lungs (cor pulmonale).  In rare cases, babies and young children show a primary and severe cardiac affection caused by myocardial fibrosis.  We could recently observe two of these cases in our clinic.  The cases are presented and discussed. In babies and young children cardiac insufficiency  caused by cardiomyopathy might be the first presenting symptom in CF. Therefore, in all children with cardiomyopathy of unknown origin, CF has to be suspected and the sweat test has to be performed.  Rapidly progressive cardiac insufficiency responding poorly to treatment and rhythm disturbances are typical.  Correct early diagnosis is important for early genetic counseling.',\n",
       " '79198': 'Chemical comparison of normal and cystic fibrosis meconium: a quantitative and qualitative analysis of carbohydrate splitting enzymes.CYSTIC-FIBROSIS: en.  GLYCOSIDE-HYDROLASES: me.  MECONIUM: en.Meconium specimens from more than 200 normal and premature and from 5 cystic fibrosis newborns were analyzed for their level of several glycosidases.  Considerable scatter of activities were found in all three groups studied and no evidence for any relation of such scatter with the blood group-specific A, B, AB, H substances was found. Alpha-glucosidase, an acid glycosidase found elevated in CF serum and fibroblasts, was elevated in all CF meconium extracts including that which had a very low albumin content.',\n",
       " '79199': 'The use and abuse of antibiotics, including in management of pulmonary manifestations in cystic fibrosis.ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: dt.  LUNG-DISEASES: dt.Individually and collectively opinion is expressed that antibiotics are among the most frequently prescribed drugs in United States, probably also in many other countries.  While it is adopted by many that the increased longevity of cystic fibrosis patients is strongly related to antibiotic usage, this has never been documented adequately.  The principles which we try to follow while using antibiotics in CF patients are outlined.',\n",
       " '79200': 'Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.ANTIBIOTICS: ad.  CYSTIC-FIBROSIS: dt.  LUNG-DISEASES: dt. TOBRAMYCIN: ad.The aim of our clinical study was to find if prolonged tobramycin therapy can prevent further rapid deterioration in cystic fibrosis patients.  Eleven courses of treatment were given to the nine patients.  Eight of these markedly improved their physical activity and gained weight.  However, only in four of these patients was clinical improvement correlated with an improved radiogram. Pseudomonas was eradicated from the sputum of only four patients during therapy but reappeared in three of them before the end of therapy.  Clinical improvement and negligible side effects suggest treatment of exacerbating Pyocyaneus bronchopneumonia with prolonged tobramycin therapy.  Dosage should be higher than 5 mg/kg/day with strict control of tobramycin blood level and awareness of side effects.',\n",
       " '79201': 'Bioavailability of oral antibiotics in cystic fibrosis.AMPICILLIN: aa.  CEPHALEXIN: me.  CYSTIC-FIBROSIS: dt.  EPICILLIN: me.The present investigation was designed to assess the absorption and disposition in cystic fibrosis patients of two commonly used antibiotics: an aminopenicillin, epicillin, and a cephalexin, Ospexin.  The pharmacokinetic parameters of epicillin in patients with CF and their normal controls differ in a number of aspects.  The difference found in the maximal plasma concentrations could be accounted for by a manifold increase in the renal clearance of the drug.  Our data support the idea that patients with CF exhibit an unusually large and rapid renal clearance of certain penicillins.',\n",
       " '79202': 'Progress in screening.CYSTIC-FIBROSIS: pc.Since the Dresden Meeting in 1977 there have only been a few new developments of interest in special field of screening for cystic fibrosis.  There is no ideal screening test for CF available today. The BM Test Meconium is the test most widely used now but many technical, psychological and methodological problems remain to be solved before the test can be endorsed without reservation.',\n",
       " '79203': 'Diagnosing cystic fibrosis in adults [letter].CYSTIC-FIBROSIS: di.Gordeuk et al. state that cystic fibrosis may be first diagnosed in adulthood, but we feel that a condition with such grave genetic and prognostic implications must be diagnosed with special caution in this age group.  In particular, the sweat test, which is the main diagnostic tool for use with children, must be interpreted in adults in the light of possible age-related increases in normal sweat-electrolyte concentration and other factors that may affect the assay.  Although it is generally accepted that \"normal\" sweat sodium and chloride concentrations are higher in adults than in children, there is no clear agreement about the upper limits of the normal range in adults.  The volume of sweat produced during the test may also have a substantial effect on electrolyte values.  For the diagnosis of cystic fibrosis in adults, an attempt should thus be made to base the diagnosis not only on \"elevated\" sweat-electrolyte values and clinical impression but also on pancreatic-function data.',\n",
       " '79204': 'Case records of the Massachusetts General Hospital.  Weekly clinicopathological exercises.  Case 8-1979.CYSTIC-FIBROSIS: pa.  ESOPHAGEAL-AND-GASTRIC-VARICES: pa. LIVER-CIRRHOSIS: pa.The case of a nine-year-old girl admitted to the hospital because of coma is presented.  She was found shortly after birth to have meconium ileus and a high concentration of sodium in her sweat indicative of cystic fibrosis.  Clinical diagnoses were cystic fibrosis of pancreas, cirrhosis of liver, and congestive heart failure secondary to electrolyte imbalance.  Anatomical diagnoses were cystic fibrosis of pancreas with cirrhosis of liver and esophageal varices, brain necrosis, metabolic encephalopathy, bronchiectasis, acute bronchopneumonia, and acute renal tubular necrosis.',\n",
       " '79205': 'Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis.CALCIUM: me.  CYSTIC-FIBROSIS: me.  MITOCHONDRIA: me. OXYGEN-CONSUMPTION.Reports of exocrine gland secretory anomalies in cystic fibrosis and increased calcium ion concentrations in some CF secretions and the importance of cellular Ca to stimulus-secretion coupling led us to study cellular Ca in CF.  We report data on Ca uptake studies with mitochondrial and microsomal fractions isolated from skin fibroblasts of subjects with CF and age-, sex- and passage number-matched controls in which mitochondria from CF cells accumulated more Ca than those from control cells.  We also describe subsequent studies which show increased mitochondrial electron transport activity, measured as oxygen uptake by whole cells, in cells from subjects with CF and obligate heterozygotes.  One can hypothesise a mechanism to link the altered mitochondrial Ca in CF fibroblasts and the major signs associated with the disease.  Data suggest that the electron transport system in CF and obligate heterozygote fibroblasts is more active than that in respective controls, in the conditions of this study.  The apparent central role of Ca in several pathogenetic pathways in CF and the data reported here in which both mitochondrial Ca capacity and oxygen consumption are increased in CF suggest that this organelle is a suitable focus for CF investigations.',\n",
       " '79206': 'Cystic fibrosis and erroneous sweat tests.CYSTIC-FIBROSIS: di.  SWEATING.Making the diagnosis of cystic fibrosis requires clinical suspicion and sweat tests.  Physicians today are aware of the main clinical features of pulmonary and pancreatic involvement and are suspecting the diagnosis earlier than in past years.  The accuracy of the sweat test is the most crucial factor in confirming the diagnosis.  The present case illustrates this point.  The main purpose of this paper is to serve as a reminder that the sweat test is often less than accurate as frequently performed.  The principal pitfall of sweat testing at present seems to be the use of a chloride electrode applied to the skin without assurance that an adequate amount of sweat is present.',\n",
       " '79207': 'Cystic fibrosis: a disease of unknown causes.CYSTIC-FIBROSIS: nu.The author looks at the disease which affects two out of every 2000 newborn children - a disease which causes most of the childhood chronic pulmonary disease in the Western world.  The author tells how the Cystic Fibrosis Research Trust can help parents of affected children. Prone immersion physical exercise therapy in three children with cystic fibrosis: a pilot study.CYSTIC-FIBROSIS: th.  EXERCISE-THERAPY: mt.  IMMERSION. PHYSICAL-THERAPY: mt.Prone immersion physical exercise therapy has been used successfully in the physical rehabilitation of middle-aged adults with moderate to severe chronic obstructive pulmonary disease. The purpose of this pilot project was to evaluate the effects of PIPE therapy in children with cystic fibrosis. Three children with CF, two boys aged 6 and 14 years and one girl aged 15 years, voluntarily participated in the experimental training program. The patients performed individualized group exercise three times a week on alternate days for 28 consecutive weeks at an intensity of approximately 75 percent aerobic capacity. Duration of exercise gradually increased from 15 (3 x 5 minutes) to 60 (3 x 20 minutes) minutes while the rest period after each exercise was constant at two minutes. PIPE training resulted in increased physical work capacity and maximal oxygen consumption in all three subjects. Curiously, these changes were not accompanied by training bradycardia.',\n",
       " '79209': 'Anemia, hypoproteinemia and edema in an infant with cystic fibrosis.CYSTIC-FIBROSIS: co.  INFANT-NUTRITION-DISORDERS: et.A patient with cystic fibrosis was encountered who presented with anemia, hypoproteinemia, edema and failure to thrive.  A blood transfusion resulted in some improvement, but the symptoms recurred in a few weeks.  Only after the correct diagnosis was made and appropriate therapy instituted did the patient show signs of improvement.  The account of this case illustrates the importance of considering the diagnosis of cystic fibrosis in any child with malnutrition.',\n",
       " '79210': 'Serum vitamin D and related mineral metabolism in cystic fibrosis.CYSTIC-FIBROSIS: me.  MINERALS: me.  VITAMIN-D: bl.Two groups of investigators have independently explored the role of vitamin D and related mineral metabolism in patients with cystic fibrosis, and found relatively minor changes.',\n",
       " '79211': \"The pyridine scale for clinical measurement of olfactory threshold: a quantitative reevaluation.PYRIDINES: du.  SMELL: ph.Serial dilutions of pyridine in water are employed for measuring the olfactory detection thresholds of patients. Experimental precautions are described that improve the precision and accuracy of the method. Existing data on the sensitivities of hyposmic patients are confirmed, but the sensitivities of normal subjects and of hyperosmic patients are believed to have been substantially overestimated in some earlier publications. Routine clinical applications of the revised pyridine odor threshold test are discussed. In the author's experience, the average cystic fibrosis patient is slightly hyposmic, and some cases of pituitary tumor are accompanied by a 100,000-fold hyperosmia.\",\n",
       " '79212': 'Cystic fibrosis in adults: an autopsy study.CYSTIC-FIBROSIS: pa.An annotated catalog of clinical and pathologic observations in an adult population with CF has been presented. The spectrum of disease is broad, and the diagnosis usually requires the demonstration of abnormalities in multiple systems. Tissues of each germ layer have been found involved in CF. Correlation of clinical and pathologic observations suggests that manifestations are essentially episodic and focal. In this population, the most characteristic abnormalities recognized by the pathologist are focal biliary cirrhosis, distinctive obstructive lesions of the male genital tract, prolonged staphylococcal or pseudomonas colonization of respiratory secretions, and obstructive bronchopulmonary disease. Some form of pancreatic atrophy is usually present.',\n",
       " '79213': \"Invited review.  The technique and scope of electron-probe X-ray analysis in pathology.ELECTRON-PROBE-MICROANALYSIS: mt.  PATHOLOGY: is.The purpose of this article is to review briefly both the techniques and applications of electron-probe x-ray analysis, but only studies of interest to pathologists will be dealt with.  The principles of x-ray fluorescence spectrometry, the capabilities and limitations of energy dispersive x-ray analysis, equipment, specimen preparation, and the method of electron-probe x-ray analysis are discussed. Applications of electron-probe x-ray analysis include mineral deposits in lungs, intranuclear bismuth inclusions, gold deposits in tissues, the nature of haemosiderin, copper in Wilson's disease, calcium in mitochondria, surgical implants, foreign bodies in eyes and wounds, the specificity of v. Kossa method for calcium, cytochemical localization of acid phosphatase, chromaffin and argentaffin reactions, the transfer of antigenic material from macrophages to lymphocytes, and the diagnosis of cystic fibrosis by electron-probe x-ray analysis of nails.\",\n",
       " '79214': \"Genetic aspects of pediatric lung disease.LUNG-DISEASES: fg.Several genetic diseases are described which affect the lung, usually or at least in some cases, in the pediatric age group. The four disorders discussed have been selected wither for their high frequency or for their demonstration of the variety of ways in which genetic factors can influence disease: cystic fibrosis, one of the most common of the metabolic disorders inherited as an autosomal recessive trait; immotile cilia syndrome, including Kartagener's syndrome, single gene disorders involving structural abnormalities of the cilia; asthma, a common disorder in children with a genetic component; and alpha1-antitrypsin deficiency, an inherited protein deficiency commonly causing obstructive lung disease in adults and occasionally affecting children.\",\n",
       " '79215': 'Perspectives in cystic fibrosis.CYSTIC-FIBROSIS: th.It would seem that early diagnosis of cystic fibrosis and the institution of an aggressive treatment program before widespread irreversible lung damage has occurred may greatly prolong survival. Individual prediction at the time of diagnosis is impossible, but there are a number of factors which, when considered together, enable the clinician to place patients in a number of broadly defined risk groups.  It is the definition and characteristics of these groups which would help the physician in assessment, counseling, and follow-up of patients with cystic fibrosis which are addressed in this article.  The heterogeneity of cystic fibrosis, sex differences, presentation and age at diagnosis, pulmonary function, radiologic assessment, and projections for the future are discussed.',\n",
       " '79216': 'Increased heparin binding in cystic fibrosis: a reflection of altered glycoprotein biosynthesis?.BLOOD-PROTEINS: me.  CYSTIC-FIBROSIS: bl.  GLYCOPROTEINS: bi. HEPARIN: bl.Some of the serum proteins which bind to heparin and contribute to the pH 5.57 \"heparin binding capacity\" of human serum are glycoproteins; those from cystic fibrosis serum were found to be 27% higher in fucose (methylpentose) content, 27% lower in sialic acid content, and 31% lower in hexose content when compared to heparin- precipitated serum glycoproteins from normal control subjects. Hexosamine content of the heparin-precipitated serum glycoproteins was the same. Results of this preliminary investigation indicate that altered carbohydrate composition in serum glycoproteins may affect significantly their heparin binding capacity.',\n",
       " '79217': 'The chronically reserpinized rat as an animal model for cystic fibrosis: I. Acute effect of isoproterenol and pilocarpine upon pulmonary lavage fluid.CYSTIC-FIBROSIS: ci.  ISOPROTERENOL: pd.  LUNG: de.  PILOCARPINE: pd. RESERPINE: pd.Lung lavage samples from rats treated in a chronic fashion with reserpine had mean increases of 133, 170, and 120% in the total protein, lipid, and carbohydrate contents, respectively, when compared with those of untreated control animals, when these values were expressed in terms of body weight.  An acute single ip injection of the beta-adrenergic agent isoproterenol (10 mg) increased the glycoprotein content of pulmonary lavage fluid from control rats approximately 15-19%, but only 9-10% in those from reserpine treated rats.  By contrast, pilocarpine (10 mg), administered in the same manner, caused a 15% increase in the total protein, carbohydrate, and lipid content of lavage samples from control rats and increased these same constituents in the lavage samples of reserpine treated rats 98, 102, and 80%, respectively. The increased  total carbohydrate content in the lavage samples of the treated animals was not associated with changes in the percent distribution of neutral sugars, amino sugars, or sialic acid.  The ratio of these various sugar components did not change in the lavage samples of control or reserpine treated rats upon stimulation with either pilocarpine or isoproterenol.  The increased total lipid content fround in the lavage samples from the treated rats probably results from an increase in phospholipids.  A decrease in phospholipid content occurred in the lavage samples of reserpine treated rats upon stimulation, while the opposite was observed in those of control animals.  Chronic treatment of rats with reserpine, thus, appears to induce an enhanced production of glycoproteins in the airways and to interfere with phospholipid metabolism in the lung.  In addition, the drug treatment enhances the secretory response to pilocarpine in comparison with the responses of control animals.  The enhanced response or hypersecretion of glycoproteins is a quantitative one and does not seem to involve alterations in the ratios or distribution of the various sugar components.  This disturbance in the secretory function of the respiratory tract, a target organ which is prominently involved in cystic fibrosis (CF) together with alterations in other exocrine glands which resemble those of CF patients, makes the reserpine treated rat a useful model for further study of possible pathogenetic mechanisms in CF.  The experimental animal model for CF developed by the chronic administration of reserpine to rats has been found to have changes in the protein content of lung lavage samples, in addition to morphologic and secretory alterations in the salivary glands and the pancreas.  Further analysis of the organic composition of lung lavage samples shows that the protein, carbohydrate, and lipid contents are significantly increased after chronic reserpine administration and that the response to stimulation with pilocarpine is enhanced in the treated animals when compared to that of untreated control rats.  It therefore appears that chronic reserpine administration causes a hypersecretion of glycoproteins and changes in lipid metabolism in the respiratory tract of the rat and that, in conjunction with previous findings in other exocrine glands, these effects on lung function make the reserpine treated rat a useful tool for the study of the pathologic disturbance seen in the major exocrine glands affected in CF.',\n",
       " '79218': 'Altered polyamine metabolism in cystic fibrosis.CYSTIC-FIBROSIS: ur.  POLYAMINES: ur.Children with cystic fibrosis excreted elevated urinary levels of all three polyamines--putrescine, spermidine, and spermine. Heterozygote parents excreted intermediate concentrations of the polyamines, but not levels significantly different from levels in normal controls. Patients with cystic fibrosis who were administered a tracer amount of [14C]spermidine excreted 11--13% of the radiolabel within 72 hr whereas normal controls excreted 60--76% of the radiolabel within 72 hr. Spermine excretion was positively correlated with increased pathology as assessed by the National Institutes of Health (NIH) clinical score, whereas urinary putrescine and spermidine levels were negatively correlated with increased pathology.',\n",
       " '79219': 'Chronically reserpinized rat as a model for cystic fibrosis: Na+ transport inhibitory effect in submaxillary saliva.CYSTIC-FIBROSIS: me.  RESERPINE: pd.  SALIVA: me.  SODIUM: me.The retrograde perfusion assay in the rat parotid gland was used to investigate the effects of salivary secretions from control and reserpine-treated rats on Na+ reabsorption. Results demonstrated that submaxillary saliva from the treated animals caused a 69% inhibition of Na+ reabsorption, accompanied by a 28% reduction in the volume of saliva secreted, and a 22% reduction in flow rate. By contrast, submaxillary saliva from control rats caused a 6% inhibition of Na+ reabsorption, a 6% reduction in volume, and a 5% reduction in flow rate. Parotid saliva from reserpine-treated rats also inhibited Na+ reabsorption to the extent of 39% and caused a 38% reduction in volume and a 33% reduction in flow. Parotid saliva from control rats only inhibited Na+ reabsorption to the extent of 2.7% and caused a 4-- 6% reduction in salivary volumes and flow rates. The inhibition of Na+ reabsorption and the reduction in salivary volume and flow rates caused by submaxillary saliva of reserpine-treated rats were either abolished or significantly reduced when the saliva was previously heated to 100 degrees C, frozen, and then thawed or kept in glass tubes at 4 degrees C for 24 hr. These results indicate that saliva from reserpine-treated rats have comparable effects in this assay system to those of saliva from cystic fibrosis (CF) patients and further support its use as an animal model for this disease.',\n",
       " '79220': 'Evidence against a specific effect of serum from patients with cystic fibrosis on sodium-dependent glucose transport in the rat jejunum.CYSTIC-FIBROSIS: bl.  GLUCOSE: me.  JEJUNUM: me.  SODIUM: pd.Sera from patients with cystic fibrosis of the pancreas (CF) and normal human sera were assayed for the ability to inhibit sodium- dependent glucose transport in rat brush-border membrane vesicles. Fresh CF and age- and sex-matched control sera were both inhibitory when compared to physiologic saline. The inhibition by CF serum was 44 +/- 13% (mean +/- SD) at a final serum concentration of 6.7%, 67 +/- 34% at 10% serum, and 68 +/- 28% at 20% serum. The ratio of the inhibition of CF sera compared to that of control sera was 1.00, 0.78, and 0.93 at 6.7, 10, and 20% serum concentrations, respectively. Although a slightly greater inhibition by CF serum was observed at a concentration of 10%, this is probably not significant because no difference could be detected at a concentration of 20% serum. Glucose transport in the presence of serum was sensitive to phlorizin indicating that the residual glucose transport was proceeding by the sodium-dependent glucose transport system. These findings suggest that CF serum does not specifically inhibit the sodium-dependent glucose transport system. The intravesicular space accessible to glucose was reduced in the presence of CF or control serum. Fresh CF serum was 1.4 times more effective than fresh control serum (P less than 0.01). The presence of substantial vesicle- shrinking activity in control serum indicates that this activity cannot be considered specific for CF.',\n",
       " '79221': 'Altered intracellular calcium in fibroblasts from patients with cystic fibrosis and heterozygotes.BODY-FLUIDS: me.  CALCIUM: me.  CYSTIC-FIBROSIS: me.  HETEROZYGOTE. INTRACELLULAR-FLUID: me.The importance of intracellular calcium (Ca) in secretion and transmembrane ion movement led us to study Ca in cells from patients with cystic fibrosis (CF) which is a lethal genetic exocrinopathy. Skin fibroblasts from patients with CF, obligate heterozygotes (HZ), and age- and sex-matched controls (C) were used in matched pair experiments measuring 45Ca exchange into and efflux from the cells over time. CF cell lines and HZ cell lines exhibit increased 45Ca exchange when compared with their respective controls (P less than 0.005). The magnitude of this difference (approximately 30%) is not reduced when cells are washed with lanthanum chloride after the exchange period. This difference is likely attributable to an altered capacity of one or more of the intracellular Ca sequestering organelles. Further evidence for this explanation was seen in 45Ca efflux experiments in which CF cells retained a higher percent of their initial 0-time 45Ca than did C cells late in the efflux period (P less than 0.05). The finding of an altered Ca pool size in both CF and particularly HZ cells suggests that altered Ca metabolism is related to the basic gene defect in CF.',\n",
       " '79222': 'Anomalous alpha 2-macroglobulin-protease complexes in cystic fibrosis: decreased uptake of the complexes by fibroblasts in culture.ALPHA-MACROGLOBULINS: me.  CYSTIC-FIBROSIS: bl, en. PEPTIDE-HYDROLASES: bl.Immunochemical and functional properties of control and Cystic Fibrosis (CF) alpha 2-Macroglobulin (alpha 2M) are compared. Crossed immunoelectrophoresis and Ouchterlony double diffusion revealed no qualitative differences between the two alpha 2-M preparations. Trypsin-esterase activity assayed with BAPNA as a substrate, in the presence of an excess STI, gave similar ratios between total and active alpha 2M. These alpha 2M-trypsin complexes were equally stable under various experimental conditions and maintained a constant STI non-inhibited esterase activity. Normal and CF-alpha 2M-trypsin complexes were taken up by normal human fibroblasts to a similar extent during a four hour period. The only significant difference was observed when the uptake of alpha 2M from untreated sera was examined. The uptake of alpha 2M from CF sera was always lower than from pooled control sera despite large variation. Mixing of control and CF serum did not affect the normal uptake and other serum components were taken up to the normal extent. Intracellular degradation of CF alpha 2M had a half life of 2.0 to 2.8 hours, which compares well to the normal half life of 2.2 hours. More work needs to be done on the nature of the interaction between alpha 2M and proteases before a reasonable explanation for the molecular nature of the abnormal behavior can be sought.',\n",
       " '79223': 'Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages.CYSTIC-FIBROSIS: bl.  MACROPHAGES: ph.  PHAGOCYTOSIS. PSEUDOMONAS-AERUGINOSA: cy.This report presents experimental observations indicating the presence of an inhibitory activity in cystic fibrosis (CF) serum which impairs phagocytosis of Pseudomonas aeruginosa by rabbit as well as human alveolar macrophages. Of the 49 patient serum samples studied, 40 consistently showed greater than or equal to 60% inhibition, 3 showed no inhibition and 6 were in the range of 20-60% inhibition of Pseudomonas phagocytosis. In parallel studies, the phagocytosis of S. aureus and S. marcescens was found not to be inhibited by CF serum. Mixing of CF serum with normal serum could not overcome the inhibitory effect, indicating the presence of an inhibitory factor rather than the lack of a necessary component. The inhibitory activity is not lost upon exposure of serum to glass, upon freezing the serum once, or upon heating at 56 degrees C for 30 minutes.',\n",
       " '79224': 'Serum ciliotoxic activity in mutant mice with some hereditary alterations resembling cystic fibrosis.CILIA: ph.  CYSTIC-FIBROSIS: bl.  SPERM-TAIL: ph.  SPERMATOZOA: ph.Serum ciliotoxic activity (SCA), which had been described in cystic fibrosis (CF), was studied in mutant mice with some hereditary alterations resembling this inherited disease. A test was developed to detect SCA in biologic fluids by means of a natural vibratile system; it consisted in the incubation of mouse sperm with different CF serum dilutions under controlled conditions, in order to determine the sperm translation cessation time (STCT) and the sperm activity cessation time (SACT). As the findings of this study were similar to those obtained by other authors who have been employing alternative systems, it was decided to apply this method on mice serum. Sera were obtained from male and female 3- to 4-wk-old mice of DBA/2J-cri, C57BL/6J-bgJ, and BALB/c inbred strains; SCA was investigated in affected homozygotes and their +/? siblings were used as controls. Male 8- to 16-wk-old BALB/c mice were employed as sperm donors. Significant differences were found between cri/cri and +/? mice of the DBA/2J-cri strain in both STCT and SACT determinations at 1/10 serum dilution. It is concluded that mouse sperm is a system sensitive enough to detect SCA in biologic fluids from human beings. Likewise, the test of the mouse sperm allowed us to detect SCA in cri/cri mice, turning this mutation into a possible animal model for CF.',\n",
       " '79225': 'Binding of 125I-labeled proteinases to plasma proteins in cystic fibrosis.BLOOD-PROTEINS: me.  CYSTIC-FIBROSIS: bl. PEPTIDE-PEPTIDOHYDROLASES: bl.  TRYPSIN: bl.Samples of plasma or serum from 53 cystic fibrosis (CF) patients, 90 relatives of CF patients , and 159 controls have been incubated with porcine or bovine 125I-trypsin, electrophoresed on polyacrylamide gel, and autoradiographed. In these individuals, the main binding protein for 125I-trypsin has been shown to be alpha 2-macroglobulin (alpha 2M). Using this method of analysis, no difference in electrophoretic migration of 125I-trypsin-alpha 2M complexes has been observed between CF and control individuals. However, trypsin binding to IgG has been observed in 80% of CF patients, 30% of their mothers, 3% of controls, and in two patients affected with pancreatitis. These trypsin binding immunoglobulins are called TbIg, and specifically, Tb1gG when referring to the G class. Experimental evidence indicates that binding of trypsin to IgG occurs through the Fab portion of the molecule. Tb1gG must be antibodies most probably induced by the exogenous trypsin ingested daily by most CF patients (and by patients affected with chronic pancreatitis). Antibodies against porcine pancreatic elastase have been observed using the same analysis, but not as frequently as Tb1g.',\n",
       " '79226': 'Serum salivary amylase in cystic fibrosis [letter].AMYLASES: an.  CYSTIC-FIBROSIS: en.  ISOENZYMES: an.  SALIVA: en.We found that cystic fibrosis (CF) patients with pancreatic insufficiency (PI) had a statistically lower total serum amylase level than normal subjects, but all values were still within the normal range.  Although we found that the absolute amount of salivary amylase, in the serum of patients with CF and PI, was the same as that for normal subjects, the percent of contribution was considerably higher.  We found that the pancreas contributed approximately 23% of the total serum amylase in CF patients with PI, a value very similar to the 34% amount found by Kamaryt et al.  We also found, as did Davidson et al., that CF patients without PI had higher total serum amylase values than did normal subjects.  Thus, we feel that Davidson et al. have misinterpreted the results of our previous study and, in fact, we feel that Davidson et al. have essentially confirmed our previous work by suggesting that CF patients with pancreatic insufficiency have an increased salivary amylase for reasons yet unknown.  Our experience has shown that, indeed, the pancreatic portion is first increased and then decreases as the patient with CF and apparent normal pancreatic function progresses, with time, toward pancreatic insufficiency.  However, the changes in serum amylase values in patients with CF are on the average due to changes in the pancreatic contribution to the serum and as expressed as a mean was highly significantly different for both normal and abnormal pancreatic function.  The second important point of our paper was that this mean variation occurred in serum samples from patients with CF that had total amylase values within the normal test range.  The serum salivary isoamylase in both normals and patients with CF and PI had a higher serum salivary percent.',\n",
       " '79227': 'Development of an improved tracheal explant bioassay for the detection of the ciliary dyskinesia factor in cystic fibrosis serum.CILIA: de.  CYSTIC-FIBROSIS: bl.  CYTOTOXINS: pd.  TRACHEA: de.A tracheal ring explant system, when used with 25% cystic fibrosis (CF) serum, displayed obvious ciliostasis. Hamster, rabbit, and guinea pig explants all had measurable decreases in ciliary activity after 24 hr of incubation in the serum. The differential response to CF serum (relative to normal serum) was greatly increased by using explants which were maintained 24-72 hr in minimal essential medium (MEM) with 10% horse serum and which were selected on the basis of optimal ciliary activity and vigor. With such a bioassay system of guinea pig tracheal explants, incubation with 25% normal serum would produce essentially no change in relative ciliary activity (score of 242 of a possible 300), whereas CF serum resulted in an 86% decrease (score of 33). Scanning electron microscopic observation indicated that the explants displaying the CF-ciliostatic effect had significant accumulations of mucous over the ciliated epithelial surface. A biochemical viability assay (dehydrogenase activity) showed no cytonecrosis when CF serum-treated tissues were compared to standard explants (10% horse serum in MEM) or control explants (25% normal human serum).',\n",
       " '79228': 'Laser light-scattering spectroscopy: preliminary results on bioassay of cystic fibrosis factor(s).BIOLOGICAL-ASSAY: mt.  CILIA: ph.  CYSTIC-FIBROSIS: bl.  LASERS. SPECTRUM-ANALYSIS: mt.The effect of 7 cystic fibrosis sera and 4 normal sera was investigated in 37 cultures of ciliated epithelium of the rabbit trachea. Serum was introduced in the Rose culture chambers in a concentration of 10% by volume. The frequency of ciliary beat was monitored by laser light-scattering spectroscopy. The results show that the response of cilia to sera can be well characterized by laser light scattering. Our preliminary evidence suggests that an early increase in the frequency of ciliary beat, followed by rapid arrest of ciliary activity, is a sensitive and characteristic response produced by cystic fibrosis serum, and not by normal serum.',\n",
       " '79229': 'Cystic fibrosis serum effect on the short circuit current of rat jejunum.CYSTIC-FIBROSIS: bl.Sera from 100 subjects were tested for the presence of the cystic fibrosis (CF) \"factor\" utilizing the short circuit current rat jejunum bioassay. Comparing the mean percent decrease in short circuit current, the presumed normal group differs from the homozygous CF group at P = 0.001 and from the heterozygous group at P = 0.05. The two CF genotypes are statistically different at P = 0.004. There is, however, a large overlap among the three groups, which limits the assay\\'s utility as a guide for factor purification as well as clinical use.',\n",
       " '79230': 'Detection of cystic fibrosis protein by isoelectric focusing of serum [letter].BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl.  ISOELECTRIC-FOCUSING.Several cystic fibrosis research groups have independently attempted to reproduce the isoelectric focusing work of Wilson et al.  The protocol that we employed with the LKB Mulitphor electrofocusing apparatus was that of Wilson et al., although fixing and staining of the polyacrylamide gels was performed in a boiling water bath for 30 min.  In 10 of 11 sera from patients with CF, the cystic fibrosis protein band was directly identified by each of two independent observers and in the sera from nine obligate heterozygote individuals, the CFP band was noted in seven and eight instances by each observer, respectively.  In sera from 26 normal control individuals, the CFP band was observed in two instances.  Our results would support the view that the CFP band is indeed directly identifiable in both CT heterozygote and homozygote sera without recourse to photographic image enhancement and that its frequency of occurrence is similar to that reported previously.',\n",
       " '79231': 'Cystic fibrosis protein, a confirmed diagnostic marker for detecting heterozygote carriers: significance in relation to future screening and to a proposed primary defect in alpha 2-macroglobulin.ALPHA-MACROGLOBULINS: me.  BLOOD-PROTEINS: an.  CYSTIC-FIBROSIS: bl. HETEROZYGOTE-DETECTION.The fact that alpha2-macroglobulin and cystic fibrosis CDA are made by fibroblasts and monocytes points to the fact that these markers and the CF protein will be of value for the detection of the CF gene antenatally.  Screening for CFP and CF-CDA by isoelectric focusing or radioimmunoassay in conjunction with quantitation of the functional capacity of A2M could distinguish a fetus homozygous from one heterozygous for the CF gene.',\n",
       " '79232': 'Serum factor in cystic fibrosis: correlation with clinical parameters.CYSTIC-FIBROSIS: bl.  PEPTIDES: bl.The relationship between the activity of the cystic fibrosis serum ciliary dyskinesia factor, detected by the rabbit tracheal bioassay, and clinical status of the patient has been investigated in children, 1-24 years old, with cystic fibrosis. No significant correlation was found between the amount of serum factor activity and age, clinical status assessed by the Schwachman score, pulmonary function (vital capacity, functional residual capacity, total lung capacity, residual volume, maximum breathing capacity, maximal midinspiratory flow, and maximal midexpiratory flow) or blood gas levels (pCO2, pO2). The activity showed no significant relationship to serum galactosyltransferase activity in children with cystic fibrosis.',\n",
       " '79233': 'Intravenous linoleic acid supplementation in children with cystic fibrosis.CYSTIC-FIBROSIS: dh.  LINOLEIC-ACIDS: tu.Ten children with CF in matched pairs were infused with either Intralipid or with 10% glucose on a double blind basis every other week for one year. Although statistically there was significantly greater gain in height and weight in the study year compared to the previous year only for the test group, both groups improved more than expected. Cumulative data analysis showed greater improvement for the Intralipid group (23 of a possible 45 points) compared to the glucose group (-2 points; P less than .02). This study indicates the need to better define the role of nutrition in the pathophysiology of CF. Meanwhile, it is recommended that all children with CF have plasma linoleic acid levels measured at least once yearly, and if levels are low, appropriate supplements should be given.',\n",
       " '79234': 'The chest roentgenogram in cystic fibrosis: a new scoring system.CYSTIC-FIBROSIS: ra.  LUNG: ra.A roentgenogram scoring system is presented that is useful in the evaluation and follow-up of patients with cystic fibrosis. The system has been shown to be reproducible by and between observers and to correlate significantly with results of pulmonary function tests, Shwachman-Kulczycki scores, and, in a short-term evaluation, morbidity.',\n",
       " '79235': 'Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis.CYSTIC-FIBROSIS: me.  OILS: pd.  SAFFLOWER-OIL: pd. SODIUM-CHLORIDE: an.  SWEAT: an.Essential fatty acid supplementation with oral safflower oil (1 gm/kg/day) to 11 cystic fibrosis patients (aged 6 months to 14 years) for one year produced no significant change in sweat chloride concentration (mEq/liter) or sweat rate (gm/min/m2), Addition of vitamin E (10 mg/kg/day) to the safflower oil had no effect on sweat chloride concentration or rate compared to placebo. No clinical improvement could be detected compared to a control group. These results do not support previous reports of the effects of fatty acid supplementation on sweat electrolyte concentrations in cystic fibrosis.',\n",
       " '79236': 'Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis.ALKALOSIS: et.  CYSTIC-FIBROSIS: co.  WATER-ELECTROLYTE-IMBALANCE: et.The records of all children in the Tucson area diagnosed as having cystic fibrosis (CF) before the age of 12 months were reviewed to ascertain the prevalence of metabolic alkalosis as a major presenting manifestation of CF. Five of eleven infants (46%) in whom CF had been diagnosed between 1 and 12 months of age initially were seen with hypokalemia, hypochloremia, and metabolic alkalosis unassociated with marked dehydration, hyperpyrexia, or major pulmonary and/or gastrointestinal symptoms. Two infants had repeated episodes of metabolic alkalosis; for one of these infants, both episodes of metabolic alkalosis occurred before the diagnosis of CF. It is postulated that chronic loss of sweat electrolytes together with mild gastrointestinal or respiratory illness may predispose the infant with cystic fibrosis to a severe electrolyte and acid-base disturbance. The lack of shock and hyperpyrexia together with the apparent chronicity of electrolyte losses differentiates metabolic alkalosis from the heat prostration syndrome, a more acute complication of cystic fibrosis. Quantitative sweat testing should be part of the evaluation of any infant with unexplained metabolic alkalosis. Serum electrolytes should be assessed regularly in infants with cystic fibrosis during hot weather months.',\n",
       " '79237': 'Multifocal myocardial necrosis and fibrosis in pancreatic diseases of children.ENDOMYOCARDIAL-FIBROSIS: pa.  MYOCARDIUM: pa. PANCREATIC-DISEASES: pa.From a review of 2,000 autopsies of children, 16 cases of extensive necrosis and scarring fibrosis of the myocardium were found. These lesions involved mainly the left ventricle and spared the endocardium, the pericardium, and the coronary vessels. These necrotic of fibrotic heart lesions were found to be closely associated with various pancreatic diseases: cystic fibrosis (11 cases), pancreatic lipomatosis (2 cases), extensive small bowel resection (3 cases, 2 of which were associated with acute interstitial pancreatitis). To explain these unexpected associations, two hypotheses can be put forth: (1) The lack of absorption of some presently undetermined substances indispensable for the correct trophicity of the myocardium, and (2) the release in the blood of proteolytic enzymes with consecutive activation of phlogistic substances such as kinins.',\n",
       " '79238': 'Vitamin E: where do we stand?.CHILD-NUTRITION.  INFANT-NUTRITION-DISORDERS: dt. VITAMIN-E-DEFICIENCY: dt.  VITAMIN-E: tu.I propose that clinicians should have a general understanding of what little physiology is known about tocopherol, be able to recognize the circumstances that cause low tocopherol levels, understand when to provide physiologic replacement therapy, and accept the responsibility for protecting their patients from uncontrolled experimental use of tocopherols.  Tocopherol physiology, tocopherol pharmacology, tocopherol deficiency, therapy in deficiency states, and pharmacological doses of tocopherol are discussed.  Patients with prolonged fat malabsorption and some premature infants receiving iron must be given vitamin E.  Use of tocopherol therapy in bronchopulmonary dysplasia and retrolental fibroplasia, while promising, is unproven and should be used only in a controlled study. Research on the role of vitamin E in human physiology is entering a rapid-growth phase.',\n",
       " '79239': 'Metabolic alkalosis in infants with cystic fibrosis [letter].ALKALOSIS: et.  CYSTIC-FIBROSIS: co.I have diagnosed six cystic fibrosis infants under 1 year of age, four of whom had documented episodes of hypoelectrolytemia and severe metabolic alkalosis.  These additional data support our previous hypothesis that chronic sweat electrolyte depletion, more frequently than previously recognized, can cause severe metabolic derangements in infants with cystic fibrosis, especially those living in both humid and dry, hot climates.',\n",
       " '79240': 'An evaluation of the forced expiration technique as an adjunct to postural drainage.BRONCHIAL-SPASM: th.  CYSTIC-FIBROSIS: th.  RESPIRATORY-THERAPY: mt.A criticism often levelled at the forced expiration technique (FET) is that it increases and may even produce bronchospasm.  It was our impression that the use of forced expiration when combined with periods of relaxed diaphragmatic breathing did not aggravate bronchospasm and shortened the postural drainage session.  Two groups of patients were studied: 24 with cystic fibrosis to evaluate the use of the FET as an independent means of postural drainage; and 20 asthmatic patients to assess the effect of the FET on bronchospasm. The studies indicate that the forced expiration technique increases the efficiency of postural drainage, but does not increase airway obstruction.  This technique can be applied to both medical and surgical conditions when postural drainage, or a modified form of postural drainage, is indicated.',\n",
       " '79241': 'A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum.CATHEPSINS: ip.  CYSTIC-FIBROSIS: en.  PANCREATOPEPTIDASE: ip. SPUTUM: en.A procedure is described which permits the rapid isolation of large amounts of elastase and cathepsin G from purulent sputum. This procedure involves: (1) digestion of sputum with DNase, (2) extraction of the insoluble residue that remains with 1 M NaCl, pH 8, (3) affinity chromatography on Sepharose-bound Trasylol, and (4) separation of the two enzymes by chromatogrphy on CM-Sephadex. Starting with 500 g of sputum it was possible to isolate 175 mg of each of these two enzymes within 7 to 10 days. Active site titration indicated both enzymes to be at least 97% pure. Disc gel electrophoresis in the presence and absence of SDS and amino acid sequence of the N-terminal region support the conclusion that the elastase and cathepsin G isolated from sputum are identical to the same enzymes isolated directly from the leukocytes of human blood.',\n",
       " '79242': 'Mitrochondrial NADH dehydrogenase in cystic fibrosis.CYSTIC-FIBROSIS: en.  MITOCHONDRIA: en. NADH-NADPH-OXIDOREDUCTASES: me.  SKIN: en.We have shown that skin fibroblast from patients with cystic fibrosis (CF) and from carriers for CF [heterozygotes (HZ)] consume more O2 than do their controls. When the mitochondrial electron transport inhibitor rotenone was added to the cells, the relative inhibition of O2 consumption was CF greater than HZ greater than controls (P less than 0.005 in both comparisons). Because rotenone specifically inhibits NADH dehydrogenase, [NADH: (acceptor) oxidoreductase, EC 1.6.99.3], which is the enzyme of energy-conserving site 1 of the mitochondrial electron transport system, activity and kinetics of this enzyme system were studied in fibroblast homogenates. NADH dehydrogenase activity was equal in cells from the three genotypes. At pH 8.0, affinity of the enzyme for its substrate was CF greater than HZ = controls; at pH 8.6, affinity was CF greater than HZ = controls (P less than 0.005 for the differences). pH optima for the genotypes were without exception 8.6 (CF), 8.3 (HZ), and 8.0 (control). HZ and control lines were distinguished unequivocally in a blind test on the basis of differences in pH optima. Purified mitochondrial preparations revealed pH optima identical to those found in whole cell homogenates. These data suggest that the mutant gene responsible for CF is expressed in the complex mitochondrial NADH dehydrogenase system.',\n",
       " '79243': 'Cystic fibrosis: potential management through manipulation of the secretory process in affected exocrine glands.CYSTIC-FIBROSIS: th.  EXOCRINE-GLANDS: se.Ten years ago, we demonstrated that chronic administration of isoproterenol to rats results is structural and functional changes of their salivary glands similar to those seen in exocrine glands of patients with cystic fibrosis.  Recently, we began to study the cellular pathophysiology of these glands and managed to achieve pharmacological control of this abnormality.  We demonstrated that administration of a beta-adrenergic antagonist in these animals resulted in the correction of the electrolyte abnormality which is very similar to that seen in the sweat glands of patients with cystic fibrosis.  These two examples of manipulation of the secretory processes in exocrine glands of experimental animals demonstrate the feasibility of this approach in the therapy of patients with cystic fibrosis.',\n",
       " '79244': 'Changing patterns of genetic counseling in a cystic fibrosis center.CYSTIC-FIBROSIS: fg.  GENETIC-COUNSELING.The change of life expectancy of cystic fibrosis patients has stimulated our interest in assessing the understanding and utilization of genetic information by adult CF patients and how this may affect their coping mechanism(s).  The present study was designed to obtain information in these areas with the expectation that more effective genetic counseling might be developed for this enlarging group of patients.  Knowledge of genetics, attitudes concerning reproduction, attitudes toward prenatal diagnosis, and attitudes toward a carrier identification study are reported for 25 males and 15 females with proven cystic fibrosis.',\n",
       " '79245': \"New test to detect carriers of gene for cystic fibrosis [news].CYSTIC-FIBROSIS: di.  HETEROZYGOTE-DETECTION: mt.Development of a new test to detect carriers of the gene for cystic fibrosis was announced.  The test involves the interaction between red blood cells from a mouse and a small amount of a person's blood serum.  The gene for cystic fibrosis is associated with a lectin, a factor in the person's blood serum that acts to agglutinate (or cluster) the red blood cells of the mouse. Cystic fibrosis--its surgical presentation.CYSTIC-FIBROSIS: co.In a series of 62 cases of cystic fibrosis presenting at the Transvaal Memorial Hospital for Children, Johannesburg, during the 10-year period 1968-1978, 15 patients required surgical treatment for 17 complications of the disease.  Meconium ileus, rectal prolapse, intussusception and ethmoiditis were the commonest surgical presentations, and portal hypertension, bronchial obstruction and nasal polyposis were also experienced.  As the basic defect is unknown, treatment today is still directed towards these usually unpredictable secondary consequences.\",\n",
       " '79247': 'Chemotherapy of chronic infections with mucoid Pseudomonas aeruginosa in lower airways of patients with cystic fibrosis.ANTIBIOTICS: tu.  CYSTIC-FIBROSIS: co.  PNEUMONIA: dt. PSEUDOMONAS-INFECTIONS: dt.The bacteriological effect of chemotherapy against Pseudomonas aeruginosa (Ps.ae.) in lungs of patients with cystic fibrosis is reviewed. During a 5-year period 49 children and adults were treated with 190 courses of different antibiotics. The mucoid strains of Ps.ae. disappeared in 72.0% of the courses in which a combination of tobramycin and carbenicillin was employed. Tobramycin given alone had only bacteriological effect in 26.6% of the courses. Colimycin alone or in combination with carbenicillin had no effect. In 18 patients who received subsequent courses of tobramycin and combination of tobramycin and carbenicillin a significant difference in favour of the combination therapy was found, also in cases with many precipitins against Ps.ae. in serum. In 74.5% of the initially successful courses the patients were recolonized with Ps.ae. within 1 month. No nephrotoxic or ototoxic side effects were demonstrated in spite of the high doses of tobramycin (10 mg/kg/24 h) emmployed and the repeated courses.',\n",
       " '79248': 'Proteins in bronchial secretion of children with chronic pulmonary diseases.  I. Relation to clinical diagnosis.BRONCHI: se.  IGA: se.  IGA-SECRETORY.  IGG: se.  LACTOFERRIN: se. LACTOGLOBULINS: se.  MURAMIDASE: se.  RESPIRATORY-TRACT-DISEASES: di.Bronchial secretions from 207 children suffering from various pulmonary diseases and from 15 healthy controls were tested concentration of IgA, IgG, lactoferrin and lysozyme. The results obtained suggest that in many cases of chronic lung diseases in children the levels of lactoferrin and immunoglobulins, especially secretory IgA, are very low. In severe infections (cystic fibrosis, bronchiectases) significant increase of IgG concentration was observed.',\n",
       " '79249': 'Proteins in bronchial secretion of children with chronic pulmonary diseases.  II.  Relation to bronchoscopic and bronchographic examination.BRONCHI: se.  IGA: se.  IGA-SECRETORY.  IGG: se.  LACTOFERRIN: se. LACTOGLOBULINS: se.  MURAMIDASE: se.  RESPIRATORY-TRACT-DISEASES: di.The concentration of immunoglobulins, lactoferrin and lysozyme we compared in bronchial secretions obtained from children with various chronic lung diseases. The IgG, lactoferrin and lysozyme, but not secretory IgA, concentrations were shown to be increased during chronic inflammatory response.',\n",
       " '79250': \"Killing of fibroblasts by dexamethasone or dibutyryl adenosine 3',5'-monophosphate is not a valid test for cystic fibrosis.CYSTIC-FIBROSIS: di.  DEXAMETHASONE: pd.  DIBUTYRYL-CYCLIC-AMP: pd. FIBROBLASTS: de.Assays based on the counting of total cells and of colony-forming cells were used to demonstrate that neither dexamethasone nor dibutyryl adenosine 3',5'-monophosphate (cyclic AMP) kills human fibroblasts under a variety of conditions. These results contradict those of previous studies showing that dexamethasone and dibutyryl cyclic AMP kill a higher percentage of fibroblasts from normal humans than from individuals with cystic fibrosis.\",\n",
       " '79251': 'Premature senescence in cultured skin fibroblasts from subjects with cystic fibrosis.CELL-SURVIVAL.  CYSTIC-FIBROSIS: pa.Cultured skin fibroblasts from subjects with cystic fibrosis exhibited normal population doubling times in early passages. After about 13 cumulative population doublings, cystic fibrosis lines doubled more slowly than controls and ceased doubling after about 19 weekly passages. Control lines continued doubling for 27 passages. The premature senescence noted in cells from subjects with cystic fibrosis reconciles controversial observations of cell doubling reported in the literature. Data presented here demonstrate that experiments with cystic fibrosis cells in late passage may generate misleading results since differences from control lines may be ascribed to generalized senile changes rather than to specific results of the cystic fibrosis genotype.',\n",
       " '79252': 'Cystic fibrosis in adolescents and young adults.CYSTIC-FIBROSIS: di.With the early diagnosis of cystic fibrosis and the better management of these patients in childhood increasing numbers are surviving to adult life. The main problem requiring continuous medical care in the older cystic fibrosis patient is persisting and often progressive chest disease. For this reason the cystic fibrosis clinic for adolescents and young adults was started in the Western Infirmary in 1975. This paper presents our observations on 13 patients who had attended between 1975 and 1977. Eleven patients are alive and well and have shown no evidence of deterioration over this period. Ten are at school or in regular employment. With optimum medical supervision it is possible to give young adults with cystic fibrosis a worthwhile existence.',\n",
       " '79253': 'Implications of cystic fibrosis for health services and the afflicted.CYSTIC-FIBROSIS: px.\"Psychosocial\" literature on cystic fibrosis (CF) is critically reviewed.  Major methodological shortcomings include the anecdotal nature of findings, overemphasis on negative consequences of the disease, and the lack of a suitable theoretical framework.  Avenues for future research are suggested.',\n",
       " '79254': 'Cystic fibrosis: diagnosis, treatment, and prognosis.CYSTIC-FIBROSIS: th.This review is intended to present a brief summary of the important areas and concepts of cystic fibrosis relevant to clinical practice, indicating those that remain controversial and offering opinions based on both relevant literature and the clinical experience of the Cleveland Cystic Fibrosis Center.  The sweat test, tests of pancreatic function, tests of pulmonary function, genetics and family history in diagnosis, infertility as a diagnostic factor, the role of circulating factors in diagnosis, heterozygote detection and prenatal diagnosis, miscellaneous factors leading to diagnosis, neonatal screening, and general observations on the diagnosis of CF are examined.  A philosophy of treatment, physical measures, antimicrobial therapy, aerosol therapy, the role of hospitalization in a therapeutic program, other drug therapy, the treatment of cor pulmonale, respiratory failure, and specific pulmonary complications are discussed.  Enzyme replacement and obstructive phenomena, glucose intolerance, the treatment of the sweat defect, psychosocial therapy, and prognosis are also considered.',\n",
       " '79255': 'Distal splenorenal shunt for decompression of portal hypertension in children with cystic fibrosis.CYSTIC-FIBROSIS: co.  HYPERTENSION-PORTAL: su.  RENAL-VEINS: su. SPLENIC-VEIN: su.Apart from the sound physiologic basis for the distal splenorenal shunt as compared with the portacaval shunt and the conventional central splenorenal shunt, there are two important reasons why we think the use of this type of shunt is especially advantageous in children with portal hypertension secondary to cystic fibrosis. Firstly, the thick, fibrotic retroperitoneal area in the porta hepatis, where a portacaval shunt has to be constructed, can be avoided, which makes the distal splenorenal shunt the easier operation. Secondly, notwithstanding the relatively small-sized vessels, a wide anastomosis can be constructed with a high flow rate and, therefore, a minimal chance of shunt thrombosis.',\n",
       " '79256': 'Cystic fibrosis: review of investigations of the mucociliary inhibitor.BLOOD-PROTEINS: ph.  CYSTIC-FIBROSIS: pp.Recently, we found the cystic fibrosis mucociliary inhibitor in urine from homozygotes and heterozygotes, but not from normals.  In recent studies we have attempted to compare the relative concentrations of CFMI in material from homozygotes and heterozygotes.  The unites of inhibition which reflect the concentration of the CFMI in serum and tissue culture medium fractions from heterozygotes is close to one-half of that in fractions from homozygous sources.  With purification of the CFMI and the generation of a monospecific antibody preparation, answers will become available to the questions of whether or not there is a normal counterpart to the CFMI and whether or not quantitation of the CFMI will be useful in heterozygote detection and prenatal diagnosis of cystic fibrosis.',\n",
       " '79257': '\"Small airways disease\" in children: no test is best.ASTHMA: di.  CYSTIC-FIBROSIS: di.Tests claimed to detect small airway disease were evaluated in children.  Fifty-two subjects who were normal, 30 with cystic fibrosis (CF), and 35 with asthma were selected on the basis of normal spirometry, informed consent being obtained from them and their parents.  Tests undertaken were measurement of maximum expiratory flow volume curves breathing air and a helium-oxygen mixture, single breath nitrogen washout curves, lung volumes, and, except in the normal subjects, measurement of arterial oxygen tension.  Closing volumes were normal in most children with CF and asthma, whereas the slope of the alveolar plateau was abnormal in 83%.  Maximum expiratory flow rate at 50% of total lung capacity was reduced in 65% and maximum mid-expiratory flow rate in 57%; residual volume increased in 51%, and results of other tests were abnormal in less than 50% of the children.  There was evidence suggesting that lung disease was more patchy in children with mild CF than in those with interval phase asthma.  These tests do not detect specific pathological processes in small airways but reflect the consequences of small airway abnormalities, which may vary in the same disease as well as in different diseases.  No one test alone appears most useful.  Together they contribute to understanding the functional abnormalities present in each individual.',\n",
       " '79258': 'Detection of a lectin in the blood of cystic fibrosis homozygotes and heterozygotes.CYSTIC-FIBROSIS: bl.  LECTINS: an.We theorize that cystic fibrosis may be a disease in which a plasma factor with lectin-like activity stimulates mucus secretion, causes precipitation of mucus glycoproteins, and incidentally affects lymphocytes in culture.  To confirm our theory, we planned to search for additional lectin-like activities in CF serum.  Our experiments suggest that the lectin-like substance in CF blood requires IgM for its red-blood-cell-agglutination activity.  Thus, no difference in agglutination titer is observed between CF homozygotes and heterozygotes, because IgM is the limiting factor, and IgM concentrations do not differ appreciably in such subjects.  We suspect that CF homozygotes have a larger pool of free lectin in their blood than do heterozygotes, so that quantitation of this free lectin pool may distinguish between the two phenotypes.  Excess free lectin may account for the signs and symptoms of CF, whereas lesser amounts may theoretically be advantageous to the heterozygote.',\n",
       " '79259': 'Deficiencies of essential fatty acids and vitamin E in cystic fibrosis.CYSTIC-FIBROSIS: pp.  FATTY-ACIDS-ESSENTIAL: df. VITAMIN-E-DEFICIENCY: pp.In 25 children (13 male; 12 female) with cystic fibrosis aged 6 months to 16 years and 24 matched controls total serum vitamin E levels and fatty acid patterns of serum cholesterol esters, phospholipids and triglycerides are demonstrated. Compared to controls (1.02 +/- 0.24 mg/dl) the total serum vitamin E levels are significantly decreased in patients with cystic fibrosis (0.30 +/- 0.26 mg/dl) (p less than 0.01). There is no significant difference comparing the fatty acid patterns of the serum ester fractions of both groups. Differences can be seen best in the cholesterol ester fraction. In this fraction linoleic acid shows a trend to be decreased in the cystic fibrosis patients compared to the control group. A possible influence of height velocity on the levels of essential fatty acids is discussed.'}"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def extract_informations(filename):\n",
    "    data = {}  \n",
    "    id_actual = None  \n",
    "    information = \"\"  \n",
    "\n",
    "    try:\n",
    "        with open(filename, \"r\", encoding='ansi') as file:\n",
    "            for line in file:\n",
    "                if line.startswith(\"PN\"):\n",
    "                    # Se h uma informao anterior, armazena no dicionrio\n",
    "                    if id_actual and information:\n",
    "                        data[id_actual] = information\n",
    "                        information = \"\"  \n",
    "\n",
    "                    id_actual = line.split()[1]  # Obtm o ID a partir da segunda palavra\n",
    "                elif line.startswith((\"TI\", \"MJ\", \"MN\", \"AB\", \"EX\")) and id_actual:\n",
    "                    information += line[3:].strip()\n",
    "                    while True:\n",
    "                        next_line = file.readline()\n",
    "                        if not next_line or re.match(r'\\b[A-Z]{2}\\s', next_line):\n",
    "                            break\n",
    "                        information += \" \" + next_line.strip()\n",
    "\n",
    "            # Adiciona a ltima informao ao dicionrio\n",
    "            if id_actual and information:\n",
    "                data[id_actual] = information\n",
    "\n",
    "    except FileNotFoundError:\n",
    "        print(\"File not founded.\")\n",
    "\n",
    "    return data\n",
    "\n",
    "# Dicionrio para armazenar os data\n",
    "data_complete = {}\n",
    "\n",
    "# Extrai as informaes de cada file\n",
    "for fn in fn_files:\n",
    "    path_file = f\"../data/{fn}\"  \n",
    "    data = extract_informations(path_file)\n",
    "\n",
    "    data_complete.update(data)\n",
    "\n",
    "data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def read_queries(file_path):\n",
    "\n",
    "    qn_list = []\n",
    "    qu_list = []\n",
    "    nr_list = []\n",
    "    rd_list = []\n",
    "\n",
    "    # L o file e processa as lines\n",
    "    with open(file_path, 'r') as file:\n",
    "        for line in file:\n",
    "            if line.startswith('QN'):\n",
    "                qn_list.append(line.split()[1])\n",
    "            elif line.startswith('QU'):\n",
    "                qu_list.append(' '.join(line.split()[1:]))\n",
    "            elif line.startswith('NR'):\n",
    "                nr_list.append(line.split()[1])\n",
    "            elif line.startswith('RD'):\n",
    "                # Separa os valores de RD e os armazena como uma lista\n",
    "                rd_list.append([int(x) for x in line.split()[1:]])\n",
    "\n",
    "    # Cria um dicionrio com as listas\n",
    "    data = {\n",
    "        'QN': qn_list,\n",
    "        'QU': qu_list,\n",
    "        'NR': nr_list,\n",
    "        'RD': rd_list\n",
    "    }\n",
    "\n",
    "    # Cria o DataFrame\n",
    "    df = pd.DataFrame(data)\n",
    "    return df\n",
    "\n",
    "df_queries = read_queries(f'../data/{fn_queries}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>QN</th>\n",
       "      <th>QU</th>\n",
       "      <th>NR</th>\n",
       "      <th>RD</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>00001</td>\n",
       "      <td>What are the effects of calcium on the physica...</td>\n",
       "      <td>00034</td>\n",
       "      <td>[139, 1222, 151, 2211, 166, 1, 311, 1, 370, 10...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>00002</td>\n",
       "      <td>Can one distinguish between the effects of muc...</td>\n",
       "      <td>00007</td>\n",
       "      <td>[169, 1000, 434, 1001, 454, 100, 498, 1000, 49...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>00003</td>\n",
       "      <td>How are salivary glycoproteins from CF patient...</td>\n",
       "      <td>00043</td>\n",
       "      <td>[23, 1000, 40, 10, 139, 2122, 190, 1, 221, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>00004</td>\n",
       "      <td>What is the lipid composition of CF respirator...</td>\n",
       "      <td>00009</td>\n",
       "      <td>[503, 1, 538, 100, 539, 100, 540, 100, 553, 1,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>00005</td>\n",
       "      <td>Is CF mucus abnormal?</td>\n",
       "      <td>00131</td>\n",
       "      <td>[23, 2220, 47, 2221, 50, 1, 60, 1, 114, 11, 13...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>00096</td>\n",
       "      <td>Is there an increased incidence of dental prob...</td>\n",
       "      <td>00012</td>\n",
       "      <td>[9, 1, 40, 1001, 43, 100, 75, 2212, 454, 2222,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>00097</td>\n",
       "      <td>Is oxygen transport by red blood cells abnorma...</td>\n",
       "      <td>00011</td>\n",
       "      <td>[52, 100, 68, 1000, 135, 1, 140, 101, 190, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>00098</td>\n",
       "      <td>What are the effects of CF on the development ...</td>\n",
       "      <td>00015</td>\n",
       "      <td>[145, 2221, 180, 2120, 270, 1, 272, 2210, 362,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>00099</td>\n",
       "      <td>Are there abnormalities of taste in CF patients?</td>\n",
       "      <td>00005</td>\n",
       "      <td>[268, 2222, 324, 2222, 449, 2122, 992, 1220, 1...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>00100</td>\n",
       "      <td>What is the incidence of and treatment for hyp...</td>\n",
       "      <td>00011</td>\n",
       "      <td>[59, 101, 183, 2222, 370, 1211, 579, 2222, 803...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows  4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       QN                                                 QU     NR  \\\n",
       "0   00001  What are the effects of calcium on the physica...  00034   \n",
       "1   00002  Can one distinguish between the effects of muc...  00007   \n",
       "2   00003  How are salivary glycoproteins from CF patient...  00043   \n",
       "3   00004  What is the lipid composition of CF respirator...  00009   \n",
       "4   00005                              Is CF mucus abnormal?  00131   \n",
       "..    ...                                                ...    ...   \n",
       "95  00096  Is there an increased incidence of dental prob...  00012   \n",
       "96  00097  Is oxygen transport by red blood cells abnorma...  00011   \n",
       "97  00098  What are the effects of CF on the development ...  00015   \n",
       "98  00099   Are there abnormalities of taste in CF patients?  00005   \n",
       "99  00100  What is the incidence of and treatment for hyp...  00011   \n",
       "\n",
       "                                                   RD  \n",
       "0   [139, 1222, 151, 2211, 166, 1, 311, 1, 370, 10...  \n",
       "1   [169, 1000, 434, 1001, 454, 100, 498, 1000, 49...  \n",
       "2   [23, 1000, 40, 10, 139, 2122, 190, 1, 221, 1, ...  \n",
       "3   [503, 1, 538, 100, 539, 100, 540, 100, 553, 1,...  \n",
       "4   [23, 2220, 47, 2221, 50, 1, 60, 1, 114, 11, 13...  \n",
       "..                                                ...  \n",
       "95  [9, 1, 40, 1001, 43, 100, 75, 2212, 454, 2222,...  \n",
       "96  [52, 100, 68, 1000, 135, 1, 140, 101, 190, 1, ...  \n",
       "97  [145, 2221, 180, 2120, 270, 1, 272, 2210, 362,...  \n",
       "98  [268, 2222, 324, 2222, 449, 2122, 992, 1220, 1...  \n",
       "99  [59, 101, 183, 2222, 370, 1211, 579, 2222, 803...  \n",
       "\n",
       "[100 rows x 4 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_queries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
